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Abstract 
 
This study was conducted as part of a large consortium (FP7 project – ENPRA) to investigate 
the potential hazard of a wide range of nanomaterials (one Ag, two ZnO, two MWCNTs and 
five TiO2) on the liver and the kidneys for the purpose of risk assessment. 
 
The in vitro C3A hepatocyte model demonstrated that Ag and ZnO NMs were consistently 
more potent with respect to cytotoxicity and cytokine production. In comparison the 
MWCNT and TiO2 nanomaterials investigated revealed relatively lower toxicity. The 
cytotoxicity of ZnO may be related to its solubility, but this is less likely for the Ag NMs. 
Urea and albumin production were measured as indicators of hepatic function. These markers 
were only altered by the coated and uncoated ZnO, which significantly decreased albumin 
production. The C3A model also showed that the NM which induced a low cytotoxicity 
(TiO2 and MWCNTs) generated intracellular ROS, induced oxidative stress (GSH depletion) 
and that an oxidative mechanism was involved in both the induction of IL8 protein 
production and genotoxicity.  
 
The C3A cells were demonstrated to be a very good model to investigate nanomaterial 
induced effects on hepatocytes when compared to primary human hepatocytes. The results 
also suggested that biotransformation enzymes in hepatocytes are not important in terms of 
determining nanotoxicology.  
 
In vivo mice models demonstrated that the instilled Ag, ZnO and positively charged TiO2 
result in distal effects on the liver in the form of oxidative stress. While all NMs with the 
exception of the two MWCNTs instilled via the lungs caused changes in gene expression in 
the liver in varying degrees.  
 
The intravenous exposure of mice to the NMs resulted in a neutrophil influx into the liver. 
These leukocytes play an important in the initiation of the immune response to the NMs. 
However the NMs were not sufficient to cause any long term neutrophil mediated 
inflammation or damage to the liver tissue. Any changes that were observed after 24 hr post 
exposure in terms of leukocyte infiltration into the tissue, antioxidants status and changes in 
gene expression related to inflammation, oxidative stress and apoptosis had resolved 72 hr 
post exposure. 
 
 
Next, we show that Kupffer cells are very important in the liver immune response to the NMs 
with a significant change in the cytokine profile following the enrichment of the macrophage 
population. 
 
Finally, investigations using the HK-2 renal model demonstrated that ZnO and Ag NMs were 
consistently more potent with respect to cytotoxicity, cytokine production (IL6 and IL8) and 
intracellular reactive oxygen species production. These results were consistent with those 
observed in the hepatocyte models.  We noted that short term sub-lethal exposure to the Ag 
and two of the TiO2 NMs (positively charged and the 94 nm TiO2) resulted in most evident 
DNA damage.  
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Chapter One 
Nanomaterials, nanotoxicology and nanotechnology 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 
 
1.1 Risk assessment of engineered nanoparticles (ENPRA) project 
 
The aim of this study was to evaluate the toxicity of a panel of engineered nanomaterials 
(NMs) on the liver and the kidneys, conducted as part of the European Commission funded 
project ENPRA (Engineered Nanoparticle Risk Assessment). Overall, the project was 
concerned with revealing the risks associated with exposure to a panel of engineered NMs. 
Therefore a number of nano scale materials (EU commission recommendation) were utilised 
in this project including a variety of titanium oxide (TiO2), zinc oxide (ZnO), silver (Ag) and 
multi-walled carbon nanotubes (MWCNT). These NMs were chosen as they are all mass 
produced and have applications in a diverse range of products and industries and might 
therefore possess a real risk to workers and the consumers.  
 
The project co-ordination and management of all twenty one partners as well as all European 
and US collaborations was led by the Institute of Occupational Medicine (IOM). The 
extensive characterisation of the material panel was carried out principally by the OECD 
(Organisation for Economic Co-operation and Development) and the JRC (Joint Research 
Centre). The dose response toxicity of the different NMs (aiming to pin point the threshold 
dose) on areas of interest, in particular pulmonary (Edinburgh University, Universite 
Catholique de Louvain, Katholieke Universiteit Leuven and Helmholtz Zentrum Munchen – 
German centre for Environmental Health), cardiovascular (Katholieke Universiteit Leuven, 
University of Copenhagen), hepatic (Edinburgh Heriot Watt University, Institut fur 
umweltmedizinische Forschung), renal (Edinburgh Heriot Watt University, Universite Paris 
Diderot, Institut fur umweltmedizinische Forschung) and developmental (Vrije Universiteit 
Brussels, Rijksinstituut voor Volksgezondheid en Milieu) were investigated in detail in vitro 
and in vivo by the different partners. Furthermore, different end points such as oxidative 
stress, inflammation, genotoxicity and fibrogenicity were also examined at sub-lethal 
concentrations as a means of determining the mechanism of action of the toxicity of the NMs 
on the cells. From the gathered data the IOM will implement a risk assessment model for the 
investigated engineered NMs. This will be followed by the execution of a risk management 
strategy by the JRC – consumer product safety and quality unit. 
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1.2 Nanotechnology 
 
The extremely rapid expansion of technological, scientific and commercial use of atomic or 
molecular scale materials, their assembly and their unique properties, has led to an escalating 
interest in the fields of nanoscience and nanotechnology (Maynard, 2007; Sandhiya, et al., 
2009). Twenty years ago little was known about the technology outside a very small 
specialist circle. Fast forward to 2012 and over 1300 consumer products on the market claim 
to contain elements of nanotechnology with these numbers increasing on a daily basis 
(Woodrow Wilson, 2012). It is estimated that worldwide sales of nano-scale products will 
bypass 3 trillion US dollars by 2014 (Sandhiya, et al., 2009).  
 
The prefix “nano” derived from the Greek nanos signifying dwarf - was specifically coined 
for particles containing tens or hundreds of atoms, with dimensions at the scale of less than 
100 nm (Buzea, et al., 2007). It is this small size which is fundamental to the field of 
nanotechnology, although other particle parameters also determine their physical, biological 
and toxicological properties (Jones, et al., 2009). Nano has become a popular label for much 
of modern science. The nanometre is a metric unit of length, and denotes one billionth of a 
meter (10
-9
 m). To put the minuscule size of these materials into some perspective, a red 
blood cell is roughly 7,000 nm in diameter while a resting macrophage in tissue is 20,000 nm 
(Matsumoto, et al., 2010).   
 
The foremost reason for producing and exploiting NMs is that they are fundamentally 
different from the bulk form of the same compound (Edwards-Jones, 2009). In theory this 
means that previously unexploited beneficial properties of a given material can be explored in 
its nano size range (Edwards-Jones, 2009). As a result the amount of interest in 
nanotechnology has risen exponentially across many fields aiming to exploit a wealth of 
opportunities. These applications include medicine, cosmetics, textiles, electronics and 
engineering (Tetley, 2007). Paradoxically, however, there is concern that the increased 
release of engineered NMs could be potentially hazardous for people living and working with 
these materials due to the radical alterations in their chemical and physical properties (Hoet, 
et al., 2004).  
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1.3 Sources of NMs 
 
Nanostructured materials did not come into existence with the recent emergence of the field 
of nanotechnology. Nanominerals are widely distributed throughout the atmosphere, oceans, 
surface and underground waters, soils and in most living organisms - even within proteins 
and viruses (Yang, et al., 2012). Nanoparticles play an important role in the lives of ocean-
dwelling phytoplankton which remove carbon dioxide from the atmosphere. Phytoplankton 
growth is limited by iron availability. In the ocean the iron source is composed of 
nanocolloids and mineral nanoparticles supplied by rivers, glaciers and deposition from the 
atmosphere (Riech, et al., 2006). On land, nm-scale hematite (iron oxide) catalyzes the 
oxidation of manganese, resulting in the rapid formation of minerals that absorb heavy metals 
in water and soils. The rate of this oxidative reaction is increased when NMs are present 
(Riech, et al., 2006). Furthermore, NMs such as fullerenes occur naturally from combustion 
processes such as forest fires and volcanoes (Oberdorster, et al., 2005). Naturally occurring 
processes generating nano-sized structures in liquid phase include erosion and chemical 
disintegration of organic (plant or microorganism debris) or geological (e.g. clays) parent 
materials (Boyle, et al., 2005). Thus nanomaterials are not new. Yet it is only with the recent 
advances in the manufacture of sophisticated synthesis and characterisation tools that the 
manipulation of matter near atomic scale has become possible and the study and industrial 
use of nano-sized materials has become a reality.  
 
Humans have been exposed to airborne NMs throughout their evolution. However this 
exposure has increased dramatically in the last century due to the introduction of 
anthropogenic materials (derived from human activity) due to the industrial revolution 
(Oberdorster, et al., 2005). The principal source of these unintentional anthropogenic NMs 
are internal combustion engines, power plants, jet engines, metal and polymer fumes, heating, 
cooking (frying, grilling) and electric motors (Nel, et al., 2006). The most widely debated and 
studied source of unintentional NMs are the ultrafine air pollution particulates mainly focused 
in urban surroundings and generally produced from combustion processes and as industrial 
by-products such as carbon black (Donaldson, et al., 2002). There have been numerous 
studies on the adverse health effects in susceptible groups associated with exposure to these 
environmental NMs (Donaldson, et al, 2002; Gilmour, et al., 2004). These individuals have 
suffered from complications such as chronic obstructive pulmonary disease (COPD), asthma 
and cardiovascular problems in part at least due to exposure to these air particulates.  
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In addition to direct release into the atmosphere, engineered NMs enter the environment by 
three main sources. Firstly, some nanomaterials are produced in mass quantities and 
undoubtedly released into the atmosphere at some point during the manufacturing process 
(Oberdorster, et al., 2005). Secondly, NMs in personal products such as cosmetics are 
continually washed off (Nel, et al., 2006). Finally, the use of NMs in products such as fuel 
cells and aerosols may leak into the atmosphere (Oberdorster, et al., 2005).    
 
Engineered NMs are deliberately and specifically produced and labelled according to their 
shape (e.g. nanotubes or nanowires). Currently there are two widely used methods of 
generating nanomaterials. The top-down method is the refinement of a starting bulk material 
into nano-scale dimensions using mechanical or chemical energy. An opposite approach, 
termed bottom-up, is to synthesise the NM from atomic or molecular species via chemical 
reactions (e.g. sol-gel processing, chemical vapour deposition (CVD), plasma or flame 
spraying synthesis, laser pyrolysis, atomic or molecular condensation) allowing for the 
precursor particles to grow in size. The formation and growth of the NMs is controlled either 
by exhaustion of one of the reactants or on the introduction of the chemical that would block 
the reaction, or physical restriction of the volume available for the growth of the individual 
nanoparticles by using templates (Gutsch, et al., 2005). Both approaches can incorporate the 
use of gas, liquid, supercritical fluids, solid states or in vacuum (Gutsch, et al., 2005). 
 
Metal NMs are principally produced by gas-phase condensation using a vacuum chamber that 
consists of a heating element. The process utilises a gas, which is typically inert, at pressures 
high enough to promote particle formation but low enough to allow the production of 
spherical materials. The metal is then taken to temperatures far above the melting point, but 
less than the boiling point, so that an adequate vapour pressure is achieved. Gas is 
continuously introduced into the chamber and removed by pumps. This gas flow removes the 
evaporated metal away from the hot element. As the gas cools metal vapour, nano-sized 
particles form. These particles are liquid since they are still too hot to be solid. The liquid 
particles collide in a controlled environment so that they grow to specification. As the liquid 
particles are further cooled under control, they become solid and no longer grow (Gutsch, et 
al., 2005). Generally human exposure to these NMs can be described as intentional as they 
are deliberately produced for a specific purpose so it is crucial to establish any potential 
hazardous side effects these particulates may possess.  
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1.4 Everyday exploitation of NMs 
 
Currently, there is intensive developmental work across many industries that utilise nanoscale 
materials and their assembly. The levels of interest in nanotechnology has risen to such an 
extent that commercialisation of NMs are often government supported in a large number of 
countries including the USA, UK, Japan, Korea, Taiwan, Singapore, Australia, China and 
Malaysia (Lines, 2008).  
 
One of the most prominent areas of research and interest in NM exploitation is the field of 
nanomedicine as a means of accurate, early diagnosis and effective treatment of disease with 
fewer side effects. The use of nanomaterials has been extremely successful as a means of non 
invasive early diagnostic imaging. Nanotechnology enabled molecular imaging techniques 
including optical, nuclear, ultrasound, computed tomography (CT) and magnetic resonance 
imaging (MRI) have become extremely successful (Caruthers, et al., 2007).  
 
Early diagnosis is ineffectual without effective therapy; therefore large investments have 
been made to apply nanotechnology to the treatment of disease. One example of current NM 
use is the dermatological application of liposomal drugs (i.e. hydrocortisone) (Banerjee, 
2001). Advances in the field of nanomedicine have allowed for the packaging of liposomal 
chemotherapeutic agents. The surface attachment of polyethylene glycol is used to increase 
the circulating half life of the liposome. The technique is widely employed against leukaemia 
and neutropenia (i.e. Abraxane a nano-sized version of Paclitaxel is more effective than the 
previously administered formulation) (Wagner, et al., 2006).  
 
One of the most important up-to-date manipulations of nanotherapeutics is the development 
of particles that can deliver specific therapy (chemical, genetic or radioactive) while 
remaining undetected by the immune system as well as having negligible side effects on 
healthy tissue (Caruthers, et al., 2007). In addition, these strategies allow materials to be 
tracked non-invasively to provide predicted efficacy and greatly improve the outcome of the 
treatment. One idea that has much popularity is the use of light absorbing nanomaterials (i.e. 
non toxic gold) for cancer treatment. The concept is based on the exposure of a region of 
tissue to a pulse laser with a wavelength for which the diseased cells have a greater 
absorption rate than the healthy tissue. At the appropriate wavelength, exposure of the NMs 
to the laser can trigger a photothermal effect in the particle whereby electronic oscillations at 
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the surface are converted to heat, which raises the particulate temperature killing the cancer 
cells (Avedisian, et al., 2009).  
 
Nanomaterials - such as carbon nanotubes (CNTs) - are widely used in the shielding and 
absorbance of electromagnetic radiation, thermal conductivity and hydrogen storage. 
Furthermore, CNTs have excellent thermal, electrical and mechanical properties so they are 
often found as semiconductor tags for numerous bio-assays (Lines, 2008). NMs are also 
incorporated in the textile industry. For years nylon and polypropylene products have been 
integrated within nanomaterials due to their long term anti-microbial characteristics - even 
after extensive thermal cycling (Benn, et al., 2008). Nano-scale zinc and copper oxide can be 
readily incorporated into the synthetic fibres prior to the spinning process with virtually no 
effect on the colour, clarity, gloss or the physical properties of the material (Lines, 2008). 
Applications include clothing, healthcare facilities and institutions, water filters and home 
furnishings. This anti-microbial activity can also be imparted to food processing and food 
services as well as general paints and coatings. Other NMs are used in a wide range of 
electronics such as storage media, flat panel displays, vacuum microelectronics, field 
emission cathodes and photonic band gap materials and devices (Mazzola, 2003). The use of 
nano-sized materials as a source of fuel has gathered in popularity and importance especially 
with the continuous escalation in prices of traditional fuels. There has been much interest in 
the use of metal oxide NMs as low temperature electrolytes in solid oxide fuel cells 
(Wildgoose, et al., 2005).    
 
Modern cosmetics often contain nano-sized components, such as nano emulsions, 
nanosomes, nanocapsules, niosomes or liposomes which are microscopic vesicles consisting 
of traditional cosmetic materials (Nohynek, et al., 2008). One of the largest applications of 
insoluble NM is their use in sunscreen products. The global production of nanomaterials for 
sunscreen products was estimated to be over 1,000 tonnes during 2003/2004 and is on a 
yearly increase (Nohynek, et al., 2008; Teow, et al., 2011). Titanium dioxide (TiO2) and zinc 
oxide (ZnO) are principally utilised in these products (Nohynek, et al., 2008). 
 
As demonstrated, NMs are increasingly used in a wide variety of industries, with this trend 
set to further increase in the next few decades (Mamalis, 2007). However, successful 
exploitation of nanomaterials will require risk evaluation which would allow an improved 
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understanding of the implication of exposure to NMs because any human or environmental 
hazard would severely slow down this rapidly expanding field (Maynard, 2007). 
 
1.5 Risk assessment of NM exposure to human health 
 
NMs can be produced from most chemicals, however many of the materials currently in 
industrial use are manufactured transition metals, carbon, silicon and metal oxides (Dreher, et 
al., 2004). As the field of nanotechnology develops, the potential for public and occupational 
exposure will also increase. Therefore, there is an urgent necessity to consider the possibility 
of any detrimental health corollaries with this sudden increase and exposure to nanomaterials. 
This is achieved in the form of a critical risk assessment (Papp, et al., 2008). Simply put, the 
risk is assessed based upon the level of exposure to the manufactured NM, toxicology of the 
material in question, route of exposure and its bio-persistence. Hence, it is necessary to 
identify the hazards associated with NM exposure both in vitro and in vivo, consequently 
assembling a knowledge base on the perils associated with NM exploitation on human health 
(Hoet, et al., 2004).  
 
In order for any nanomaterial to be considered a potential hazard to human health it must first 
be biologically available. In other words exposure must occur and the NM must be available 
in sufficient quantities to exert toxic effects on the host. Consequently, the extent of exposure 
and the potential hazard will vary within different occupational groups (healthy vs. immune 
compromised or genetic disorder), surroundings (good ventilation, filtration, respirators and 
appropriate protection masks and gloves vs. poor ventilation and working conditions) and 
consumers (amount of day to day NM exposure) (Maynard, et al., 2007). Secondly, the 
material in question whether in powder, aerosol, liquid or aggregate form should have the 
potential to initiate a response not associated with the same chemical in bulk form (Maynard, 
et al., 2007). At this point it is important to note that NMs are often bound within materials or 
coated with various proteins and are rarely available in a ‘free form’. However as part of a 
risk assessment it is important to strategise for NM release into the atmosphere and the 
environment (Papp, et al., 2008). Release of silver NMs from anti-microbial socks into the 
environment following consequential washes is an example of this (Benn, et al., 2008).   
 
With conventional risk assessment paradigms the potential hazard can be evaluated via 
toxicity and health outcomes (dose and route). However with engineered NMs a third 
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component needs to be considered - namely the characterisation of the material (Hoet, et al., 
2004; Maynard, 2007). It has been suggested that for any comprehensive toxicity testing of a 
given NM, physiochemical parameters such as surface area, surface chemistry, size 
distribution and material charge have to be thoroughly characterised (Oberdorster, et al., 
2005). It is important to note that understanding the hazard and establishing the dose and 
route of exposure will only allow for quantification of engineered NM risk. Controlling 
exposure and reducing the potential risk is fully dependent on safe workplaces and products. 
 
1.6 Physicochemical characteristics of NMs 
 
All NMs have the commonality of their very small size, however there are numbers of 
physicochemical variables that have a significant influence on the nanomaterial properties 
and toxicity. These include variations in their dimensionality, morphology, chemical 
composition, surface structure, charge, surface coating, solubility and agglomeration (Nel, et 
al., 2006; Tsuji, et al., 2006). For any toxicity study it is essential to try to understand the 
impact of these characteristics. 
 
1.6.1 Importance of NM size  
 
Nanomaterials have a very large surface area and high particle number per unit mass 
compared to the bulk form of the same compound. For example, one carbon particle with a 
diameter of 60 µm has a mass of 0.3 µg and a surface area of 0.01 mm
2
. The same mass of 
carbon in nanoparticulate form, where each particle has a diameter of 60 nm, has a surface 
area of 11.3 mm
2
 and consists of 1×10
9
 nanoparticles. The ratio of surface area to volume or 
mass for a particle with a diameter of 60 nm is 1000 times greater than a particle with a 
diameter of 60 µm (Buzea, et al., 2007). As the material in the nano-scale form presents a 
much larger surface area for chemical reactions, reactivity is enhanced roughly 1000 fold 
(Roduner, 2006). As chemical reactivity generally increases with decreasing material size, 
surface coatings and other modifications can have complicating effects, even reducing 
reactivity with decreasing size in some instances (Roduner, 2006). The atoms situated on the 
surface of a NM have less neighbours than bulk atoms, resulting in lower binding energy per 
atom with decreasing size (Roduner, 2006). A consequence of reduced binding energy per 
atom is a melting point reduction with particle radius (Roduner, 2006). One such example is 
the melting temperature of 3 nm gold NMs, which is more than 300 degrees lower than the 
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melting temperature of bulk gold (Roduner, 2006). This size related unique physicochemical 
characteristic might be extremely beneficial as a source of new applications and products, 
however it has been shown that this property also accounts for size dependent toxicity i.e. as 
size decreases toxicity increases (Johnston, et al., 2010). In other words engineered NMs may 
partly behave like new chemical substances.  
 
1.6.2 Importance of NM shape and structure 
 
The first important distinction of NMs is that they are either in the form of thin films or fixed 
nano-scale objects or unconstrained particles (Jones, et al., 2009). The morphology of a 
nanoparticle plays a crucial role in their classification, property and toxicity. In general NMs 
can be classified based on their number of dimensions. Nanoparticles with one dimension are 
typically engineered as a monolayer in the form of thin films or surface coatings (computer 
chips or hard coatings on eye wear) (Huang, et al., 2009). Two dimensional NMs include 
nano-scale structures which are mostly films with nanostructures firmly attached to a 
substrate or nano filters used for particle separation and filtration. Carbon nanotubes are an 
example of a material which can be nano-scale in two dimensions (Buzea, et al., 2007). 3D 
materials are nano-scaled in all three dimensions and include colloids and free nanoparticles 
with various morphologies.  
 
High aspect ratio nanomaterials (HARN – any nanomaterial that has one dimension out with 
the nano scale) include: nanowires, nanohelices, nanopillars, nanotubes and nanobelts. Low 
aspect ratio NMs include spherical, helical, oval, cubic, pillar and prism shaped particles 
(Aitkin, et al., 2006; Buzea, et al., 2007) (Figure 1.1). The effects of the shape of NMs with 
regards to their toxicity is not fully understood, however the shape might affect the deposition 
and absorption in the body (Oberdorster, et al., 2005).  
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Figure 1.1. Different forms of some a) high and b) low-aspect ratio NMs. (Image adapted from Buzea, et al., 
2007). 
 
1.6.3 Importance of nanomaterial composition 
 
Any NM can be composed of a single constituent material or be a composite of two or more 
materials. For the purposes of characterisation, nanomaterials are often categorised as carbon 
based, organic and inorganic polymers as well as metal and metal oxide compounds or 
composites (Grill, et al., 2009). The engineered NM composites currently include coated, 
encapsulated and mixed structures (Grill, et al., 2009). The biological effects and toxicity of 
these materials will vary drastically depending on the surface chemistry, impurities and the 
particular reactive groups on the surface of the NM (Oberdorster, et al., 2005).  
 
1.6.4 Importance of NM uniformity and agglomeration  
 
NMs can exist as dispersed aerosols, suspensions/colloids or in an agglomerate state based on 
their chemistry and electromagnetic properties (Handy, et al., 2008). In colloid chemistry, 
particles may remain dispersed or alternatively aggregate which may remove the material 
from the liquid phase. In practise, even apparently stable dispersions will gradually 
agglomerate out of the aqueous phase over time (Buzea, et al., 2007). The rate of 
agglomeration of NMs in an aqueous medium will partly depend on particle – particle 
collision frequency and the attractive - repulsive properties of the materials involved (i.e. 
surface charges on two positively charged materials) (Handy, et al., 2008). After the initial 
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collision, particles may remain as single particles, or form particle – particle, particle – 
cluster or cluster – cluster agglomerates. The agglomeration phenomena, has many 
implications, such as the attachment of materials to the walls of experimental equipment 
(glassware, scientific instruments) (Handy, et al., 2008). There are also toxicological 
implications regarding the fate and behaviour of the materials, and the types of ecosystems 
and organisms exposed. In an agglomerated state, NMs may behave as one larger particle, 
hence losing the chemical and toxicological characteristics associated with nanomaterials. 
Any attempt to prevent aggregation or agglomeration of NMs will alter body distribution and 
drastically affect the toxicity in the examined biological systems (Oberdorster, et al., 2005). 
Therefore the existence of free mono-dispersed NMs is extremely important for any in vitro 
toxicity test. This being said, it is important to consider the tendency of nanomaterials to 
agglomerate, as any natural human exposure may and in probability does not involve 
individual particulates but instead much larger agglomerates would be incorporated (Hirano, 
2009). To this end, any prior knowledge into the physiological properties of the material and 
mechanism of human encounter will be extremely advantageous for the inauguration of all 
experiments and analysis of the results (Hirano, 2009; Jones, et al., 2009).  
 
1.6.5 Importance of NM charge on behaviour and toxicity  
 
The surface charge of a nanomaterial is principally imposed by its composition and surface 
attachments. This charge can be positive, negative or neutral. The charge of the NM plays a 
crucial role in its agglomeration state (Handy, et al., 2008; Nafee, et al., 2009). The 
weakening of the electrostatic repulsive forces (zeta potential falling below 30 mV) is usually 
associated with originally well dispersed particles coming together (Lakshminarasimhan, et 
al., 2008). However it is now understood that the charge also influences the toxicity of the 
NM. Recent studies have demonstrated that cationic nanomaterials induce certain cell 
damage through their interaction with anionic components of the glycoproteins on the surface 
of epithelial cells (Fischer, et al., 2003). Furthermore surface charge of a nanomaterial may 
influence its uptake and its eventual location within a cell (Yue, et al., 2011).  
 
1.7 Nanotoxicology – a brief historical review 
 
The rapid expansion of nanotechnology is a very profitable industry and promises to have 
great benefits for mankind. However there is growing concern about the effects of engineered 
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NMs on the environment and potential toxicity to workers and consumers of these nano 
products. To ease these concerns and fears, regulatory, industrial and funding agencies have 
been financing projects to evaluate the toxicological profiles of mass produced engineered 
NMs (Oberdorster, et al., 2007).  
 
The roots of nanomaterial toxicity can be traced back to the early 1990s where the current 
paradigm of nanotoxicology was being formed with greater understanding of the toxicity of 
metal fumes, dust, silica, asbestos and other synthetic fibres and more recently air pollution 
particles such as PM10 (extremely small sub-divisions of solid or liquid matter suspended in a 
gas or liquid smaller than 2.5 μm) (Oberdorster, et al., 2007). The understanding that 
materials in the nano-scale have their unique biological properties was the turning point in the 
field of nanotoxicology. In the early 20
th
 century numerous studies investigated the exposure 
to NMs without the realisation of the importance of ultrafine particles (Oberdorster, et al., 
2007). The first study to bring into focus the importance of anthropogenic NMs was in the 
1970s where combustion engine emissions were characterised (Whitby, et al., 1975). An 
important milestone in the history of nanotoxicology was the discovery that NMs are taken 
up by cells and are capable of translocation to other tissues and organs from the sites of 
exposure (Oberdorster, et al., 2007). This was significant as this ability is unique to ultrafine 
particles; (30 nm intratracheally instilled gold particles were observed to cross the alveolar-
capillary barrier and accumulated in platelets (Berry, et al., 1977)). This was followed by 
revolutionary experiments by a German group demonstrating the deposition of inhaled 
particles in the lower respiratory tracts in humans (Heyder, et al., 1986). This and subsequent 
deposition studies confirmed the realization that NMs have unique toxicological properties 
(Oberdorster, et al., 2007).  
 
The first direct in vivo comparison of nano and micro particles was carried out in 1990 with 
TiO2 (Ferrin, et al., 1990) and Al2O3 particles (Oberdorster, et al., 1990). These studies 
showed significantly higher levels of pulmonary inflammation and interstitial translocation 
associated with nano sized materials. In 1992 an important paper was published concluding 
the increased toxicity associated with NMs is due to their large surface area and their ability 
to translocate. In other words, same mass dose exposure of these compounds might not 
exhibit any toxicity in micro or bulk form (Ferrin, et al., 1992). In 1998, a pulmonary toxicity 
study of fine and ultrafine nanoparticles demonstrated that in addition to size other 
characteristics such as surface area and chemistry are also extremely important in particle 
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toxicology (Donaldson, et al., 1998). It is now widely accepted that for any comprehensive 
toxicological study all aspects of NM physicochemical properties must be investigated 
(Oberdorster, et al., 2007). 
 
The first comprehensive step in establishing oxidative stress as a possible mechanism for 
small material pathogenesis was a 1980s asbestos study (asbestos has size and shape 
similarities to carbon nanotubes). The team demonstrated that asbestos was responsible for 
cell damage and subsequent pathogenesis. The same group later showed that antioxidants 
such as glutathione reduce asbestos pathogenicity (Mossman, et al., 1983; 1986). Other 
mainstream studies at this time were linking particle induced oxidative stress and 
inflammation (Janssen, et al., 1993). Furthermore, trials into the adverse effects of harmful 
particulates, in particular PM10 and better understanding of stress responsive pro-
inflammatory transcription factors resulted in the generalisation of the oxidative stress 
hypothesis to nanomaterials (Oberdorster, et al., 2007). The next important milestone in the 
history of nanotoxicology was the realisation that some NMs are capable of acting as haptens 
and induce an antibody mediated immune response (e.g. recognised and processed fullerenes 
as protein conjugates) (Chen, et al., 1998).  
 
One of the important concepts of nanotoxicology in the early 21
st
 century was the idea that 
the physicochemical properties of different NMs influence the adsorption of certain proteins 
or lipids from different body compartments, hence governing the subsequent destination of 
the particle in the body (Muller, et al., 2004).  
 
Although there have been huge leaps forward in terms of the current understanding into the 
toxicity of NMs, there are major knowledge gaps yet to be filled. One important factor that 
has to be considered for any future experimentation is that any toxicological information on 
nanomaterials must be considered at relevant human exposure levels. Any material 
irrespective of size would have detrimental effects at high enough doses (Oberdorster, et al., 
2007). For any in vivo or in vitro toxicity study to have any real relevance, doses must be low 
enough to anticipate for possible human exposure.  
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1.8 Routes of NM exposure 
 
Biological systems usually integrate multiple pathways of toxicity into a limited number of 
pathological outcomes including: inflammation, apoptosis, necrosis, fibrosis, metaplasia and 
carcinogenesis (Nel, et al., 2006). With the ever increasing sources of NMs, we are 
constantly bombarded with materials of all shapes and sizes. It is widely accepted that the 
skin, lungs and the gastrointestinal tract (GT) are in constant contact with the external 
environment, so it is not surprising to find all three systems being primary exposure sites for 
NMs (Yokel, et al., 2011) (Figure 1.2). However, as has been previously discussed, most 
materials are able to translocate to secondary target organs located at a distance from the 
original point of entry (Figure 1.2).   
 
 
Figure 1.2. Routes of exposure and potential destiny of the NM dependant on its physicochemical properties 
and protein exposure. (Adapted from Yokel, et al., 2011). 
 
 
 
 
 
 
16 
 
1.8.1 NMs and the skin 
 
Although in general nanomaterial toxicity is associated with inhalation, there is an ever 
increasing concern of subsequent translocation to secondary target organs following dermal 
exposure (Hoet, et al., 2004). It has been suggested that certain NMs are able to penetrate the 
skin and are distributed throughout the body via the circulatory system (Oberdorster, et al., 
2005). Nanomaterial based products are commonly used in a wide range of cosmetic products 
including conditioners, sunscreens and lotions. These emulsions combine traditionally 
utilised materials emulsified in water and oils in the nano-scale. This alteration in size renders 
the products transparent and much more pleasant to the touch (Nohynek, et al., 2008). The 
use of titanium dioxide and zinc oxide NMs has drastically improved the transparency of 
sunscreen products, hence there has been a noticeable improvement in the protection of skin 
against UV damage (WHO – accessed July 2012). Furthermore the development of liposome 
vesicles has been extremely beneficial to the cosmetic industry as they have been proven to 
improve skin stability and tolerance to ingredients such as vitamins and antioxidants 
(Nohynek, et al., 2008). In addition to cosmetic products, airborne NMs are also capable of 
coming in contact with the skin. 
 
The first point to be addressed regarding NM toxicity and the skin, is the organs structural 
integrity. The skin is composed of several layers including the stratum corneum, stratum 
spinosum and stratum basale which form a tight protective layer for the underlying dermis 
and the subcutaneous layer making the organ fairly impermeable. A study using a series of 
substances has demonstrated that human skin is relatively impermeable compared to the skin 
of the rat (magnitude of 11 fold) (Ravenzwaay, et al., 2004). Subsequent studies utilising 
TiO2 have shown that both micro and nano-scale materials remain on the skin surface and do 
not penetrate through the layers (Crosera, et al., 2009).  
 
It is important to state that compromised skin (dermal abrasion, cuts, eczema or severe 
sunburn) may have a greater susceptibility to penetration of NMs, as illustrated by an 
American group showing deeper penetration of quantum dots in damaged skin (Zhang, et al, 
2008). However, it has been argued that skin inflammation produces a significant thickening 
of the epidermis layer hence enhancing the barrier properties of the skin (Nohynek, et al., 
2008). Overall, the current weight of evidence suggest that nanomaterials are unable to 
penetrate the human skin, hence there is little chance of toxicity from exposure to cosmetic 
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products and very little chance of translocation of these NMs to secondary organs (Crosera, et 
al., 2009).  
 
1.8.2 Inhalation of nanomaterials 
 
Inhaled NMs deposit in different sites of the respiratory tract by diffusion. The method by 
which they are transported through the lung is predominately influenced by endocytosis, 
phagocytosis or transcytosis across epithelial and endothelial cells (Papp, et al., 2008). This 
in turn might result in the NMs being released into the blood and being transported to a 
varied range of secondary target organs including the liver, kidneys, lymph nodes, spleen, 
heart, and even the brain (most likely via the olfactory nervous system) (Mailander, et al., 
2009; Sadauskas, et al., 2009b). As previously mentioned the surface properties of each 
individual nanomaterial are extremely important in their interaction with the pulmonary and 
immune cells and possibly their final destination (Mailander, et al., 2009).  
 
Any pathogenic effects of inhaled NMs are dependent on a substantial lung burden which is 
determined by rates of deposition and clearance (clearance in turn is influenced by material 
size and surface properties) (Muhlfeld, et al., 2008). It is understood that nanomaterials 
deposit throughout the lung, penetrating as deep as the alveolar regions (Hoet, et al., 2004). 
The upper pathways of the lung are predominately cleared by mucociliary transport, while 
alveolar clearance is mediated by pulmonary macrophages (Muhlfeld, et al., 2008). The 
phagocyte influenced clearance of NMs is associated with release of pro-inflammatory 
cytokines, reactive oxygen species and a host of other mediators and chemokines. This mode 
of toxic impact or pathogenicity is usually associated with cases in which the deposition rate 
of NMs exceeds the clearance rate (Hoet, et al., 2004). Furthermore numerous studies have 
demonstrated that the deposition of solid NMs - such as single walled carbon nanotubes in 
experimentally large doses - resulted in granuloma formation in the lung (Lam, et al., 2003; 
Poland, et al., 2008). Currently, it is assumed that in the majority of instances, inhaled NMs 
are cleared from the lung and do not cause toxic effects on the organ, as long as the clearance 
mechanism is unaffected by the nanomaterial characteristics or the exposure is not in large 
enough doses to hamper the clearance mechanism (this is associated with toxicity and 
pathogenesis) (Hoet, et al., 2004).  
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1.8.3 Nanomaterials and the intestinal tract 
 
Ingestion of NMs can occur directly from food, water or orally administered medicines. It is 
believed that the vast majority of ingested nanomaterials are rapidly passed through the 
gastrointestinal tract and lost via the faeces (Papp, et al., 2008). However, a minor fraction of 
NMs are translocated from the lumen of the intestinal tract, perhaps via Peyer’s patches 
containing M cells and normal intestinal enterocytes (Yamanaka, et al., 2008). Once again 
surface properties of nanomaterials play an important role in their translocation from the 
intestinal tract. It has been suggested that charged materials exhibit poor bio-availability due 
to electrostatic repulsion and mucus entrapment (Hoet, et al., 2004). Once in sub-mucosal 
tissue, NMs are capable of entering both the lymphatics and the blood capillaries. In a 1990 
study mice were fed polystyrene spheres ranging from 50 nm to 3 microns for a period of ten 
days. It was found that as much as 26% of the 100 nm materials were detectable in the blood 
(Jani, et al., 1990). 
 
There is conflicting data on the mechanisms of the toxicity of NMs in the gastrointestinal 
tract. However, it has been suggested that the disruption of the epithelial barrier function by 
apoptosis of the enterocytes is a possible mechanism for mucosal inflammation (Hoet, et al., 
2004).  
 
1.8.4 NMs in the blood 
 
In addition to the translocated NMs from pulmonary and gastrointestinal exposure (Sections 
1.8.2 and 1.8.3), direct injection of materials loaded with drugs and diagnostics are the 
principle routes of NM entry in the circulatory system. The presence of nanomaterials in the 
blood allows distribution to a wide range of target organs including the liver, kidneys, heart 
and spleen. When NMs reach systemic circulation they can interact with plasma proteins, 
platelets, coagulation factors, erythrocytes and white blood cells. The binding to plasma 
proteins in particular is thought to be extremely important in the distribution and excretion of 
NMs (Hagens, et al., 2007). It seems that the addition of serum might result in reduced 
cytotoxicity in vitro in some instances as demonstrated by Lovric and colleagues. They 
showed quantum dots pre-treated with bovine serum albumin result in a smaller number of 
cell dying compared with cells treated with unmodified materials (Lovric, et al., 2005). 
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Furthermore, it seems sensible to incorporate serum into in vitro experiments in order to 
extrapolate results to in vivo situations (Hagens, et al., 2007).  
 
It has been shown that certain materials (i.e. titanium dioxide) can be found inside human red 
blood cells (Rothen-Rutishauser, et al., 2006). This is a very interesting finding as 
erythrocytes do not have phagocytic receptors. This seems to suggest that in this case cellular 
uptake does not involve phagocytosis or endocytosis (Rothen-Rutishauser, et al., 2006). Red 
blood cells must incorporate a non specific mechanism for NM uptake which might be 
diffusion or the utilisation of trans-membrane channels. It is understood that intracellular 
TiO2 NMs are not membrane bound and have direct access to cellular DNA and organelles 
which undoubtedly increases their toxic potential (Rothen-Rutishauser, et al., 2006). Finally, 
it might be possible that some materials can cross the trans-placental barrier. Although there 
is very limited information in this area, data exists from a very interesting study in which 
pregnant mice were intraperitoneally injected with soluble fullerenes (C60). At high 
concentrations all embryos died, while at lower concentrations abnormalities were observed 
around the head region of the embryos (Tsuchiya, et al., 1996). This study indicates that the 
NMs were transferred to the embryo via the trans-placental passage or directly from the 
peritoneal cavity into the uterus (Tsuchiya, et al., 1996). 
 
1.8.5 Eventual fate of the nanomaterials 
 
Under normal circumstances materials absorbed by the gastrointestinal tract will be directly 
transported to the liver via the portal vein. The liver is fully capable of active removal of 
hazardous substances from the blood. However there is contradictory evidence about the 
percentage and the properties of overall number of NMs that are cleared from the blood in 
this manner.  
 
It seems unlikely that inert NMs - such as fullerenes and carbon nanotubes can be 
metabolized by enzymes within the body (Hagens, et al., 2007). Therefore, it seems sensible 
to hypothesise that NMs with functionalised groups are more susceptible to enzyme activity. 
There are numerous routes in which an absorbed NM can be excreted. The first of these 
elimination pathways is renal clearance. A recent study showed that intact fullerene and 
single walled carbon nanotubes were detectable in the urine from rats three and half hours 
following intravenous injection of the materials (Singh, et al., 2006). However this is not 
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always the case as NM size as well as its chemical properties all influence clearance. This is 
demonstrated in a study in which quantum dots were still present in the lymph nodes and 
bone marrow of mice 133 days after the initial injection (Hardman, 2006).  
 
Bile is another excretion route suggested by some as the clearance mechanism of certain 
NMs. In a 2001 study polystyrene NMs (50 and 500 nm) were intravenously injected into 
rats. It was discovered that a fraction of 50 nm materials were internalised by the hepatocytes. 
After a 24 hour period 5% of the total dose was excreted in the bile (Nagayama, et al., 2001). 
The larger NMs however were predominately phagocytosed by the Kupffer and endothelial 
cells (Nagayama, et al., 2001). This seems to suggest that bile secretion of nano particulates 
is size dependent. Another potential excretion routes for NMs could be breast milk. However 
corroborating data is currently unavailable to confirm these routes (Hagens, et al., 2007). It is 
also believed certain nanomaterials are degraded in the lysosomes of certain immune cells 
(Stern, et al., 2012). 
 
1.9 Engineered NMs used to investigate toxicity to the liver and the kidneys 
 
Many engineered NMs are manufactured from a diverse group of substances, hence for a risk 
assessment study a varied range needs to be evaluated for a comprehensive toxicity profile. It 
is very possible that each nanomaterial will differ in the levels of toxicity and the mechanism 
by which they exert these adverse effects. The ENPRA particle panel was appraised fully in 
order to establish the toxicity of each material on liver and kidneys. 
 
1.9.1 Silver 
 
Nanosilver particles generally contain 20-15000 silver atoms. At the nano-scale, silver 
exhibits remarkably unusual physical, chemical and biological properties. Due to its strong 
antibacterial activity, silver coatings are used on various textiles as well as coatings on certain 
medical implants. Furthermore, the NM is used for treatment of wounds and burns or as a 
contraceptive as well as being marketed as a water disinfectant and room spray (Chen, et al., 
2008b). With ever increasing intimate exposure to silver NMs it is very important to establish 
the concentration in which the material becomes toxic to human cells. From a historical point 
of view it is assumed that apart from some mild cases of argyria, silver is relatively non toxic 
to mammalian cells (Drake, et al., 2005). However as discussed previously, once a substance 
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reaches the nano-scale it can have completely different properties. It is known that materials 
smaller than an aerodynamic diameter of 2.5 µm can penetrate down to the alveoli of the 
lungs. Most commercialised silver nanomaterials are smaller than 100 nm, therefore exposure 
of NMs in the lung could induce impacts such as oxidative stress in lung epithelial cells. With 
a highly pro-oxidative environment such as the intra-alveolar spaces of the lung and their 
extremely large surface area, it might be sensible to assume that silver NMs could be 
sufficient facilitators of free radical generation (Chen, et al., 2008). In addition silver NMs 
can easily be translocated to secondary organs via endocytosis and transcytosis. A 2001 study 
shows that silver particles of 15 nm rapidly decrease in numbers in the lung following 
inhalation and intratracheal instillation. These particulates were later located in the blood and 
other organs including the liver and the kidneys (Takenaka, et al., 2001). The authors note 
that up to 20% of the silver was observed in the liver (Takenaka, et al., 2001). 
 
Silver NMs are regularly utilised in water disinfection and food preservation, so there is a 
very real possibility for the materials reaching the gastrointestinal tract. Intestinal                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
particles are readily taken up by Peyer’s patches or the enterocytes. Once in sub-mucosal 
tissue, silver NMs are able to enter the lymphatics and capillaries. It seems that despite this, 
any toxicity associated with ingestion of silver NMs seems to be localised to the liver and is 
not observed systemically (Carlson, et al., 2008; Hussain, et al., 2005; Takenaka, et al., 
2001).  
 
As for the mechanism of toxicity of silver NMs, it has been suggested that exposure 
significantly decreases cellular mitochondrial function, followed by apoptosis like 
morphological changes in exposed BRL 3A cells (Hussain, et al., 2005). The same team have 
indicated that depletion of GSH levels and increased oxidative stress was associated with the 
mitochondrial perturbation (Hussain, et al., 2005).  
 
In this study one silver NM (<20 nm, NM 300) was investigated. The materials were capped 
with PVP (polyvinylpyrolidone) to improve dispersion in aqueous media (Table 3.1).  
 
1.9.2 Multi walled carbon nanotubes 
 
Carbon nanotubes (CNTs) consist of a network of carbon atoms arrayed in graphene sheets, 
rolled up into tubes with a diameter in the nano-scale. There are two classes of CNTs: single 
22 
 
walled (SWCNT) – composed from only one CNT layer and the multi walled (MWCNT) 
variety generated from two or more layers of rolled-up graphene sheets. These NMs have 
unique physical and chemical properties making them an ideal candidate in a multitude of 
industrial applications including high resistance composites and electronic devices (De 
Nicola, et al., 2009). CNTs are also widely used in diagnostic and therapeutic tools for the 
detection and treatment of diseases including certain cancers (Ferrari, 2005). In addition, 
burning of natural gases, such as propane and methane is a source of CNT release into the 
atmosphere (Murr, et al., 2004). CNTs have the tendency to aggregate and form rope - like 
structures which has to be considered in any toxicological study (Donaldson, et al., 2006; 
Poland, et al., 2008). 
 
The toxicity of CNTs is widely documented. Adverse effects observed include pulmonary 
inflammogenicity (Ellinger-Ziegelbaur, et al., 2009), with the effects of SWCNTs being 
higher than that of MWCNTs. In contrast in vitro exposure of RAW264.7 macrophage cell 
line to SWCNTs was associated with the active production of transforming growth factor β 
and reduced levels of the pro-inflammatory cytokines TNF-α and IL1-β (Shvedova, et al., 
2005). In the same study no ROS activity was identified. In a contrasting study however it 
was shown that SWCNTs enriched with iron generated considerable amounts of hydroxyl 
radicals (Kegan, et al., 2006). Therefore it seems that iron contamination of CNTs might 
influence the toxicity of the materials.  
 
The toxicity of asbestos to mesothelial cells is well recognized. This has led many to draw 
comparisons between asbestos and the fibrous, rigidly shaped and non-soluble CNTs 
(Donaldson, et al., 2011; Murphy, et al., 2012). To this end many studies have been carried 
out and it has been shown that well dispersed CNTs are less toxic than agglomerated CNTs, 
at least in mesothelioma cells (Wick, et al., 2007). Thus the degree of agglomeration seems 
paramount in evaluating the toxicity of any CNT (Wick, et al., 2007). This being said it is 
important to note that due to the nature of the materials and van der Waals forces there will 
always be some degree of agglomeration despite the concentration and type of dispersant 
utilised (Mitchell, et al., 2007).  
 
In this study two entangled MWCNTs of different length (NM 400 - D: 5-35 L: 700-3000; 
NM 402 - D: 6-20 L: 700-4000) was investigated as representatives of engineered CNTs in 
industry (Table 3.1). 
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1.9.3 Zinc oxide 
 
Zinc oxide (ZnO) NMs have been shown to have great benefits in society and are currently 
being applied in a broad range of industries including cosmetics (sunscreens), biosensors and 
numerous electronic goods as well as being a constituent of metal fumes in welding (Deng, et 
al., 2009). Furthermore, due to their antibacterial properties these materials have huge 
potential in the development of prophylactic drugs. Many studies have focused on the 
influence of ZnO NMs on bacterial growth. An example of one such study demonstrates that 
ZnO severely inhibits the growth of E.coli and protects intestinal cells from an 
enterotoxigenic form of the bacteria (Roselli, et al., 2003), while another group have 
publicized that the particulate has bacteriostatic effects against Staphylococcus aureus and 
Streptococcus agalactiae (Huang, et al., 2008).  
 
A recent in vivo study in which mice were exposed to ZnO NMs (272 nm) via an oral route 
resulted in significant accumulation of materials within the liver as well as cellular injury. 
The authors also noted elevated levels of alanine aminotransferase and alkaline phosphates in 
serum as well as pathological lesions in the liver (Sharma, et al., 2012b). In the same study 
ZnO exposure was associated with induction of oxidative stress and DNA damage within the 
liver (Sharma, et al., 2012b). The same team have also shown in vitro oxidative stress and 
genotoxicity in HepG2 (liver cell line) following exposure to the ZnO NMs (Sharma, et al., 
2012a). In another set of trials it was shown that ZnO NMs have significant toxic effects on 
aortic endothelial cells, with 50% of cells dying after a 4 hr incubation period with the 50 nm 
materials (Gojova, et al., 2007). Furthermore, another study on mouse neural stem cells 
revealed that a 24 hr incubation with 30, 60 and 200 nm ZnO materials results in 
manifestation of a clear dose dependant toxicity on the cells. The team propose that the ZnO 
NMs induces apoptosis of the treated cells (Deng, et al., 2009).    
 
In this study two different engineered ZnO NMs were utilised. Firstly, NM 110 which is an 
uncoated 100 nm material. The second ZnO NM (NM 111) (130 nm) was coated with 
Triethoxycaprylylsilane - a silicone based surfactant and functions as a binding agent and 
emulsifier (to allow better dispersion) (Table 3.1).  
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1.9.4 Titanium dioxide 
 
Titanium dioxide (TiO2) NMs have a wide range of uses including the production of paints, 
paper, plastics, food additives and colorants, as well as in pharmaceutical and cosmetic 
industries (Jin, et al., 2008). In addition, due to the unique ability of anatase TiO2 NMs to 
strongly absorb UV light with very low scattering, it is widely utilised in sunscreen products 
and self cleaning windows (Jin, et al., 2008). There are three natural forms of TiO2 – with 
rutile being its most common form. Rutile is the preferred polymorph of TiO2 because it has 
the lowest molecular volume of three forms. Anatase, the second mineral form of TiO2, is 
most commonly found in nature as small isolated and sharply developed crystals in a 
tetragonal system. Brookite, the least common naturally occurring form of TiO2 crystallises 
in an orthorhombic system (Dubrovinsky, et al., 2001). 
 
Currently there are conflicting views on the adverse effects of the TiO2 nanomaterials. On 
one side of the argument it is suggested that in sufficient doses TiO2 can cause inflammation, 
fibrosis, and pulmonary damage. It has also been shown that after translocation from the 
primary site of exposure the NM can induce oxidative stress - mediated toxicity in many cell 
types by producing large amounts of free radicals (Jin, et al., 2008; Kang, et al., 2008; Wang, 
et al., 2007b). Oxidative stress can damage proteins, lipids and nucleic acids, leading to 
interference in cell signalling and modulation of transcription factors (i.e. NFκ-B). This in 
turn can result in cell death due to oxidative DNA damage and increased cellular nitric oxide 
(Jin, et al., 2008).  
 
It has been shown that exposure of rats via an IV route to 50 mg/kg of 100 nm TiO2 
nanomaterials resulted in pathological lesions within the liver. Furthermore there was an 
increase in reactive oxygen species and a down regulation of intracellular antioxidants within 
liver cells (Meena, et al., 2012). In a similar study injection of 5 nm TiO2 NM resulted in 
liver DNA damage, histopathological changes and hepatocyte apoptosis. This was associated 
with increases in mRNA expressions of TNF-α, IL6, IL4 and IL1-β (Ma, et al., 2009). In 
another study 25 nm TiO2 NMs resulted in increased DNA strand breaks in HepG2 cells 
(Petkovic, et al., 2011).  
 
However, in a contrasting study there was no cytotoxicity to human derived Caco-2 cells 
following 24 hr exposure to TiO2 NMs. The team did discover however that the NMs were 
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able to cross the epithelial lining of the intestinal model by transcytosis and penetrate into the 
cells (Koeneman, et al., 2009)  
 
TiO2 nanomaterials in general have very low solubility, hence once in solution there is a 
tendency for the particulates to agglomerate which has to be considered in cytotoxicity and 
molecular pathogenesis studies (Kang, et al., 2008). It is also interesting to note that in a 
related study TiO2 NMs did not cause toxicological injury to mammalian cells under dark 
conditions (Xia, et al. 2006). 
 
In this study five different TiO2 materials were investigated. First of these NMs was photocat 
7 (NM 101) (7 nm anatase). There were also three 10 nm anatase TiO2 NMs (one neutrally 
charged, one positively and one negatively charged NM – termed NRCWE 001, NRCWE 
002 and NRCWE 003 respectively). The final TiO2 was NRCWE 004 (anatase 94 nm) (Table 
3.1).  
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Chapter Two 
Liver and the kidneys - the nanotoxicological 
concerns with these organs  
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2.1 The Liver 
 
The liver is considered by many as the metabolic centre of the body. The organ has a crucial 
role in metabolic homeostasis, as it is responsible for the storage, synthesis, metabolism and 
redistribution of carbohydrates, fats and vitamins (Kmiec, 2001). The liver produces large 
numbers of serum proteins, mainly albumin, an array of enzymes and acute phase proteins. 
The organ is also the principal detoxification centre of the body, removing xenobiotics and 
waste products by metabolism or biliary excretion (Kmiec, 2001). As previously mentioned, 
some NMs are capable of distributing from the site of exposure to a number of secondary 
organs, one of which is the liver. 
 
2.2 The blood supply to the liver 
 
The two main vessels supplying the liver with blood are the hepatic artery, which delivers 
oxygenated blood from the heart (constituting around 35% of overall blood supply) and the 
hepatic portal vein which delivers blood rich in nutrients, vitamins and xenobiotics from the 
small intestine (65% of the total blood supply) (Figure 2.1). The hepatic vein returns de-
oxygenated blood to the heart via the vena cava, while other incoming and outgoing blood 
vessels are connected by sinusoid vessels (Kmiec, 2001). It is important to understand the 
blood supply as this is the main route of the NM translocation from the primary exposure site 
to this organ. This being said the liver sinusoid which is a fenestrated blood vessel (associated 
with supply of oxygen rich blood from the hepatic artery and nutrient rich blood from the 
portal vein) has also been implicated as a potential route for nanomaterial access to the liver 
(Shi, et al., 2010a) 
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Figure 2.1. Blood supply to the liver. (Adapted from Kanel, et al., 2005) 
 
2.3 Cells important in normal liver function 
 
The liver is a dark red/brown coloured organ divided into four lobes which can be further 
organised into smaller structural hexagonal units known as liver lobules composed of 
parenchymal and nonparenchymal cells (Kmiec, 2001).  
 
2.3.1 Hepatocytes 
 
Parenchymal cells which are principally the hepatocytes constitute the major cellular 
compartment of the liver (approximately 65% of total liver volume). Hepatocytes are 
polyhedral multifaceted cells with eight or more faces, and range between 25-30 µm in length 
(Kmiec, 2001). In addition, many mammalian hepatocytes are bi-nucleated or polyploid 
(Kmiec, 2001). These cells participate in almost all functions that are attributed to the liver. 
One of the most important of these roles is the release of glucose in the process of 
glycogenolysis and producing glucose from non carbohydrate substrates via gluconeogenesis 
(Kmiec, 2001). Hepatocytes are the only known cells that inactivate ammonia in the urea 
cycle. These cells are responsible for the manufacture of important serum proteins such as 
acute phase proteins (i.e. complement components) crucial in mammalian innate immune 
system (Kmiec, 2001). They also play a substantial role in the metabolism of exogenous and 
endogenous lipids and catabolism of blood - derived cholesterol enriched protein (Kmiec, 
2001). Hepatocytes also produce bile components such as bile acids, cholesterol, 
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phospholipids and conjugated bilirubin (breakdown product of normal heme catabolism) 
(Kmiec, 2001). Moreover, hepatocytes synthesize a wide array of hormones and cytokines 
including IL8 (Dong, et al., 1998), IL6 (Saad, et al., 1995), TNF-α (Saad, et al., 1995) and 
MCP-1 (Dong, et al., 1998). In a healthy liver parenchymal cells very rarely divide, however, 
upon severe injury hepatocytes proliferate at extremely rapid rates to restore the organ mass 
(Kmiec, 2001). It is understood that the metabolic heterogeneity of the hepatocytes is at least 
partially determined by their location inside the lobule. Periportal hepatocytes localized at the 
periphery of the lobule are in a micro-environment rich in oxygen, substrates and hormones 
in the blood from the terminal afferent vessels. In contrast, perivenous hepatocytes (located 
around the central vein) function with blood partially depleted of oxygen and nutrients but 
rich in carbon dioxide and other metabolism products (Kmiec, 2001). 
 
The cytochrome P450 (CYP450) superfamily are a number of heme containing enzymes that 
are involved in a diverse array of substrate specific and catalytic activities (Guengerich, 
2001). The CYP450 enzymes and their co-factors are embedded in the membrane of the 
endoplasmic reticulum and play a crucial role in the metabolism of drugs, chemicals and 
endogenous substrates in the liver (Westerink, et al., 2007). Due to their importance in 
healthy functioning hepatocytes this superfamily is usually investigated as markers for 
normal cells in vitro (Villeneuve, et al., 2004).  
 
It is widely argued that in vitro hepatocyte systems (including cell lines and systems without 
optimal artificial extracellular matrices) might not be ideal for functional and metabolic 
studies as the cells lose key liver specific functions especially their cytochrome P450 activity 
(Kim, et al., 2011a; Mingoia, et al., 2007). Hence the cells used in such experiments are not 
fully representative of primary hepatocytes in vivo. The use of cell lines in an in vitro 
scenario however does have its advantages as the cells are cheaper and easier to maintain and 
much more suitable candidates for high throughput toxicology screening compared to 
primary cells.  
 
2.3.2 Sinusoidal endothelial cells    
 
Sinusoidal endothelial cells of the liver (SEC) (3% of total liver volume) differ in many 
structural and functional aspects from other endothelial cells of the body (Fainboim, et al., 
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2007). Firstly, they do not have a basement membrane and are often embraced by the 
cytoplasmic processes of underlying hepatic stellate cells (Fainboim, et al., 2007). SECs form 
an important filtration barrier between macromolecules (might also include NMs) and blood 
cells and hepatocytes – preventing direct contact and influencing the extent of exchange of 
various substances. SECs form a continuous lining of the liver sinusoids separating 
parenchymal cells (hepatocytes) and hepatic stellate cells from direct contact with the blood 
(Kmiec, 2001). They are flat elongated cells with numerous thin cytoplasmic processes. 
These cells are separated by sieve plates (fenestrations of 100-200 nm in clusters of 10-50 
pores representing 6% of the endothelial surface) (Kmiec, 2001). SECs contain a large 
number of lysosomes, phagosomes and micro and macro-pinocytotic vesicles (Fainboim, et 
al., 2007). The main functions of the SECs are assumed to be the formation of a general 
barrier against pathogenic agents, as well as serving as a selective sieve for certain substances 
from the blood to the stellate cells and hepatocytes (main mechanism for this is understood to 
be receptor mediated endocytosis) (Kmiec, 2001). The receptor mediated endocytosis of 
substances such as collagen, hyaluronic acid, fibronectin, entacin and chondroitin sulphate 
proteoglycan is a major physiological role for SECs (Kmiec, 2001). In addition, SECs exhibit 
a number of other receptors including specific receptors for fibronectin, LPS (TLR4), 
scavenger receptors (i.e. for mannose), CD14 (LPS binding protein receptor), IL1, IL6, TNF-
α, TGF-β, PGE2, PGD2, oestrogen, glucagon, and C5a (Kmiec, 2001).  
 
The liver is continuously exposed to food and microbial antigens from the intestine. In 
addition, the liver as the primary metabolic organ produces a multitude of new antigens. 
Therefore the risk of self-immunity seems extremely high in the liver. However, the liver has 
acquired specialized mechanisms of immune tolerance in order to avoid over-activation of the 
immune system. SECs are not only involved in the clearance of particulate and soluble 
antigens, but are also extremely important in the process of the development of specific 
tolerance to non-pathogenic antigens (Tiegs, et al., 2009). SECs have the capacity to function 
as non-professional antigen presenting cells (APCs), as they constitutively express both MHC 
class I and II, co-stimulatory molecules including CD80, CD86, CD40 as well as CD4, 
CD11, CD54 and VCAM-1 - all necessary or at least beneficial for recognition, processing 
and presentation of antigens to T lymphocytes (Tiegs, et al., 2009). Although SECs stimulate 
the proliferation of naive CD4 cells, these lymphocytes do not proliferate towards a Th1 
phenotype - instead they demonstrate characteristics most associated with Th2 cells (cytokine 
profile IL10, TGF-β) (Tiegs, et al., 2009) (Figure 2.2). The IL10 produced by the SECs and 
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Kupffer cells (which will be discussed in detail in section 2.3.3) decreases the constitutive 
expression of MHC class II as well as CD80 and CD86 and completely diminishes the 
activity of mannose receptor responsible for antigen uptake, resulting in specific T cell 
anergy (Tiegs, et al., 2009). In addition, SECs produce the negative co-stimulatory molecule 
PD-L1, inducing CD8 cell tolerance (Tiegs, et al., 2009). It is important to note that although 
in normal healthy conditions in the liver, tolerance is favoured over immunity; the immune 
system of the organ is more than capable of clearing pathogenic antigens. It has been shown 
that activation of TLR3 (polyl:C binding) or TLR4 (LPS binding) induces CD8 mediated 
hepatitis. In addition as SECs constitutively express MHC class I, they are able to cross 
present antigens to CD8 cells (Kmiec, 2001).      
 
  
Figure 2.2. Cell types and their interaction with in the liver. (Adapted from Tiegs, et al., 2009) 
 
2.3.3 Kupffer cells 
 
Kupffer cells (KC) (20% of total cell numbers in a healthy liver) are the resident 
macrophages of the liver. These cells represent the largest number of macrophages in the 
mammalian body. KCs are responsible for the clearance of gut-derived bacteria and potential 
bacterial toxins such as endotoxins and peptidoglycans (Kmiec, 2001). These cells very much 
resemble other macrophages in the body – characterised by numerous microvillious 
projections, blebs and lamellipodia (Tiegs, et al., 2009). KCs are generally concentrated in 
the periportal region of the liver which allows monitoring of the blood entering the organ 
(Kmiec, 2001). These macrophages are positioned to have constant contact with gut-derived 
antigens. It is hypothesized that due to the constant exposure to low levels of gut bacterial 
products, KCs are in a permanent semi-activated state (Tiegs, et al., 2009). Under 
HSC 
Treg 
Hepatocyte 
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pathological conditions, bacteria that bypass the intestinal barrier are the most important 
activators of KCs. These macrophages have the largest array of surface receptors designed for 
identification of most gut-derived antigens. Some of these receptors include mannose 
receptors, IgG receptors (FcγRII and III), scavenger receptors type I and II, FcαRI, 
Complement receptors, C5a receptor, a wide range of TLRs including TLR4, cytokine 
receptors (IL1, IL2-β, IL6, TGF-β, TNF-α), platelet activating factor receptors, glucagon 
receptors and Fas (CD95) (Kmiec, 2001). In addition, similar to other macrophages, once 
KCs are activated they are capable of producing an array of mediators involved in wide range 
of functions including: protein degradation, modulation of cell function and defence 
mechanisms and cytotoxicity. Some of the most crucial of these secretory products include 
MMP-13, proteoglycans, NO, PAF, IL1-α, IL1-β, IL6, IL8, IL12, IL18, IL21, IL23, TNF-α, 
TGF-β, reactive oxygen species, lysozyme and osteopontin (Baffy, 2009). In contrast to 
SECs which only remove soluble molecules from circulation, KCs can accumulate process 
and present both soluble and particulate antigens from the portal circulation (Kmiec, 2001). 
Beside these typical macrophage duties, the KCs have the essential role of removing 
damaged erythrocytes from the blood, and subsequently degrading haemoglobin and re-
circulating iron (Kmiec, 2001).  
 
Although KCs have the capacity for initiating and sustaining an immune response to 
eliminate pathogenic antigens, under normal circumstances they are extremely important in 
the maintenance of liver tolerance (Tiegs, et al., 2009). It is understood that following the 
initial activation and production of a pro-inflammatory response, KCs release IL10 which 
down-regulates the production of TNF-α and IL6 and other potentially damaging pro-
inflammatory cytokines (Tiegs, et al., 2009).  
 
2.3.4 Hepatic stellate cells 
 
Hepatic stellate cells (HSC) (6% of the total number of liver cells) are located in the 
perisinusoidal spaces in direct locality to the endothelial cell layer with their cell bodies often 
compressed between the hepatocytes (Kmiec, 2001). HSCs exhibit two phenotypes: a 
quiescent one in a normal liver and an activated form in a diseased liver. The inactive HSC 
are characterised by abundant lipid droplets and a low proliferative rate. The activated cells 
however lose their lipid vacuoles, while demonstrating increased proliferation and enhanced 
production/secretion of extracellular matrix components (Kmiec, 2001). The non-activated 
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HSCs have a number of functions in a healthy liver. One of the most important of these 
functions is the metabolism of retinoid. More than 85% of vitamin A in the body is stored in 
the liver and about 90% of all the retinoid in the liver is in the lipid droplets of the HSCs 
(Kmiec, 2001). HSCs are also one of the major producers of extracellular matrix components 
and ECM-degrading enzymes. In a healthy liver, HSCs express all the major isoforms of 
hepatocyte growth factor, transforming growth factor β and insulin-like growth factors 
(Kmiec, 2001). These cells are also involved in the synthesis of erythropoietin and 
plasminogen activation system (Kmiec, 2001). Once activated, HSCs play a pivotal role in 
the initiation and progression of liver fibrosis. The secretion of leptin (hormone that plays a 
key role in regulating energy intake and energy expenditure i.e. in metabolism) by activated 
HSCs seems to be very important in modulation and activity of many pro-inflammatory 
cytokines (Tiegs, et al., 2009). In addition it is now believed that HSCs can function as 
antigen presenting cells (APCs) and present protein or lipid antigens to conventional T cells 
as well as CD1d - restricted T cells and Natural killer T (NKT) cells (Tiegs, et al., 2009).  
 
Like other cells in the liver, HSCs are involved in maintenance of tolerance in the liver. As 
already mentioned HSCs store vitamin A and many believe that CD4 cells coming in contact 
with such cells can be converted to induced regulatory T cells via vitamin A - derived retinoic 
acid (Tiegs, et al., 2009). Moreover, activated HSCs express the negative co-stimulator PD-
L1 (Programmed Death Ligand-1 or CD274 binds PD-1 on activated T cells and induces 
apoptosis in target cells) as well as being major sources of TGF-β (Tiegs, et al., 2009).  
 
2.3.5 Other cells in the liver 
 
Morphological data has indicated that the liver sinusoids contain a large and heterogeneous 
population of resident lymphocytes, which compromises the conventional αβ T cells, pit cells 
(natural killer cells – CD3-CD56+), γδ T cells, NKT cells and small numbers of B 
lymphocytes (Tiegs, et al., 2009). In addition, there is a subset of professional antigen 
presenting cells resident in the liver which are the dendritic cells (DC). These cells comprise 
of both myeloid and plasmacytoid DCs (Baffy, 2009). These liver DCs express very low 
levels of MHC class II and co-stimulatory molecules (CD80, CD86, CD40) – hence 
exhibiting an immature phenotype (Tiegs, et al., 2009). These cells produce large levels of 
IL10, stimulating a Th2 cytokine response. In addition IL10 enhances the expression of 
CCR5 (chemokine receptor) while down-regulating CCR7 expression by the DCs thus 
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preventing homing to secondary lymphoid tissue (Tiegs, et al., 2009). Finally it is important 
to mention a specialized group of regulatory T cells (CD4
+
CD25
+
Foxp3
+
), which are 
extremely important in maintaining liver tolerance by producing substantial amounts of IL10 
(Tiegs, et al., 2009). 
 
2.4 Albumin 
 
Albumin is the most abundant protein in serum, containing 585 amino acids and a molecular 
weight of 66 kDa. This highly soluble globular protein is present in human plasma at normal 
concentrations between 35 and 50 gram/litre (Roche, et al., 2008). Albumin is synthesized in 
the liver and catabolised by all metabolically active tissues. Albumin makes a large 
contribution to plasma colloid osmotic pressure due to its small size and abundance (35-50% 
of total plasma proteins by weight). It has many important physiological and pharmacological 
functions. Albumin is responsible for the transportation of metals, fatty acids, cholesterol, 
bile pigments, insoluble organic substances (e.g. unconjugated bilirubin), drugs as well as 
being a key element in the regulation of osmotic pressure and distribution of fluid between 
different compartments (Roche, et al., 2008). In normal conditions albumin has a half life of 
about 20 days and its plasma concentration represents equilibrium not only between its 
synthesis in the liver and its catabolism (Peters, 1996). 
 
2.5 Urea 
 
Ammonia plays a central role in nitrogen metabolism. It is a major by-product of protein and 
nucleic acid catabolism. The nitrogen from ammonia can incorporate into urea, amino acids, 
nucleic acids and many other nitrogenous compounds (Sands, 2003). Ammonia is present in 
body fluids as both NH3 and NH4
+
 - these are constantly in equilibrium. NH3 can diffuse 
freely across membranes via aquaporins (Sands, 2003), while NH4
+
 is carried in the liver by 
an active transport system – termed the RhB glycoprotein system (Sands, 2003). In a healthy 
human the blood ammonia concentrations are normally below 35 µmol/L. This is important 
as ammonia is neurotoxic at higher concentrations. Excessive cerebral ammonia uptake in 
hyperammonaemic states leads to astrocytic glutamine accumulation and cerebral oedema, a 
major factor in hepatic encephalopathy (Häussinger, et al., 2008). 
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The liver is the most important site of ammonia metabolism. The organ is responsible for 
removal of most of the toxic ammonia. By doing so, the liver also plays a major role in the 
metabolic regulation of systemic pH, due to the fact that hydrogen ions released from NH4
+
 
during the synthesis of urea neutralize the excess bicarbonate produced by the breakdown of 
amino acids (Häussinger, et al., 1990). Urea is electrically neutral and is transported across 
biological membranes by facilitated diffusion. Urea transporters in the liver include 
aquaglyceroporin - AQP9, and urea transporter UT-B1 (Sands, 2003). Urea is excreted by the 
kidney, and is normally present in plasma and body fluids at a concentration of 3.0–6.5 
mmol/l (Häussinger, et al., 2008). 
 
2.5.1 Sources of ammonia 
 
Whereas urea production takes place largely within the liver, much of the ammonia used in 
urea synthesis is derived, directly or indirectly, from extra-hepatic tissues. Ammonia is 
largely released from the intestine and the kidneys, with the liver, resting muscle, and brain 
acting to remove ammonia from the blood (Olde Damink, et al., 2002). A large proportion 
(25%) of all the nitrogen utilized in urea synthesis reaches the liver via the portal vein, from 
ammonia formed in the small intestine and colon. Furthermore, most of the nitrogen 
transported to the liver for incorporation into urea is carried not as ammonia but as amino 
acids, such as alanine or glutamine (Olde Damink, et al., 2002). 
 
Once in the liver, glutamate and glutamine are major sources of ammonia. Glutamate is 
released directly from proteins, but more importantly it is formed from other amino acids 
(with the exception of lysine and threonine) released from protein breakdown in 
aminotransferase reactions. Glutamate is directly formed by deamidation of glutamine, and 
from proline and histidine (Olde Damink, et al., 2002). Ammonia is released from glutamate 
by its oxidative deamination by glutamate dehydrogenase, a mitochondrial enzyme. This 
enzyme is present in most tissues, but it has utmost activity in the liver (Olde Damink, et al., 
2002). Amino acids can also be transaminated with glyoxalate to form glycine, which is 
deaminated by glycine oxidase to yield ammonia.  
 
Ammonia can also be generated by the deamidation of glutamine and asparagine and in the 
histidine lyase reaction, as well as serine, threonine, cysteine, cystathione and homoserine, in 
pyridoxal phosphate-dependent deamination reactions, which occur mainly in the liver. Most 
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of the ammonia produced from purine nucleotides is derived from adenosine monophosphate 
(AMP), in a reaction catalysed by adenylate deaminase. This pathway becomes particularly 
important during exercise when ammonia formation and release from muscle is increased 
(Olde Damink, et al., 2002). 
 
The intestine is also a major site of ammonia production. Some 15–30% of the urea 
synthesized by the liver is degraded by bacterial ureases in the gut, with the liberation of 
ammonia and carbon dioxide. A second source of ammonia from the gut, quantitatively of 
equal importance, is the intestinal mucosa itself. The small intestine produces a significant 
quantity of ammonia, which comes primarily from the metabolism of glutamine removed 
from arterial blood (Morris, 2002). 
 
2.5.2 Urea production 
 
Approximately 90% of surplus nitrogen in humans enters the urea cycle for irreversible 
conversion to urea, which is excreted by the kidneys, with approximately 30 grams of urea 
being excreted daily in healthy adults. Using tracer techniques, it has been observed that 
calculated urea production exceeds urinary urea excretion by about 20–30%. This difference 
is attributed to extra-renal losses, largely accounted for by the intestinal hydrolysis of urea 
(Beliveau-Carey, et al., 2003). Short term regulation of urea synthesis occurs at the levels of 
substrate provision and enzyme activities, whereas long term control is transcriptionally 
affected by changes in enzyme concentrations. Substrate provision for the urea cycle depends 
on amino acid delivery, the activity of amino acid transport systems and amino acid 
metabolizing enzymes (Beliveau-Carey, et al., 2003). 
 
It is important to note that changes in urea-cycle enzyme expression can occur following 
alterations in dietary protein. In such time glucagon, insulin and glucocorticoids are 
extremely important mediators (Morris., 2002). When protein intake is increased, there is a 
proportional increase in the total hepatic content of all urea cycle enzymes resulting in 
increased urea production. Long term regulation of urea cycle enzymes occurs primarily at 
the level of transcription (Morris., 2002). Glucagon, which increases during starvation and 
glucocorticoids predominately associated with protein breakdown are both involved with 
increased enzyme levels and urea production (vom Dahl, et al., 1991). Glucagon also 
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regulates urea synthesis by activation of mitochondrial glutaminase, amino acid transport, N-
acetylglutamate synthesis, and stimulation of hepatic proteolysis (vom Dahl, et al., 1991). 
 
2.5.3 Urea and ammonia metabolism in liver disease 
 
Urea synthesis is greatly reduced in severe liver disease, in parallel with glutamine synthesis. 
This tends to be correlated with deterioration in other markers of hepatocellular function 
(Racine-Samson, et al., 1996). In patients with liver disease, there is a tendency for blood 
ammonia levels to rise. The main reason for this is presumably the failure of the liver, 
because of hepatocellular dysfunction, to remove ammonia from the portal venous blood 
(Racine-Samson, et al., 1996). One hypothesis in this study was that NM exposure could 
interfere with urea synthesis by hepatocytes hence it seems an important endpoint to study in 
order to gain a better understanding of how these particular ENPRA NMs are affecting liver 
function. 
 
2.6 C reactive protein  
 
C reactive protein (CRP) is a protein synthesised and secreted by the hepatocytes of the liver 
in response to inflammatory cytokines, in particular IL6. It is a member of the pentraxin 
family of proteins - composed of five identical subunits arranged in a cyclic pentameter 
shape. These subunits are non-covalently bonded and have a total molecular weight of 
118,000 daltons (McWilliam, et al., 2010). Although CRP is often used clinically as a marker 
for inflammation, it also functions as a key component of the innate immune response to 
inflammation and infection. It plays this role by mediating phagocytosis, activating the 
complement cascade and by producing further inflammatory cytokines (Gabay, et al., 1999). 
CRP forms complexes by binding to a range of molecules, such as polysaccharides and 
peptopolysaccharides present on bacteria, parasites and fungi (Gabay, et al., 1999). CRP also 
plays a role in clearance of cellular debris by binding components of damaged host cells 
(both membrane and intracellular components) (McWilliam, et al., 2010). These CRP–ligand 
complexes bind to Fc receptors on phagocytic cells (neutrophils, macrophages, etc.) 
mediating phagocytosis of pathogens opsonised by CRP and stimulating a pro-inflammatory 
response via the production of further cytokines (IL1, TNF-α). CRP–ligand complexes are 
also able to bind to C1q, the first component of the classical complement cascade, which 
again triggers phagocytic activity (Du Clos, et al., 2004). 
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CRP (the prototypical acute phase protein in humans) was discovered in 1930 by Tillett and 
Francis (McWilliam, et al., 2010). They studied the sera of patients with acute pneumococcal 
pneumonia and identified a substance in the sera that formed a precipitate when combined 
with the C polysaccharide of the pneumococcal cell wall. As patients recovered, the ability of 
their sera to form this precipitate disappeared. Likewise, sera from healthy individuals did not 
form this precipitate. Ultimately, this “C reactive” component was found to be a protein and 
was given the name “CRP” (McWilliam, et al., 2010). 
 
In humans, plasma levels of CRP can increase markedly as much as 1000 fold or more, after 
an acute inflammatory stimulus, largely reflecting increased synthesis by hepatocytes. It is 
important to note however that CRP induction is part of a larger picture of re-orchestration of 
liver gene expression during inflammatory states, the acute phase response, in which 
synthesis of many plasma proteins are increased (Du Clos, et al., 2004). At least 40 plasma 
proteins are defined as acute phase proteins, based on changes in circulating concentration 
after an inflammatory stimulus. This group includes clotting proteins, complement factors, 
anti-proteases, and transport proteins. These changes presumably contribute to defensive or 
adaptive capabilities of the host immune response (Du Clos, et al., 2004). 
 
2.6.1 Experimental evidence of CRP in action 
 
CRP has been shown to play a protective role in a variety of inflammatory conditions, 
including protecting mice from lethal challenge with bacterial LPS and various mediators of 
inflammation (Black, et al., 2004). In addition, CRP has been found to delay the onset and 
development of experimental allergic encephalomyelitis, an aseptic animal model of multiple 
sclerosis (Szalai, et al., 2002). In a murine model of chemotactic factor-induced alveolitis, 
CRP has also been shown to inhibit the influx of neutrophils and protein into the lungs 
(Black, et al., 2004).  
 
In addition to these mouse models, a polymorphism in the human CRP gene resulting in a 
lower basal level of CRP has been associated with an increased risk of developing systemic 
lupus erythematosus (Black, et al., 2004).  
 
CRP is an ancient protein whose initial role as a pattern recognition molecule may have been 
to defend against bacterial infections, but whose present biological role appears quite 
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complex. It is likely that the activity of CRP in humans, either pro- or anti-inflammatory is 
dependent on the context in which it is acting. Therefore it seems important that CRP is 
studied in order to gain a better understanding of the effects of engineered nanomaterials on 
the human liver and the eventual clearance of these materials from the organ.  
 
2.7 Inflammation 
 
The term inflammation is derived from the Latin “inflamatio” meaning to set on fire (Scott, et 
al., 2004). It is an extremely complicated process involving the innate and adaptive immune 
systems with many cells and molecules contributing to the generation of different 
physiological and pathological outcomes; such as wound healing and infection (Coussens, 
2002). An inflammatory response can be initiated by both antigen dependent or independent 
stimulation (Baniyash, 2006). The former is initiated by pathogen associated membrane 
proteins (PAMPs) - mainly nucleotide-binding oligomerization domain (NOD) proteins and 
Toll like receptors (TLRs) inducing the production of lipid mediators, cytokines and 
chemokines from neutrophils, macrophages, and mast cells. These events lead to a co-
ordinated increase in vascular permeability, up regulation of adhesion molecules (L-, P-, and 
E-selectins in early stages and 41, 14 integrins binding vascular cell adhesion molecule 
-1 (VCAM-1) and mucosal vascular addressin cell adhesion molecule 1 (MadCAM-1) at later 
junctures on the blood vessels, important for direction and migration of leukocytes to site of 
injury (Carneiro, et al., 2008).  
 
This is subsequently followed by activation of phagocytes and promotion of their 
microbicidal action, pursued shortly by activation of natural killer cells and the release of 
cytokines (IFN-) essential for enhancing cytotoxicity and further activation of macrophages 
which are the most important cells as a source of growth factors, cytokines and modulating 
tissue repair (Beutler, 2004; Hamerman, et al., 2005).  
 
The main mediators of inflammation are TNF-α, I-1, IL6, prostaglandins (PGE2 believed by 
many to be the most potent mediator of them all), leukotrienes, histamine, bradykinan and 
PAF (Coussens, 2002). Collectively they control inflammatory cell populations, up-regulate 
vascular permeability and adhesion, increase cytotoxicity of natural killer cells, pain as well 
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promoting production of phagocytes and acute phase proteins from the liver (Coussens, 
2002).  
 
Chemokines are crucial for directing cells to the targeted areas of inflammation. Some of 
these important soluble proteins include neutrophil attracting factors like IL8, C5a, Kalikerin 
and monocyte guiding proteins such as monocyte chemo-attractant proteins 1, 2 and 3, 
Tumour growth factor β (TGF-) and macrophage inflammatory proteins 1 and 1 
(Carneiro, et al., 2008).  
 
2.8 Oxidative stress 
 
The recent abundant evidence suggesting the involvement of oxidative stress in the 
pathogenesis of various disorders and diseases has attracted much attention both in the 
scientific community and general public. 
 
Reactive oxygen species (ROS) and other free radicals are critical intermediates in the normal 
physiology and pathophysiology of the liver in particular with regards to the hepatocytes 
(Diesen, et al., 2009). ROS are important in the creation of oxidative stimuli required for 
normal physiologic homeostasis of hepatocytes. However, the equilibrium between ROS 
generation and the antioxidant defence within a cell can be disrupted resulting in an overall 
net oxidative stress (Kang, 2002). In the liver, free radicals triggered by ROS are created by 
the neutrophils, Kupffer cells, mitochondria, and cytochrome P450 (Kang, 2002). The 
damage created by oxidative stress affects all cells within the liver by inducing inflammation, 
ischemia, apoptosis and necrosis. ROS affect the pathophysiology of many diseases such as 
atherosclerosis, adult respiratory distress syndrome, cystic fibrosis, cataracts, cancer, liver 
disease, diabetes, neurological conditions and ischemia/reperfusion injuries (Lieber, 1997). 
Currently, it is believed that ROS also affects signal transduction pathways that when 
unbalanced may lead to hepatic inflammation, necrosis, fibrosis, and/or apoptosis (Diesen, et 
al., 2009) as has been shown in the lung and other cell types (Clift, et al., 2010). ROS include 
superoxide (O2
-
), hydrogen peroxide (H2O2) and hydroxyl radical (OH
-
). Of these, those with 
an unpaired electron are known as ‘‘radicals’’ (Diesen, et al., 2009). Superoxide (O2
-
) is the 
most common radical that can serve as a precursor for several other ROS species. It is 
important to note however, that O2
-
 by itself is also a potent oxidant. Superoxides are 
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constitutively produced by mitochondria as a by product of oxidative phosphorylation, as the 
mitochondria reduce approximately 1 – 3% of respiratory oxygen molecules to superoxide 
anions (Nohl, et al., 2003). Mitochondria contain enzymes and compounds that consume 
ROS, including superoxide dismutase that converts superoxide anion (O2
-
) to hydrogen 
peroxide (H2O2), catalases (H2O2 dismutases) and peroxidases that reduce H2O2 to water, 
frequently by employing the reducing power of NAD(P)H. Metals including iron and copper 
can further react with hydrogen peroxide to produce hydroxyl radicals via the Fenton reaction 
(Nohl, et al., 2003). The Fenton reaction recycles iron from Fe (II) to Fe (III) by oxidizing 
superoxide anion to oxygen. Hydroxyl radicals are then created resulting in an increase in the 
levels of bioactive iron. This process can occur in Kupffer cells in pathologic conditions such 
as cirrhosis (Nohl, et al., 2003). The ability of superoxide to activate this reaction makes it an 
important factor in oxidative stress. 
 
Reactive oxygen species are necessary for many normal physiological functions. Reactive 
oxygen species are implicated in cell signalling and are considered by some to be the second 
messengers that can trigger cytokine, hormone, and growth factor release from certain cells 
(Diesen, et al., 2009). ROS can also affect gene expression, as well as playing a role in the 
normal induction of apoptosis though the exact mechanisms are currently unclear (Diesen, et 
al., 2009). Since ROS are ubiquitous in the normal physiology of so many processes, it is not 
surprising that when excess ROS are produced they subsequently affect many normal 
functions of a healthy cell. 
 
2.9 Antioxidants  
 
To combat excess ROS, the body utilizes antioxidants. Endogenous antioxidants are usually 
small molecules that are able to prevent or limit oxidative damage by detoxifying ROS 
(Glantzounis, et al., 2005). Common antioxidants in hepatocytes include glutathione (GSH), 
glutathione peroxidase, and reductase enzymes superoxide dismutase (SOD), hemeoxygenase 
(HO), peroxidases and metal binding proteins (Glantzounis, et al., 2005). Low molecular 
weight compounds, such as bilirubin, melatonin, lipoicacid, coenzyme Q and uric acid also 
have antioxidant properties (Glantzounis, et al., 2005). Antioxidants can be classified into 
hydrophilic (e.g. GSH) and hydrophobic (e.g. α-tocopherol) categories allowing protection 
for all components within the cell (Teixeira, et al., 2012).  
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Glutathione is a ubiquitous tri-peptide which primarily functions to react with hydrogen 
peroxide utilising glutathione peroxidase to create glutathione disulfide (GSSG). GSH also 
scavenges other ROS molecules and prevents oxidation of protein sulfhydryl groups (Diesen, 
et al., 2009). In addition to glutathione, catalase and peroxidases are able to break down 
hydrogen peroxide to less reactive metabolites. Catalase converts hydrogen peroxide to water 
and oxygen, while peroxidase is also able to reduce it to water with reducing equivalents, 
usually thiol-containing molecules such as thioredoxin. Thioredoxin contains two sulfhydryl 
groups, which are oxidized to a disulfide. Another antioxidant enzyme - superoxide 
dismutase (SOD), catalyzes the reaction of two superoxide radical anions with each other, 
leading to the formation of one molecule of molecular oxygen and one molecule of hydrogen 
peroxide (Glantzounis, et al., 2005). Peroxide is relatively stable but in the presence of a 
transit ion metal may form hydroxyl radicals. It is well known that transition metals may 
create reactive oxygen species (e.g. via Fenton reaction), therefore it is a very real possibility 
that metal binding proteins may also have antioxidant properties (Diesen, et al., 2009). Iron 
may be bound by transferrin and lactoferrin, while ceruloplasmin and albumin bind copper. 
Haemoglobin and myoglobin both contain iron and heme. When exposed to excessive 
oxidative stress, the heme group and the iron may disassociate, thus promoting lipid 
peroxidation. When this occurs, haemoglobin binding proteins such as haptoglobin and heme 
binding proteins like hemopexin, bind these proteins to decrease the level of lipid 
peroxidation (Diesen, et al., 2009).  
 
Exogenous antioxidants may also be consumed through the diet: common dietary forms 
include vitamin C (ascorbate), vitamin E, carotenoids, and plant phenols. Lipophilic α-
tocopherol, the active form of vitamin E, scavenges peroxyl radicals and prevents lipid 
peroxidation (Birlouez-Aragon, et al., 2003). Carotenoids are a source of vitamin A and also 
scavenge free radicals, while plant phenols are able to scavenge ROS and to chelate metals 
(Diesen, et al., 2009).  
 
2.10 Distribution and deposition of the NMs in the liver (current understanding) 
 
There is some evidence that nanomaterials administered via intravenous (IV), intraperitoneal 
(IP) and inhalation routes will eventually reach the liver (Chen, et al., 1999; Semmler-
Behnke, et al., 2008). The organ has prominent importance as it receives NMs at extremely 
high volumes compared to other organs and alongside the kidneys might be responsible for 
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the clearance of these materials from the blood (Chen, et al., 1999). In a recent study, mice 
were injected with gold NMs sized 2 and 40 nm. It was observed that the 40 nm materials 
administered via the IV route were only located within the mice Kupffer cells of the liver 
(Sadauskas, et al., 2007). The uptake of 2 nm NMs was slower and only some of the Kupffer 
cells internalising the materials with the rest being traced to some of the macrophages in the 
spleen (Sadauskas, et al., 2007). Intraperitoneal administration of the NMs resulted in less 
intense staining of the Kupffer cells (still markedly higher than other organs). Instead the 
particulates were located within the macrophages of the mesenterial lymph nodes and 
lymphatic tissues of the spleen and the small intestine (Sadauskas, et al., 2007). These 
findings are extremely interesting as after IP injection the NMs pass numerous lymph nodes 
packed with macrophages and other immune system cells, yet the majority travel to the liver 
and are taken up by the Kupffer cells. These and other findings indicate that Kupffer cells 
could well be central to the elimination of NMs that reach the liver (Sadauskas, et al., 2007; 
2009a; Xiong, et al., 2008). It is believed that NMs are potentially taken up by the Kupffer 
cells via trancytosis (Sadauskas, et al., 2009a). 
 
2.11 Neutrophils and the liver 
 
Neutrophils also referred to as polymorphonuclear leukocytes (PMNs) are the most abundant 
of all white blood cells comprising of up to 70% of all leukocytes (Freitas, et al., 2009). 
Neutrophils are the front line effectors of the innate immune system: after differentiation 
these short lived cells circulate in the bloodstream for up to 7 hr before migrating into tissues 
(Quinn, et al., 2004). These cells are solely responsible for surveillance and constituting the 
first line of defence against foreign antigens (Nauseef, 2007). Hence it is not surprising that 
in the event of an inflammatory response there is usually an increase in PMN numbers, 
mobility, tissue influx and phagocytic ability (Freitas, et al., 2009). Neutrophils are the most 
active phagocytic cells in the hosts immune system arsenal. They are capable of ingestion of 
antigens into specialised phagosomes and producing a wide array of cytotoxic agents to 
eliminate the foreign particle (Nauseef, 2007). The role of PMNs in disposal of NMs is not 
yet fully understood, however it has been shown that nanomaterial exposure in the lungs 
results in a large increase in PMN numbers in the tissue (Donaldson, et al., 2003).  
 
In order to gain entry into the liver neutrophil rolling and adhesion requires up-regulation of β 
integrins, selectins and endothelial receptors (Jaeschke, et al., 2006). It has been shown that 
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the most common neutrophil mediated response in the liver is governed by the adhesion of 
the cells to hepatocytes (via ICAM-1 binding Mac-1) (Bautista, 2002; Ramaiah, et al., 2007). 
This adhesion triggers the formation of reactive oxygen species (ROS) by NADPH oxidase 
and release of proteases through the degranulation of the PMNs. This process could lead to 
neutrophilic hepatitis characterised by self aggravating mechanisms resulting in chronic 
disease (Bautista, 2002).  
 
2.12 The kidneys 
 
Human kidneys are fist sized organs located at either side in the lower abdomen. The kidneys 
are principally responsible for the removal of metabolic waste. This term is generally taken as 
nitrogenous waste; namely urea and ammonia, however it is widely accepted that other waste 
products and toxic substances such as carbon dioxide, bile and possibly nanomaterials are 
excreted through urine (Wang, et al., 2009). The blood and all tissue fluids contain a variety 
of solutes including glucose and salts dissolved in water. The concentrations (relative and 
absolute) of these solutes have to be tightly regulated as does their total concentration relative 
to water (Raven, et al., 2008).  This solute concentration must be kept constant in both the 
blood and tissue fluids (osmoregulation) (Raven, et al., 2008). The two processes of excretion 
and osmoregulation are governed by the urinary system and the kidneys. 
 
2.13 Blood supply to the kidneys 
 
The kidneys receive blood from the renal arteries, left and right, which branch directly from 
the dorsal aorta. Despite their relatively small size, the kidneys receive approximately 20% of 
the entire cardiac output (Roberts, et al., 2000). Each renal artery branches into segmental 
arteries, dividing further into interlobar arteries which penetrate the renal capsule and extend 
through the renal columns between the renal pyramids. The interlobar arteries then supply 
blood to the arcuate arteries that run through the boundary of the cortex and the medulla. 
Each arcuate artery supplies several interlobular arteries that feed into the afferent arterioles 
that supply the glomeruli (Figure 2.3) (Raven, et al., 2008). After filtration in the glomeri 
occurs, the blood moves through a small network of venules that surround the kidney tubule 
structures before they converge into interlobular veins. As with the arteriole distribution, the 
veins follow in the same pattern, the interlobular veins provide blood to the arcuate veins 
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flowing back to the interlobar veins, which form the renal vein exiting the kidney for 
transfusion of blood (Raven, et al., 2008).  
 
 
Figure 2.3. The blood supply to the kidney (Adapted from Raven, et al., 2008). 
 
2.14 A healthy functioning kidney 
 
Each kidney contains about one million functioning filtering units (nephrons). Mammalian 
kidneys contain a mixture of juxtamedullary nephrons which are characterised by long loops 
(loop of Henle) dipping into the medulla and cortical nephrons with shorter loops (Raven, et 
al., 2008).  
 
Each nephron consists of a long tubule and associated small blood vessels. The blood enters 
the nephrons via afferent arterioles. Here the blood is filtered by the glomerulus - the blood 
pressure forces through the porous capillary walls (Wang, et al., 2009). Erythrocytes and 
plasma proteins are too large to enter the glomerular filtrate but large quantities of plasma, 
containing water and dissolved molecules and potentially NMs, leave the vascular system at 
this step. The filtrate immediately enters the Bowman’s capsule and is in turn released into 
the proximal convoluted tubule located in the cortex (Raven, et al., 2008). Water is re-
absorbed as it passes through the loop of Henle. After leaving the loop the fluid is delivered 
to distal convoluted tubules in the cortex that drains into a collecting duct (Roberts, et al., 
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2000). The collecting ducts from the millions of different nephrons empty into one of the two 
ureters. Most of the water and dissolved solutes are re-absorbed during the passage through 
this tubule system. This selective re-absorption in the collecting duct is driven by an osmotic 
gradient produced by the loop of Henle (Raven, et al., 2008). The re-absorption of glucose, 
amino acids and other essential molecules needed in the body is driven by active transport 
and other co-transport carriers, with the maximum rate of transport achieved when the 
carriers are saturated (Jaitovich, et al., 2009). If a person has a higher than normal blood 
glucose level (above 180 mg/ml; individuals suffering from diabetes mellitus) the glucose in 
the filtrate is expelled in the urine (Villar, et al., 2009). The secretion of foreign molecules 
and waste products involves the transport of these entities across the membranes of the blood 
capillaries and kidney tubules into the filtrate. This process is similar to re-absorption but 
proceeds in the opposite direction (Raven, et al., 2008). 
 
Urine with high H
+
 concentration helps maintain the acid-base balance of the blood within a 
narrow range (pH 7.35 - 7.45). Moreover, the excretion of water in urine contributes to the 
maintenance of blood volume and pressure (i.e. large volumes of urine excreted reduce blood 
volume) (Roberts, et al., 2000). The purpose of kidney function is therefore homeostasis – 
maintaining the constancy of the internal environment (Villar, et al., 2009). 
 
2.15 Proximal convoluted tubules 
 
Water is only able to pass through a cell through osmosis; however this process is not 
possible between two isotonic solutions. Therefore some mechanism is needed to create an 
osmotic gradient between glomerular filtrate and the blood to allow re-absorption of water 
(Raven, et al., 2008). Virtually all the nutrient molecules in the filtrate are re-absorbed back 
into the systemic blood by the proximal convoluted tubules. In addition, two-thirds of the 
sodium chloride and water filtered into the Bowman’s capsule is immediately re-absorbed 
across the walls of the proximal convoluted tubules (Raven, et al., 2008). The re-absorption is 
driven by the active transport of Na
+
 out of the filtrate and into the surrounding peritubular 
capillaries. Cl
-
 follows Na
+ 
passively because of electrical attraction and water follows 
because of osmosis (Jaitovich, et al., 2009). As NaCl and water are removed from the filtrate 
in proportionate amounts, the filtrate remaining in the tubule is still isotonic to the blood 
plasma (Jaitovich, et al., 2009). The luminal surface of the epithelial cells of this segment of 
the nephron is covered with densely packed microvilli named the brush border cells. The 
47 
 
microvilli greatly increase the luminal surface area of the cells. The cytoplasm of these cells 
are densely packed with mitochondria - largely found in the basal region within the foldings 
of the basal plasma membrane. The mitochondria are needed in order to supply the energy for 
the active transport of sodium ions out of the proximal tubule. Cuboidal epithelial cells lining 
the proximal tubule have extensive lateral inter-digitations between neighbouring cells 
(Roberts, et al., 2000). The agonist re-absorption of the proximal tubular contents after 
interruption of circulation in the capillaries surrounding the tubule often leads to disturbance 
of the cellular morphology of the proximal tubule cells, including the ejection of cell nuclei 
into the tubule lumen (Roberts, et al., 2000). 
 
2.16 Loop of Henle 
 
As previously stated, the function of the loop of Henle is to create a gradient of increasing 
osmolarity from the cortex to the medulla (Figure 2.4). This allows water to be re-absorbed 
by osmosis in the collecting duct as it runs down the medulla past the loop of Henle (Roberts, 
et al., 2000).  
 
Figure 2.4. Mammalian nephron (Adapted from Roberts, et al., 2000). 
 
The descending and ascending limbs of the loop of Henle differ structurally and in their 
permeability. This produces a gradient of increasing osmolarity from the cortex to the 
medulla (Figure 2.4) (Raven, et al., 2008). The ascending limb of the loop of Henle is 
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composed of a thick layer of low simple cuboidal epithelium cells, while the descending limb 
is compiled of relatively thin layers of simple squamous epithelial cells (Raven, et al., 2008). 
The entire ascending limb is impermeable to water. This thick portion allows active 
transportation of Na
+ 
out of the tubule with Cl
- 
following
 
passively. The descending limb is 
thin and permeable to water but not to NaCl. The Na
+
 and Cl
- 
are lost by the ascending limb, 
therefore the osmalarity of the interstitial fluid is higher than the descending limb, hence 
water moves out of the limb by osmosis (Roberts, et al., 2000). The sodium chloride pumped 
out of the ascending limb of the loop is re-absorbed from the surrounding interstitial fluid 
into the vasa recta renis (capillaries in the medulla) (Raven, et al., 2008). 
 
2.17 Distal convoluted tubules and the collecting duct 
 
The filtrate reaching the distal convoluted tubules is hypotonic and by the time it reaches the 
collecting duct it is removed by a strong osmotic gradient into the surrounding blood vessels 
(Raven, et al., 2008). The osmotic gradient normally remains constant but the permeability of 
the distal convoluted tubule and the collecting duct is adjusted by anti-diuretic hormone 
(ADH) (Raven, et al., 2008). When the animal needs to conserve water the posterior pituitary 
gland secretes more ADH. The increase in the hormones correlates with a rise in the number 
of water channels in the plasma membrane of the collecting duct cells resulting in the release 
of hypertonic urine (Roberts, et al., 2000). In addition the re-absorption of NaCl in the distal 
convoluted tubules and the collecting duct is under the control of the hormone aldostrone 
(Raven, et al., 2008).  
 
2.18 Immunology of the kidneys 
 
In the immune system, a complex orchestration of cytokines and other molecules act in a 
paracrine, autocrine or endocrine fashion to control the differentiation, proliferation and 
activity of immune cells. The kidneys maintain a delicate equilibrium between pro-
inflammatory cytokines and their inhibitors. Therefore, any cytokine response to infection or 
injury is a well-coordinated and precisely controlled process aimed at maintaining the body 
homeostasis (Carrero, et al., 2008). 
 
It is important to distinguish between local and systemic inflammation. Locally produced 
pro-inflammatory mediators include IL8, IL12, IL18, TNF-α and IFN-γ and IL6. In the 
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kidney these cytokines are produced predominately by T helper lymphocytes and 
macrophages. Th1 cytokines stimulate the synthesis of nitric oxide and other inflammatory 
mediators, the functional activity of cytotoxic T cells, natural killer cells and activated 
macrophages, altogether exerting a pro-inflammatory action. On the other hand, Th2 
cytokines inhibit macrophage activation, T cell proliferation and the production of pro-
inflammatory cytokines, therefore are involved in anti-inflammatory processes. Th1 and Th2 
responses are mutually inhibitory (Carrero, et al., 2008). Many believe that day to day 
immunity of the kidneys is predominately controlled by the macrophages. Studies in which 
urine samples were collected from patients with acute rejection episodes following kidney 
transplantation demonstrated significantly higher levels of IFN-γ and TNF-α. Elevated 
concentrations of these pro-inflammatory cytokines in urine unaccompanied by high 
concentrations of IL2, seems to suggest an ongoing undetected nonspecific macrophage-
mediated Th1 immune response, capable of amplifying the allo-immune response in the early 
phases of post surgery, leading to immunity (Karczewski, et al., 2009).  
 
This being said it is important to mention that the renal epithelial cells are also able to 
contribute to the immune response in the organs by producing a wide array of cytokines and 
chemokines under certain conditions including IL10 (Liu, et al., 2012), MCP-1 (Liu, et al., 
2012), vascular endothelial growth factor a (VEGF-a) (Fernandez-Martinez, et al., 2012), IL6 
(Fitzgerald, et al., 2012) and IL8 (Fitzgerald, et al., 2012).   
 
Over all it seems that unlike the liver, in the kidneys immunity is favoured over tolerance. 
Hence all lymphoid and myeloid cells such as dendritic cells, natural killer cells, neutrophils 
and the lymphocytes contribute to the immunity of the kidneys (Carrero, et al., 2008). 
 
2.19 Distribution and deposition of the NMs in the kidney (current understanding) 
 
The kidneys are particularly susceptible to xenobiotics due to their high blood supply and 
their ability to concentrate toxins (L’azou, et al., 2008). In theory both the glomerular 
structures (during plasma filtration) and tubular epithelial cells may be potentially exposed to 
nanomaterials. Previous experiments have demonstrated that mice exposed to copper NMs 
had severe damage to the proximal tubular cells (Chen, et al., 2006), while Wang and 
colleagues observed glomerulonephritis and pathological degeneration of the renal proximal 
convoluted tubules following oral TiO2 administration (Wang, et al., 2007a). The kidney is 
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composed of different cell types with varying levels of sensitivity to toxic substances. 
Mesenglial cells for example are perivascular pericytes located within the central portion of 
glomeular tuft between the capillary loops and are involved in the control of glomeular 
hemodynamics. They encounter blood filtrate in large volumes and are very possibly one of 
the cell types most likely to encounter NMs in vivo (L’azou, et al., 2008). Proximal tubule 
cells are characterised by well-developed basal infolding and an apical brush border and 
characterised by their ability for intense pinocytic activity. Furthermore they are capable of 
variable transport and co-transport of various materials (Cartiera, et al., 2009). Hence these 
cells were an ideal candidate for an in vitro nanotoxicological investigation. 
 
2.20 Aims 
 
To evaluate adverse effects of a range of manufactured nanomaterials on the liver and 
kidneys (due to their potential for NM accumulation, both organs have an essential role in 
maintaining health and their contrasting immunological profiles) as part of the Seventh 
Framework programme (FP7) project ENPRA. A number of endpoints were thoroughly 
investigated. These included cytotoxicity, oxidative stress, inflammation and genotoxicity.  In 
addition we utilised a full dose reposnse which will provide information for the development 
of structure activity relationships and risk assessment model to be implemented by the JRC. 
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Chapter Three 
Materials and methods 
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This work was conducted as part of a large collaborative project. All of the methods 
described below were conducted by Ali Kermanizadeh.  Methods conducted by collaborators 
are provided in the appendices and are indicated below as appropriate. 
 
3.1 Equipment 
 
Throughout all experiments the following equipment were utilised: Sartorius ME36S  
balance, Ultrawave Q series ultrasonic sonicator, ESCO class II BSC Airstream biohazard 
safety cabinet, New Brunswick Galaxy 170S incubator, Grant OLS 200 water bath, Dynex 
Magellen Biosciences MRX Revelation plate reader, FLUOstar Optima Microplate reader, 
Grabt-Bio PMS-1000 Orbital Microplate shaker, Hitachi S-4800 Type II Field Emission Gun-
Scanning Electron Microscope and Tecnai 12 and Joel 2010 Transmission Electron 
Microscopes. 
 
3.2 Nanomaterials 
 
Nanomaterials were purchased as stated: NM 101 (Hombikat UV100; rutile with minor 
anatase; 7 nm), NM 110 (BASF Z-Cote; zinkite, uncoated, 100 nm), NM 111 (BASF Z-Cote;  
zinkite coated with triethoxycaprylylsilane, 130 nm), NM 300 (RAS GmbH; Ag capped with 
polyoxylaurat Tween 20 - < 20 nm), NM 400 (Nanocyl; entangled MWCNT, diameter 30 
nm), NM 402 (Arkema Graphistrength C100; entangled MWCNT, diameter 30 nm). These 
NMs were originated from the European Commission Joint Research Centre (JRC, Ispra, 
Italy). The above mentioned nanomaterials were sub-sampled by the JRC under Good 
Laboratory Practice conditions and preserved under argon in the dark until use. The NRCWE 
samples were procured by the National Research Centre for the Working Environment 
(NRCWE). Sub-sampling was completed by NRCWE into 20 ml Scint-Burk glass pp-lock 
with Alu-Foil (WHEA986581; Wheaton Industries Inc.) after pooling and mixing 0.1 to 1 kg 
of the material to cover the need of the ENPRA project. NRCWE 001, TiO2 rutile 10 nm was 
purchased from NanoAmor (Houston, USA) and was also used for production of NRCWE 
002 (TiO2 rutile 10 nm with positive charge) and NRCWE 003 (TiO2 rutile 10 nm with 
negative charge) using the procedures described below (Section 3.3). NRCWE 004 (TiO2 
rutile 94 nm) was purchased from NaBond. The Ag was supplied in de-ionised water (85%) 
with 7% stabilizing agent (ammonium nitrate) and 8% emulsifiers (4% each of 
Polyoxyethylene Glycerol Trioleate and Tween 20). All other materials were supplied as dry 
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powders. The complete list of investigated nanomaterials including information provided by 
the suppliers is reported in Table 3.1. 
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NM NM Code  Average Size (nm) 
(Supplier 
information) 
Additional information CAS - number 
TiO2 NM 101 7 nm anatase, thermal 13463-67-7 
ZnO NM 110 100 nm uncoated 1314-13-2, EINECS 
215-222-5 
ZnO NM 111 130 nm triethoxycaprylylsilane 
coated 
1314-13-2, 2943-75-1 
EINECS 215-222-5, 
220-941-2 
Ag NM 300 < 20 nm Polyoxylaurat Tween 20 
capped 
7440-22-4 
MWCNT NM 400 30 nm 
5 µm long 
short entangled 7782-42-5, EINECS 
231-955-3 
MWCNT NM 402 30 nm 
5 µm long 
long entangled 7782-42-5, EINECS 
231-955-3 
TiO2 NRCWE 001 10 nm (XRD) rutile 13463-67-7 
TiO2 NRCWE 002 10 nm (XRD) rutile  - 
TiO2 NRCWE 003 10 nm (XRD) rutile  - 
TiO2 NRCWE 004 94 nm (XRD) rutile 13463-67-7 
Table 3.1. List of engineered nanomaterials investigated, with the original source codes, the nominal sizes 
and properties as provided by the supplier. 
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3.3 Surface functionalisation of titanium dioxide (conducted by the NRCWE) 
 
The surface functionalistion of NRCWE 002 and NRCWE 003 was carried in the National 
Research Centre for the Working Environment in Copanhagen. Details are provided in 
appendix 1.  
 
3.4 Nanomaterial characterisation (conducted by University Ca’ foscari Venice) 
 
The majority of the work in characterising the panel of ENPRA nanomaterials was taken 
place at the Department of Environmental Sciences, Informatics and Statistics, University 
Ca’ Foscari Venice. Details are provided in appendix 2.  
 
Primary and aggregate size range, shape and crystal structure of the test materials were 
determined by Transmission Electron Microscopy (TEM) on a Jeol (Tokyo, Japan) 3010 
transmission electron microscope operating at 300 kV. Surface areas and pore volumes were 
obtained by nitrogen adsorption on a Micrometritics ASAP2000 Accelerated Surface Area 
and Porosimetry System at an adsorption temperature of -196°C, after pre-treating the sample 
under high vacuum at 300°C for 2 hr (Brunauer, et al., 1938). The selected degassing 
conditions may affect the coating on some of the powder nanomaterials. 
 
3.5 Dynamic light scattering  
 
The hydrodynamic size distributions of the NMs dispersed in William’s E medium (Life 
Technologies, UK), Keratinocyte serum free media (K-SFM) (Life Technologies, UK), RPMI 
with 10% fetal calf serum (FCS) (Sigma, UK) and HepatoZyme (Life Technologies, UK) 
were determined in the 1 - 128 µg/ml concentration range (equivalent to the cell exposure 
concentration range utilised in this study) by dynamic light scattering (DLS) using a Malvern 
Metasizer nano series – Nano ZS (USA). 
 
3.6 Atomic absorption spectroscopy (AAS) 
 
Stock solution of standards was prepared for both Ag and Zn in water ranging from 4 down 
to 0.1 ppm. The Ag and ZnO NMs (NM 300, NM 110 and NM 111) were dispersed in the 
ENPRA dispersant and sonicated (section 3.8). To ascertain the dissolution of ZnO and Ag, 
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the materials were diluted in both ultrapure and filtered water and Minimum Essential 
Medium Eagle (MEM) (Invitrogen, UK) with 10% FCS, 2 mM L-glutamine, 100 U/ml 
Penicillin/Streptomycin, 1 mM sodium pyruvate, and 1% non essential amino acids (termed 
complete medium). The nanoparticle dispersions and blank samples were incubated in 
triplicate for 24 hr at 37°C, 5% CO2 (identical exposure conditions as used for the treatment 
of cells). The NMs were centrifuged at 13000 g for 1 hr before the supernatant was passed 
through a 5000 KDa (25 nanometers) ultrafilteration column (Sartorius, USA). Supernatants 
were stored at 4°C until accessed by AAS. The analysis was carried out using a Perkin Elmer 
AAnalyst 200 Atomic Absorption Spectrometer (Ag and Zn Hollow Cathode Lamp). 
 
3.7 Cell culture 
 
The human hepatoblastoma C3A cell line was obtained from the American Type Culture 
Collection (ATCC) (USA). The cells were maintained in complete C3A medium (Section 
3.5), at 37ºC and 5% CO2. 
 
The primary human hepatocytes were purchased from Life Technologies, UK. The cells were 
maintained in Williams E medium (Life Technologies, UK) with 5% FCS, 10 µM 
dexamethasone in DMSO, 100 U/ml Penicillin/Streptomycin, 4 µg/ml bovine insulin, 2 nM 
Glutamax and 15 mM of HEPES, at 37ºC and 5% CO2.  
 
The immortalized adult human renal proximal tubule epithelial cells (HK-2) were obtained 
from the ATCC (USA). The cells were maintained in Keratinocyte Serum Free Medium (Life 
Technologies, UK) containing 25 µl of bovine (pituitary) extract, 0.2 ng/ml human 
recombinant epidermal growth factor and 100 U/ml penicillin/streptomycin (termed K-SFM) 
or RPMI (Sigma, France) with 10% FCS and 100 U/ml penicillin/streptomycin (termed 
complete RPMI), at 37ºC and 5% CO2. Two different media were utilised to allow 
comparisons of cytotoxicity and a better understanding of how the nanomaterials behave in 
different media with varying amounts of protein. 
 
3.8 Nanomaterial treatment 
 
NMs were dispersed in MilliQ de-ionised water with 2% FCS. For coated ZnO (NM 111), the 
particles were wetted with 0.5 % vol ethanol before the addition of the dispersion media. The 
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nanomaterials were sonicated for 16 mins without pause following the protocol developed for 
ENPRA (Jacobsen, et al., 2010). Following the sonication step, all samples were immediately 
transferred to ice (all NMs were used within 15 mins of being sonicated).   
 
To ascertain the toxicity of nanomaterials to the cells ten concentrations between 0.16 μg/cm2 
and 80 μg/cm2 were utilised (corresponding to 0.5 µg/ml to 256 µg/ml) by diluting in 
complete medium for each cell type (at room temperature). All NM treatments were carried 
out in the dark. 
 
3.9 WST-1 cell viability assay 
 
The WST-1 assay is based on the enzymatic cleavage of tetrazolium salt to a water soluble 
formazan dye by the mitochondria (tetrazolium reductase) in viable cells. An expansion in the 
number of viable cells results in an increase of overall activity of mitochondrial 
dehydrogenases, hence more WST-1 is converted to the formazan which can be detected and 
quantified. This absorbance value is representative of cell viability (Al-Nasiry, et al., 2007).  
 
All cells were seeded in 96 well plates (10
4
 cells per well in 100 µl of the cell culture 
medium) and incubated for 24 hr at 37ºC and 5% CO2. The following day the cells were 
exposed to the materials or controls for 24 hr at 37ºC, 5% CO2. Subsequent to NM treatment, 
cell supernatants were collected and frozen at -80ºC and later used for enzyme linked 
immunosorbent assays (ELISA), FACSArray, urea analysis and CYP450 activity 
measurement where appropriate. The cells were washed twice with phosphate buffered saline 
(PBS), followed by the addition of 10 μl of the WST-1 cell proliferation reagent (Roche, 
USA) and 90 μl of fresh medium. Cells were then incubated for 1 hr at 37ºC, 5% CO2. The 
plates were spun for 2 mins at 1000 g. The supernatant was transferred to a fresh plate and 
the absorbance measured by dual wavelength spectrophotometry at 450 nm and 630 nm using 
a micro-plate reader (supernatants were transferred into fresh plates in order to decrease the 
potential interference of the NMs during the measurement of the absorbance).  
 
3.10 Alamarblue cell viability assay 
 
Alamarblue is a non-toxic, cell-permeating compound that is blue in colour and virtually non-
fluorescent. Upon entering cells, resazurin is reduced to resorufin, which produces very 
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bright red fluorescence. Viable cells continuously convert resazurin to resorufin, thereby 
generating a quantitative measure of viability and cytotoxicity (Al-Nasiry, et al., 2007).  
 
The cells were plated and exposed to the selected NMs as previously described (Section 3.7 
and 3.8). The supernatants were removed and the plates washed twice with PBS. Alamarblue 
cell proliferation reagent (Invitrogen, UK) (10 µl) and 90 μl of fresh medium was added to 
each well. The plates were incubated for 2 hr at 37ºC, 5% CO2. The supernatant from each 
well was then transferred to a fresh plate and the absorbance measured using a 
spectrophotometer at a wavelength of 570 nm. 
 
3.11 Enzyme-linked Immunosorbent assay (ELISA) 
 
After exposure, the cell supernatants were collected and stored at -80ºC. The supernatants 
were centrifuged at 1000 g and cytokine and albumin levels determined by ELISA according 
to the manufacturer’s instructions. Human IL8, TNF-α and IL6 ELISA kits were purchased 
from Invitrogen (UK), human CRP ELISA from Immune systems (Paignton, UK), human 
albumin ELISA from Bethyl laboratories (USA), rat cytokine-induced neutrophil 
chemoattractant-1 (CINC-3) from  R and D Systems (USA) and rat IL10 from Abcam (USA). 
 
As a positive control the hepatocytes were treated with 10 µg/ml of LPS for 24 hr (Sigma, 
UK). 
 
3.12 Cytometric Bead Array cytokine and chemokine analysis 
 
The levels of human IL6, IL8, TNF-α and monocyte chemo-attractant protein 1 (MCP-1) 
produced by the HK-2 cells and IL6, TNF-α, and IFN-γ produced by a co-culture of primary 
rat hepatocyte and Kupffer cells was measured using the BD
TM
 Cytometric Bead Array 
cytokine flex sets (bead based immunoassay) according to the manufacturer’s instructions.     
 
In this assay flow cytometry is used to discriminiate between different bead population based 
on size and fluorescence. The flex sets employ micro particles with discrete fluorescence 
intensities to detect soluble anylates (in this case different cytokines or chemokines). Each 
bead provides a capture surface for a specific protein and is analogous to an individually 
coated well of an ELISA plate. 
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3.13 Urea assay 
 
In order to investigate the effects of NM exposure on urea production, a QuantiChrom Urea 
assay kit (BioAssay Systems, USA) was utilised. After exposure to the materials, the C3A 
cell supernatants were collected (Section 3.6). All samples were diluted (1:50) in distilled 
water and 50 µl of each sample was added to appropriate wells. Working reagent (200 µl) 
made from two components (reagent A: – o-phthalaldehyde <0.40%, Brij 35 <0.04%, 
sulphuric acid 10% and reagent B: – Primaquine diphosphate <0.08%, boric acid <0.8%, 
sulphuric acid 22% and Brij 35 <0.04%) was also added to all wells (1:1). The plates were 
incubated for 30 mins at room temperature and the absorbance read at a wavelength of 430 
nm on a plate reader. 
 
3.14 Antioxidant pre-treatment of hepatocytes 
 
The C3A cells were seeded in 96 well plates at 10
4
 cells per well in 100 µl of the complete 
cell culture medium and incubated for 24 hr at 37ºC and 5% CO2. In order to investigate the 
possible intervention of antioxidants on cytotoxicity, ROS or cytokine production from the 
hepatocytes, they were pre-treated with 100 µM of Trolox (6-hydroxy-2,5,6,7,8-
tetramethylchroman-2-carboxylic acid) in complete medium for 1 hr. The medium containing 
the antioxidant was removed before the addition of the nanomaterials as described above 
(Section 3.7). 
 
3.15 2',7'-dichlorfluorescein-diacetate (DCFH-DA) assay  
 
C3A cells were seeded on a 96 well plate in complete phenol red free (reduce interference) 
C3A medium (1x10
4
 cells per well) and incubated at 37°C, 5% CO2 for 24 hr. The cells were 
exposed to the NMs or equivalent control (hydrogen peroxide 100 µM – positive control) in 
complete medium for up to 24 hr. 
 
DCFH-DA is air, light and temperature sensitive so great care was taken when preparing the 
final working concentration. Following incubation, cells were rinsed and 100 µl of 2 mM 
DCFH-DA was added before the plates were incubated in the dark at room temperature for 1 
hr. Cells were rinsed again and 200 µl of 90% DMSO in PBS was added and incubated on a 
shaker for 5 mins at room temperature. The plates were wrapped in foil to protect from light 
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before being centrifuged for 2 mins at 250 g. This was followed by the measurement of 150 
µl of supernatant in black 96 well plates at an excitation wavelength of 485 nm and emission 
wavelength of 520 nm.  
 
3.16 HE Oxidation (conducted by Université Paris Diderot-Paris 7) 
 
The dihydroethidium (HE) oxidation experiment was carried by partners at the Université 
Paris Diderot-Paris 7, with the details provided in appendix 3.  
 
3.17 Measurement of total glutathione 
 
The protocol is adapted from Senft, et al., 2000. A 3 ml cell suspension of cultured cells (1x10
6 
cells per ml) was added to 6 well plates and incubated overnight at 37C and 5% CO2. The 
cells were exposed to the NMs or equivalent control dispersant in complete medium for 24 hr 
before being scraped into ice cold phosphate buffered saline and centrifuged (700 g for 2 
mins). The cell pellet was re-suspended in ice-cold lysis buffer, mixed and incubated on ice 
for 10 mins before being centrifuged at 15000 g for 5 mins to generate lysates and protein 
pellets. Glutathione was quantified in the lysate by reaction of sulfhydryl groups with the 
fluorescent substrate o-phthaladehyde (OPT) (OPT reacts with intracellular GSH to generate 
fluorescence) using a fluorimeter with an excitation wavelength of 350 nm and emission 
wavelength of 420 nm. 
 
The protocol was slightly modified to include measurements of total glutathione by reducing 
oxidase glutathione dimers (GSSG) by addition of 7 µl of 10 mM sodium dithionite to all 
samples and incubating at room temperature for 1 hr. 
 
The rat and mice liver tissues were thawed on ice and homogenised in 2 ml of lysis buffer on 
ice and centrifuged (700 g for 5 mins). The pellet was re-suspended in ice-cold lysis buffer 
(Senft, et al., 2000), mixed and incubated on ice for 10 mins before being centrifuged at 
15000 g for 5 mins. Glutathione was quantified in the lysate by reaction of sulfhydryl groups 
with the fluorescent substrate OPT using a fluorimeter with an excitation wavelength of 350 
nm and emission wavelength of 420 nm. 
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3.18 FPG modified Comet assay  
 
The FPG (formamidopyrimidine [fapy] – DNA glycosylase) modified Comet assay was used 
to measure DNA strand breaks and specific oxidative DNA damage such as 7, 8-dihydro-8-
oxoguanine, 8-oxoadenine, fapy-guanine etc., based on the method described by Speit, et al., 
2004. In this study the tail moment (Wilkland, et al., 2003) was measured using an automatic 
image analyser (Comet Assay IV; Perceptive Instruments, UK) connected to a fluorescence 
microscope. Images were captured using a stingray (F-033B/C) black and white video 
camera.  
 
After a 4 hr NM treatment (or positive control - 60 µM of H2O2), the cells were rinsed twice 
with PBS and detached using trypsin before being suspended in 5 ml of culture medium. 
Cells were centrifuged for 10 mins at 250 g, 4ºC and re-suspended at a concentration of 1.5 x 
10
6
 cells/ml in complete medium. A 20 µl volume of calculated cell suspension was added to 
240 µl of 0.5% low melting point agarose. Next, 125 µl of the mixture was added to pre-
coated slides (1.5% agarose) in triplicate. Following 10 mins of solidification on ice, slides 
were lysed overnight at 4ºC in lysis buffer (2.5 M NaCl, 100 mM EDTA, 10 mM Tris-base, 
pH 10, containing 10% DMSO and 1% TritonX-100). The slides were washed three times for 
5 mins with FPG-enzyme buffer (40 mM HEPES, 100 mM KCl, 0.5 mM EDTA, 0.2 mg/ml 
BSA - pH 8), covered with 100 µl of either buffer or FPG in buffer (1:30), sealed with a 
cover slip and incubated for 30 mins at 37ºC. FPG cleaves DNA at locations of oxidation 
leading to a greater tail for cells exhibiting oxidative DNA damage (Wilkland, et al., 2003). 
All slides were then transferred into a black chilled electrophoresis tank. After alkaline 
unwinding (pH 13) for 20 mins, electrophoresis was performed for 15 mins at 270 mA, 24 V. 
Slides were neutralized three times for 5 mins using a neutralization buffer (0.4 M TrisBase, 
pH 7.5). Before analysis, slides were dried in air for 10 mins and stained with GelRed (2 in 
10000, 40 µl per slide). A total of 50 cells were analyzed per slide per experiment. 
 
The longer term genotoxic ability of Ag NM (NM 300) was also investigated. The C3A cells 
were exposed to the NMs for 24 hr before being allowed to recover for 72 hr. The cells were 
then detached by treating with trypsin before being transferred to a new flask.  After 48 hr the 
cells were treated with the Ag NMs for 24 hr, with the whole process being repeated for a 
period of 8 weeks. 
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3.19 Cytochrome P450 assay 
 
After exposure, the hepatocyte supernatants (from both the control and treated cells as 
described in Section 3.7) were collected and stored at -80ºC. The supernatants were 
centrifuged at 1000 g and a DetectX
®
 P450 activity kit (ArborAssays, USA) was utilised to 
quantitatively measure the enzymatic activity of CP450s from the C3A and primary 
hepatocytes according to the manufacturer’s instructions.  
 
3.20 Transmission Electron Microscopy (TEM) 
 
The hepatocytes were seeded in 6 well plates in cell culture medium (minimum of 1 x 10
6 
cells per well) and incubated at 37°C, 5% CO2 for 24 hr. Cells were exposed to 5 µg/cm
2
 of 
the chosen NMs for 4 hr (control cells were treated with fresh medium). The samples were 
thoroughly washed with fresh medium (x2) before being removed from the plastic and 
transferred to BEEM capsules. The tubes were spun for 5 mins at 1000 g, before the addition 
of 1 ml of 2.5% gluteraldehyde in PBS for 2 hr. The cells were then washed (x3) with PBS 
followed by the addition of 1 ml of 1% osmium tetroxide in PBS to the pellet for 10 mins 
before being rinsed five times with PBS and two times with distilled water. The samples were 
dehydrated in 50%, 70%, 90% and 100% ethanol for 10 mins each. After the removal of the 
ethanol a 50:50 mixture of resin and ethanol was added for 45 mins before being replaced 
with 100% resin and incubated for 24 hr. The samples were embedded and cured before 
being fastened to a trimming block. An ultramicrotome was used to produce a final trapezoid 
shape of around 1 mm or less. The samples were cut into 50-100 nm sections and transferred 
onto TEM grids. The grids were coated with 5 nm of evaporated carbon prior to imaging to 
minimise charging. A FEI Tecnai TF20 FEGTEM microscope fitted with a Gatan Orius 
SC600 CCD camera and an Oxford Instruments 80 mm
2
 X-Max EDX detector was utilised to 
image the cells and perform chemical analysis via energy dispersive X ray (EDX) analysis. 
The TEM analysis was carried out at the Leeds Nanoscience and Nanotechnology Research 
Equipment Facility.  
 
3.21 Scanning Electron Microscopy (SEM) 
 
C3A and the primary hepatocytes were seeded on 10 mm sterile cover-slips in 24 well plates 
(2x10
5
 cells per well in 500 µl of the cell culture medium) and incubated for 24 hr at 37ºC 
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and 5% CO2. Cells were exposed to 5 µg/cm
2
 of the chosen NMs for 4 hr. The cells were 
washed with 0.1 M sodium cacodylate buffer (pH 7.3) before being fixed with 2% 
gluteraldehyde for 2 hr at 4°C. The cells were washed (x3) with 0.1 M sodium cacodylate 
buffer before being dehydrated in 50%, 70%, 90% and 100% acetone for 10 mins each. The 
samples were then critical point dried and mounted on aluminium stubs and sputter coated 
with gold for 45 sec. A FEI Quanta 3D SEM was utilised to image the cell and NMs surface 
interaction. A special mention to Mrs Marian Millar for her invaluable help with the SEM 
analysis. 
 
3.22 Statement of Animal Welfare 
 
The animal studies related to this project were either conducted by Dr Ilse Gosens (RIVM, 
The Netherlands) or myself in Edinburgh. All work conducted by the RIVM is described in 
appendix 4. 
 
All UK experiments involving animal cells described were performed under a Project License 
and Personal License issued by the United Kingdom Home Office. Sprague Dawley rats 
(male, 3 months old) and C57BL/6 mice (female, 10 weeks old) were obtained from 
Biomedical Research Resources, Royal Infirmary Edinburgh (Edinburgh, UK) and housed in 
conditions approved by the UK Home Office. The animals were caged in pairs with free 
access to food and water and at a temperature of 23 ± 1°C. The animals were kept under 
specific pathogen free conditions. 
 
3.23 Rat liver cells isolation and culture 
 
Liver cells were isolated using a classical two-step collagenase perfusion method, modified to 
obtain higher yields of cells. Briefly, after a first anterograde perfusion through the hepatic 
portal vein, the liver was perfused in a retrograde fashion through the inferior vena cava with 
a Hank’s buffered salt solution devoid of calcium (HBSS) (Sigma, UK) before being perfused 
with L15 medium (Life Technologies, UK) supplemented with HEPES (10 mM), glutamine 
(2 mM), Gentamycin (50 μg/ml) and 40 U/ml of collagenase (Roche) for 25 min. The liver 
was then cut down to small pieces, rinsed with ice-cold cell culture medium before being 
incubated again in the collagenase solution for 10 min. The resulting cell suspension was then 
filtered with a nylon gauze and then left to sediment for 15 min at 4°C. The cell pellet and the 
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unsettled cells in the supernatant were collected for further processing and Kupffer cell 
isolation (termed second pass cells). The settled cell suspension was spun down at 300 g and 
the supernatant discarded. A typical isolation resulted in a suspension of 70x10
6
 single cells 
and duplet/triplet with over 90% viability, as assessed by trypan blue exclusion.  
 
The freshly isolated cells were seeded on rat tail collagen (Serve, Germany) or matrigel (BD, 
UK) coated 96 well plates in HepatoZyme medium at 37ºC and 5% CO2 for a minimum of 4 
hr before NM treatment (10
4
 cells per well). 
 
3.24 Rat liver cell characterisation 
 
This work was carried out principally by my colleague Dr Celine Filippi at Heriot Watt 
University and is described in appendix 5 and 6. 
 
3.25 Kupffer cell isolation and enrichment 
 
For the isolation of Kupffer cells, the fraction of cells mentioned above (Section 3.23) was 
centrifuged at 800 g and the supernatant discarded. The pellet was used to positively select 
Kupffer cells using a magnetic-bead based cell purification system (MACS) (Miltenyi 
Biotech, Germany) with an anti CD163-PE coupled antibody (MCA342PE) (AbD Serotec, 
UK) and Anti PE microbeads (Miltenyi Biotech, Germany). Briefly following the addition of 
the primary PE conjugated antibody the cells were incubated in the dark for 10 mins at 4°C. 
The cells were washed with autoMACS Rinsing solution (Miltenyi Biotech, Germany) to 
remove unbound primary antibody. The Anti PE microbeads were added (20 µl per 10
7
 cells). 
The cells were mixed well and incubated for 15 mins at 4°C in the dark. The cells were once 
again washed and added to the column. The Kupffer cells magnetically attached to the 
column while the other cell types were eluted. This typically increased the Kupffer cell 
content from 4% to 30% of the cell suspension.  
 
3.26 Intravenous injections 
 
Prior to injections the NMs were dispersed in sterile water with 2% mouse serum according 
to the ENPRA protocol (Jacobsen, et al., 2010). C57/BL6 mice were randomly assigned into 
cages in groups of two before being injected via the lateral tail vein using a 27 gauge needle. 
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All animals were kept under isoflurane anaesthesia during the injection process (placed on a 
thermostat controlled heating device at 37°C). Animals were exposed to either a single dose 
of the different nanomaterials (128 µg/ml – 100 µl) or three doses of 100 µl of 64 µg/ml 
every 24 hr. A positive control of LPS (50 µl - 100 µg/ml) was also employed. The mice 
were dissected 6, 24, 48 and 72 hr after the single IV injection, or 72 hr after the triple 
injection regime (anaesthetised before being killed by cervical dislocation). The liver was 
then divided into four pieces. The middle lobe was divided into two – one section was frozen 
in liquid nitrogen for GSH measurements (about 0.2 g of tissue), while the other half was 
stored in RNAlater® (Life Technologies, UK). The left lobe was removed for 
myeloperoxidase (MPO) analysis (about 0.3g of tissue). The Right lobe was preserved in 
10% formaldehyde for immunohistochemistry (about 0.3g of tissue).  
 
3.27 Myeloperoxidase assay 
 
A mouse MPO ELISA kit (Hycult Biotech, USA) was utilised to quantify neutrophil influx 
into the liver tissue. Briefly, the tissue was lysed in a lysis buffer consisting of 5 mM EDTA, 
10 mM Tris, 10% glycerine, 1 mM phenylmethylsulfonyl fluoride, 1 µg/ml leupeptin and 28 
µg/ml aprotinin (pH 7.4). The samples were centrifuged twice at 1500 g for 15 mins at 4°C 
and the supernatant removed to reduce contamination with cell debris. All samples were 
diluted 4 fold before being used in the ELISA kit according to the manufacturer’s 
instructions. 
 
3.28 Immunohistochemistry 
 
The fixed tissue sections (section 3.26) were transferred to embedding cassettes before being 
dehydrated in 70% ethanol (2 changes, 1 hr each), 80% ethanol (2 changes, 1 hr each), 95% 
ethanol (2 changes, 1 hr each), 100% ethanol (3 changes, 1 hr each) and Histoclear II (3 
changes, 1 hr each). The tissues were then embedded in paraffin wax (56-58ºC - 2 changes, 
1.5 hr each). The blocks were cut into thin slices (4 µm) before being transferred to a 45ºC 
water bath. The paraffin sections were moved onto polysine glass slides, brushed into 
position before being dried overnight at 37ºC. The slides were rehydrated in Histoclear II (2 
changes, 3 mins), Histoclear II 1:1 with 100% ethanol (3 mins), 100% ethanol (2 changes, 3 
mins), 95% ethanol (3 mins), 70% ethanol (3 mins), and 50% ethanol (3 mins). The sections 
were then washed in tris buffered saline (TBS) plus 0.025% triton (2 x 5 mins) and blocked 
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with 10% FCS in TBS for 2 hr at room temperature. The primary antibody diluted in TBS 
with 1% BSA (rat anti-mouse Ly-6B.2 alloantigen – AbD Serotec, UK) was applied (100 µl 
per slide). The slides were incubated overnight at 4°C. 
 
The slides were rinsed 2 x 5 mins in TBS plus 0.025% triton and incubated in 0.3% H2O2 in 
TBS for 15 mins. The horse radish peroxidise (HRP) conjugated secondary antibody was 
applied (human anti rat IgG2b: HRP – AbD Serotec, UK) before incubation at room 
temperature for 1 hr. The slides were rinsed 3 x 5 in TBS and developed with 100 µl of DAB 
substrate kit (Abcam, USA). The slides were washed and mounted with Mowiol 4-88 
(Polysciences Inc., UK).  
 
3.29 Intratracheal instillation 
 
The installation procedures were carried out at Centre for Environmental Health Research, 
National Institute for Public Health and the Environment (Netherlands). Deatils are provided 
in Apppendix 4.  
 
3.30 RNA isolation, RT reaction and Real time PCR 
 
Liver samples were homogenised in liquid nitrogen using a mortar and pestle. Homogenised 
tissues were stored at -80°C before RNA was extracted and isolated using the MagMAX
TM -
96 Total RNA Isolation Kit (Ambion, USA). RNA concentration and purity were measured 
on a Nanodrop 2000c system (Thermo Scientific, UK). The High Capacity cDNA RT kit 
(Applied Biosystems, UK) was used according to the protocol to transcribe RNA into cDNA. 
Equal quantities of RNA from 3 animals in the same treatment group were pooled and 300 ng 
of RNA were used in RT reactions. 
 
PCRs were conducted in triplicate on a 7900 RT fast PCR system and SDS 2.3 software in 
384 well plates (Applied Biosystems, USA), using TaqMan kits with FAM dye under 
standard TaqMan conditions for 50 cycles. The following Applied Biosystems kits were 
used: Mouse kits Mm00437762-m1 – B2m (housekeeping gene); Mm00436450-m1 – 
CXCL2; Mm00439614-m1 – IL10; Mm00443258-31 – TNF-α; Mm00437858-m1 – C3; 
Mm00438864-m1 – Fas ligand; Mm00516023-m1 – ICAM-1; Mm00802090-m1 – albumin 
and Mm00446190-m1 – IL6. 
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3.31 Statistical analysis 
 
The statistical significance of the results was assessed using ANOVA (analysis of variance 
test), with a Tukey multiple comparison, using the Minitab 15 programme. ANOVA analysis 
was specifically selected as it allows for comparisons to be made between the means of 
several treatment groups. All findings were considered significant if the p value was below 
0.05. The null hypothesis for ANOVA analysis is that the means from different treatment 
groups are the same. Therefore, if the null hypothesis is rejected (i.e. if p<0.05), it can be 
concluded that at least one group differs from the rest. To reveal which groups were different 
from one another a Tukey comparison was incorporated within the test. This test determines 
if there are any significant differences between the different groups. If these differences are 
evident it establishes what groups are significantly different from each other. Accordingly 
within this study it is absolutely critical to consider if the different particle treatments differ 
to the control groups. All experiments were repeated a minimum of three times. 
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Chapter Four 
In vitro assessment of engineered nanomaterials 
using C3A hepatocytes: Cytotoxicity, pro-
inflammatory cytokines and function markers 
 
 
 
 
 
 
 
 
 
Based on publication: Kermanizadeh A, Pojana G, Gaiser BK, Birkedal R, Bilaničová D, 
Wallin H, Jensen KA,
 
Sellergren B, Hutchison GR, Marcomini A, Stone V. (2012c). In vitro 
assessment of engineered nanomaterials using a hepatocyte cell line: cytotoxicity, pro-
inflammatory cytokines and functioal markers. Nanotoxicology DOI: 
10.3109/17435390.2011.653416. 
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4.1 Aims and chapter outline 
 
To investigate the potential of the panel of engineered NMs to induce an inflammatory 
response in the hepatoblastoma cell line (C3A), measured by the release of pro-inflammatory 
cytokines (IL6, IL8 and TNF-α), C reactive protein (CRP) and the functional markers 
albumin and urea. 
 
4.2 Characteristics of nanomaterials and exposure media 
 
Investigated NMs were characterised by a combination of analytical techniques in order to 
infer primary physical and chemical properties useful to understand their toxicological 
behaviour. A list of the measured physical and chemical properties of selected NMs is 
presented in Table 4.1. All of this data was generated by University Ca’ foscari Venice, but it 
is included here as characterisation of NM is fundamental to understanding their toxicity. 
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ENM 
code 
ENM 
type 
Phase XRD 
Size 
[nm] 
TEM 
Size 
Primary 
characteristics by  
TEM analysis 
Surface 
area 
(BET) 
[m
2
/g] 
Known 
coating 
 Size 
in 
MEM 
(DLS) 
Ψ 
NM101 TiO2 Anatase
€ 
9 4-8 /50-
100 
Two structures found; 
type 1 show agglomerates 
in the 50 - 1500 nm range 
322 none 185, 742 
NM110 ZnO Zincite 70 to 
> 100 
20-250 / 
50-350 
Mainly 2 euhedral 
morphologies: 1) aspect 
ratio close to 1 (20 - 250 
nm range and few 
particles of approx. 400 
nm) 
2) Ratio 2 to 7.5 (50-350 
nm). Minor amounts of 
particles with irregular 
morphologies observed.  
14 none 306 
NM111 ZnO Zincite 58-93 20-200 / 
10-450 
As NM110, but with 
different size 
distributions. 1) Particles 
with aspect ratio close to 
1 (~90% in the 20-200 nm 
range); 2) particles with 
aspect ratio 2 to 8.5 
(~90% in the 10-450 nm 
ratio). 
18 Trie-
othoxy-
capry-
lsilane 
130 
313 
NM300 Ag Ag 7
$ 
14£ 
<18 / 
15 / > 
100# 
8-47 
(av.: 
17.5) 
Mainly euhedral NM; 
minor fractions have 
either elongated (aspect 
ratio up to ~ 5) or sub-
spherical morphology 
NA none 12, 28, 
114 
NM400 MWCNT - - D: 5-35 
L: 700-
3000 
Irregular entangled kinked 
and mostly bent MWCNT 
(10-20 walls). Some 
CNTs were capped and 
some cases multiple caps 
were found due to 
overgrowth. Fe/Co 
298 none * 
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catalysts (6-9 nm, average 
7.5 nm) were found inside 
the tubes. 
NM402 MWCNT - - D: 6-20 
L: 700-
4000 
Entangled irregular, 
mostly bent MWCNT (6-
14 walls). Some tubes 
were capped by unknown 
material. Some nano-
onions (5-10 nm) and 
amorphous carbon 
structures mixed with Fe 
(5-20 nm). Residual 
catalyst was observed. 
Individual catalyst 
particles up to 150 nm 
were also detected. 
225 none * 
NRCWE 
001 
TiO2 Rutile
§ 10 80-400 Irregular euhedral 
particles detected by TEM 
99 none 203 
NRCWE 
002 
TiO2 Rutile 10 80-400 Irregular euhedral 
particles detected by TEM 
84 Positive 
charged  
287 
NRCWE 
003 
TiO2 Rutile 10 80-400 Irregular euhedral 
particles detected by TEM 
84 Negative 
charged 
240, 
1487 
NRCWE 
004 
TiO2 Rutile App. 
100 
1-4/ 10-
100/ 
100-
200/ 
1000-
2000 
Five different particle 
types were identified: 1) 
irregular spheres, 1-4 nm 
(av. Diameter); 2) 
irregular euhedral 
particles, 10-100 nm 
(longest dimension); 3) 
fractal-like structures in 
long chains, 100-200 nm 
(longest dimension); 4) 
big irregular polyhedral 
particles, 1-2µm (longest 
dimension); 5) large 
irregular particles with 
jagged boundaries, 1-2 
µm (longest dimension). 
  339 
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€
 1 percent rutile found in one of two samples analyzed 
$
 wet XRD in capillary tube 
£
 dried samples 
#
 sample with deposits 
§
 ca. 6% anatase was observed in one of two samples analyzed 
* Not detectable by DLS due to the very large aspect ratio 
Ψ Intensity based size average in biological media after 15 mins. 
 
Table 4.1. Main physical and chemical properties of tested ENMs (Reproduced from Kermanizadeh, et al., 
2012c). 
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4.3 Impact of the selected panel of NMs on C3A cell viability 
 
From the WST-1 data it was evident that there was a dose dependent decrease in cell viability 
at 24 hr across the entire nanomaterial panel (Figure 4.1). However, an LC50 could only be 
determined for exposures to Ag (NM 300) 2 µg/cm
2
, uncoated ZnO (NM 110) 7.5 µg/cm
2
 
and coated ZnO (NM 111) 15 µg/cm
2
 after a 24 hr exposure (Figure 4.1b, c and d). The 
Alamarblue data obtained also showed similar results across the ten NMs. However, this 
assay gave a slightly higher LC50 value (Table 4.2). The WST-1 assay was relatively more 
sensitive over the steepest part of the curve when compared to the Alamarblue. Silver 
materials (NM 300) induced the greatest level of toxicity within the C3A cells, followed by 
the uncoated ZnO (NM 110) and coated ZnO (NM 111) NMs. All of the TiO2 and MWCNT 
NMs were considered to be low toxicity materials as the LC50 was not reached after a 24 hr 
exposure to the C3A cells at the range investigated.  
 
We also investigated the toxicity of the ENPRA dispersants namely NM 300 dispersant 
termed (NM 300 DIS) and 0.5% ethanol in complete C3A medium. We found no toxicity of 
either dispersant to the C3A cells (data not shown) so we conclude that all observed toxicity 
is due to exposure to the NMs investigated. 
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Figure 4.1. Cytotoxicity (grey line) and IL8 production (black bars) by C3A cells following exposure to a 
panel of engineered nanomaterials. The cells were exposed to cell medium (control)/medium and dispersant for 
NM 300 and NMs for 24 hr with cytotoxicity measured via WST-1 assay. IL8 production within cell 
supernatants was measured by ELISA. Values represent mean ± SEM (n=3), significance indicated by * = 
p<0.05 and **= p<0.005, when material treatments are compared to the control. A) NM 101 B) NM 110 C) NM 
111 D) NM 300 E) NM 400 F) NM 402 G) NRCWE 001 H) NRCWE 002 I) NRCWE 003 J) NRCWE 004. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
J 
 
78 
 
 LC50 (WST-1) - µg/cm
2 
LC50 (Alamarblue) - µg/cm
2
 
NM 101 LC50 not reached up to 80 µg/cm
2 
  LC50 not reached up to 80 µg/cm
2 
  
NM 110 LC50 between 5 and 10 μg/cm
2
 LC50 around 10 μg/cm
2
 
NM 111 LC50 is between 10 and 20 μg/cm
2
 LC50 around 20 μg/cm
2
 
NM 300 LC50 is between 1.25 and 2.5 μg/cm
2
 LC50 is between 2.5 and 5 μg/cm
2
 
NM 400 LC50 not reached up to 80 µg/cm
2 
  LC50 not reached up to 80 µg/cm
2
   
NM 402 LC50 not reached up to 80 µg/cm
2  
 LC50 not reached up to 80 µg/cm
2
   
NRCWE 001 LC50 not reached up to 80 µg/cm
2
   LC50 not reached up to 80 µg/cm
2
   
NRCWE 002 LC50 not reached up to 80 µg/cm
2 
  LC50 not reached up to 80 µg/cm
2
   
NRCWE 003 LC50 not reached up to 80 µg/cm
2  
 LC50 not reached up to 80 µg/cm
2
   
NRCWE 004 LC50 not reached up to 80 µg/cm
2  
 LC50 not reached up to 80 µg/cm
2 
  
Table 4.2. WST-1 and Alamarblue cytotoxicity following 24 hr exposure of C3A hepatocytes to  NM 101 
(TiO2 - 7 nm), NM 110 (ZnO  -  uncoated 100 nm), NM 111 (ZnO  -  coated 130 nm), NM 300 (Ag  -  <20 nm) 
and NM 400 (MWCNT), NM 402 (MWCNT), NRCWE 001 (TiO2 - rutile 10nm), NRCWE 002 (TiO2 - rutile 10 
nm with positive charge), NRCWE 003 (TiO2 - rutile 10 nm with negative charge) and NRCWE 004 (TiO2 - 
rutile 94 nm) NMs. 
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Identifying the soluble fraction of Ag and ZnO NMs added to the cells is extremely important 
for the discrimination between effects induced by the NMs and dissolved elements therein. 
Therefore, 24 hr dissolution of NM 110, NM 111 and NM 300 was investigated in pure water 
and the C3A complete medium at 1, 16 and 128 µg/ml (Table 4.3). It was observed that silver 
(NM 300) had very low, but dose-dependent solubility in water (<0.01%). This solubility was 
slightly lower in the C3A medium. It is important to note that the C3A medium contained 3 x 
10
-4
 mg of water soluble Zn/ml. The solubility of the NM 110 samples was between 6 x 10
-4
 
and 3.73 x 10
-4
 mg/ml in water (1 and 128 µg/ml). In C3A medium, this concentration varied 
from 7 x 10
-4
 to 5.92 x 10
-4
 mg/ml in from the lowest to the highest concentration. The 
solubility of NM 111 in water was lower than NM 110 (2 x 10
-4
 to 1. 72 x 10
-4
 mg Zn/ml 
from the lowest to highest concentration). These results suggest that about 40 to 50% of the 
added ZnO NMs were dissolved in the cell-medium after 24 hr. The amount of dissolved Ag 
was low and less than 1 % by weight. 
 
 
 
 
Treatment (µg/ml) NM 110 NM 111 NM 300 
 H2O Medium H2O Medium H2O Medium 
1 59.90% 46.70% 17.60% 38.90% < 0.01% < 0.01% 
16 31.68% 33.12% 10.06% 25.13% 0.78% 0.19% 
128 29.14% 23.36% 13.43% 26.48% 0.59% 0.47% 
Table 4.3. Percentage values of the Ag (NM 300) and the ZnO nanomaterials (NM 110, NM 111) dissolved 
in Water and C3A complete medium following 24 hr of incubation at 37°C, 5% CO2. 
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4.4 Impact of the engineered NMs on C3A hepatocyte IL8 production 
 
Changes in cytokine production as a consequence of NM exposure were assessed within the 
supernatant of exposed hepatocytes and quantified via ELISA. For the low toxicity TiO2 and 
MWCNT samples (NM 101, NM 400, NM 402, NRCWE 001, NRCWE 002, NRCWE 003 
and NRCWE 004) the IL8 production increased in a dose dependent manner, reaching 
statistical significance compared to the control at high exposure concentrations (Figure 4.1a, 
e, f, g, h, i and j). However, in the presence of the highly toxic particles Ag and ZnO (NM 
110, NM 111 and NM 300) there was a significant increase in the level of IL8 protein 
production that peaking around the LC50 values, followed by a decrease in the amounts of the 
cytokine produced as the toxicity increased (Figure 4.1b, c and d).  
 
4.5 Impact of the NMs on C3A hepatocyte IL6, TNF-α and CRP production 
 
Secretion of IL6, TNF-α and CRP into the supernatant of exposed C3A hepatocytes was 
quantified using ELISA analysis. There was no significant increase or decrease in the 
production of IL6, TNF-α or CRP after the exposure of the C3A cells to any of the selected 
nanomaterials (data not shown).  
 
4.6 Impact of engineered NMs on urea and albumin production by C3A hepatocytes 
 
In order to establish whether any of the NMs affected urea and albumin production, four 
exposure concentrations were chosen for each material. These concentrations included the 
LC50 and three subsequently lower concentrations for the highly toxic materials (NM 110, 
NM 111 and NM 300) and two high and two low concentrations for the low toxicity 
nanomaterials (80, 20, 2.5 and 0.31 µg/cm
2
). It was observed that none of the investigated 
NMs were able to modify urea production following a 24 hr exposure period (Figure 4.2). 
There was a significant decrease in levels of albumin secreted at LC50 concentrations for both 
ZnO NMs – NM 110 and NM 111 (compared to the control) (Figure 4.2b and c). However, 
none of the other eight NMs were capable of affecting albumin production by hepatocytes. 
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Figure 4.2. Albumin production (black line) and urea secretion (grey line) from C3A cells in the presence of 
a panel of engineered nanomaterials. Cells were exposed to medium (control) or NMs for 24 hr. Values 
represent mean ± SEM (n=3), significance indicated by * = p<0.05, compared to the control. A) NM 101 B) NM 
110 C) NM 111 D) NM 300 E) NM 400 F) NM 402 G) NRCWE 001 H) NRCWE 002 I) NRCWE 003 J) 
NRCWE 004. 
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4.7 Discussion 
 
As part of the FP7 project – ENPRA we investigated the potential hazard of a wide range of 
nanomaterials on a variety of targets for risk assessment. For this reason, the wide dose 
response ranges were used in order to allow calculation of values such as LC50 for 
comparisons between different materials and cell target types both in vitro and in vivo. 
 
In this chapter the focus was on the impact of the investigated nanomaterials on C3A cells 
with respect to cytotoxicity, pro-inflammatory cytokine production and markers of function. 
The data shows that the nanomaterials vary in terms of their toxicity and impact on cell 
function after acute (24 hr) exposure in vitro. 
 
This acute in vitro cytotoxicity study indicates that the NM panel can be segregated into a 
low (TiO2 and MWCNT) and a high toxicity group (Ag and coated and uncoated ZnO) 
(Table 4.2). The silver NMs were the most toxic with an LC50 as low as 2 µg/cm
2
. Our results 
are similar to previous studies in which hepatocytes exposed to uncoated 5–10 nm Ag 
particles for a period of 24 hr were toxic at concentrations as low as 0.5 µg/ml (Kawata, et 
al., 2009; Park, et al., 2010). It has been shown that at nano-scale, silver exhibits remarkably 
unusual physical, chemical and biological properties (Chen, et al., 2008).  
 
The coated and uncoated ZnO NMs also exhibited significant toxicity to C3A cells (NM 110 
– LC50 7.5 µg/cm
2
 and NM 111 - LC50 15 µg/cm
2
). In a recent set of trials, it was shown that 
ZnO NMs have significant toxic effects on aortic endothelial cells, with 50% of cells dying 
after a 4 hr incubation period with 50 nm particles (Gojovo, et al., 2007). In another study on 
mouse neural stem cells, a 24 hr incubation with 30, 60 and 200 nm ZnO particles resulted in 
manifestation of a clear dose dependant toxicity to the cells (LC50 8-20 µg/cm
2
). The authors 
proposed that the ZnO induced apoptosis of the treated cells (Deng, et al., 2009).  
 
Both Ag and ZnO have been reported elsewhere to exhibit solubility resulting in the release 
of ions that contribute to the toxicity of these NMs (Fabrega, et al., 2011; Kim, et al., 2011b; 
Park, et al., 2011; Song, et al., 2010; Wong, et al., 2010; Zheng, et al., 2011). Our assessment 
of dissolution in complete C3A medium showed that less than 1% of Ag (NM 300) dissolves 
in this medium after 24 hr of incubation so it is very unlikely that the toxicity witnessed is 
due to the release of ions. Similarly in a recent study A549 cells (alveolar cell line) were 
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exposed to both Ag NMs and ions in a dose dependant manner. The authors noted very low 
toxicity following exposure to the Ag
+
 at the lower concentrations (Foldbjerg, et al., 2011). 
Furthermore our Ag solubility findings are similar to studies in which it was noted that very 
little silver is dissolved in the tested media (Chappell, et al., 2011; Gaiser, et al., 2011). 
However it seems that the two ZnO NMs (NM 110 and NM 111) were partially soluble in the 
medium utilised, so there is a real possibility that the high toxicity of these materials is in part 
due to the release of ions. Around 40 to 50% of the added ZnO NMs were found as soluble 
Zn in the cell medium utilised. Some soluble Zn (2.9 µg/ml) was already present in the 
original cell medium, but addition of the NM 110 and NM 111 increased the concentrations 
in a dose-dependent manner up to 128 µg/ml in the cell medium. Further understanding of the 
dissolution kinetics of these partially soluble compounds in both the test item preparation step 
and in the cell media are crucial for further understanding of the toxicology of these 
nanomaterials. 
 
It has been suggested that in sufficient doses TiO2 can cause pulmonary inflammation, 
fibrosis and damage (Jin, et al., 2008). Based on recent in vivo studies, inflammation may 
persist for several months, but does not reach the level of inflammation induced by quartz 
(Roursgaard, et al., 2011). It has also been shown that after translocation from the primary 
site of exposure, the NMs can induce oxidative stress - mediated toxicity in many cell types 
by producing large amounts of free radicals (Jin, et al., 2008; Kang, et al., 2008; Wang, et al., 
2007b). All five TiO2 were of relatively low toxicity to the C3A cells (LC50 at 24 hr was not 
reached in the presence of any of the NMs up to 80 µg/cm
2
). Similarly, in a study using 
Caco2 cells it was found that there was no cytotoxicity following a 24 hr exposure to TiO2 
NMs (Jin, et al., 2008). Xia, et al., discovered however, that TiO2 nanomaterials did cross the 
epithelial lining of the intestinal model by transcytosis, albeit at low levels. TiO2 was able to 
penetrate into and through the cells without disrupting junctional complexes (Xia, et al., 
2006). It is also interesting to note that a recent study suggests that TiO2 NM exposure did not 
result in any toxicological effects to intestinal cells under dark conditions (Koeneman, et al., 
2010). Our exposures here were also conducted in the dark. In addition the data presented 
here indicates that relatively high TiO2 exposure concentrations can induce production of the 
pro-inflammatory cytokine IL8, which agrees with other in vitro studies (Monteiller, et al., 
2007). 
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Finally, the data showed the MWCNTs tested were relatively non-toxic to the C3A cells at 
the times and concentrations tested. The toxicity of MWCNTs is widely documented, with 
adverse effects observed as pulmonary inflammogenicity (Ellinger-Ziegelbauer, et al., 2009), 
hepatotoxicity (Ji, et al., 2009), dermal and ocular irritation (Kishore, et al., 2009) as well as 
monocyte (De Nicola, et al., 2009) and macrophage (Hirano, et al., 2008) mediated 
pathogenesis to name but a few. Like other nanomaterials, CNTs may be capable of entering 
the bloodstream and can be translocated to secondary organs. Most of the manufactured 
MWCNTs are of an inhalable size and although most dust by mechanical agitation is coarse 
they could be potentially dangerous to anyone exposed (Hoet, et al., 2004). It has been shown 
that the cytotoxicity of SWCNTs is higher than that of MWCNTs (Shvedova, et al. 2005). In 
vitro exposure of RAW264.7 macrophage cell line to SWCNTs was associated with the 
active production of TGF-β and reduced levels of the TNF-α and IL1-β (Shvedova, et al. 
2005), with no increase in intracellular ROS production (Shvedova, et al. 2005). The data 
presented here also supports the activity of MWCNT to induce the production of the pro-
inflammatory cytokine IL8, but only at relatively high exposure concentrations. 
 
Although some NMs adsorb proteins and form a protein corona (Montes-Burgos, et al., 2010) 
which could influence uptake and fate of the particle, we believe it is physiologically more 
relevant for the hepatocytes to be exposed to the NMs in a medium containing serum as for 
any nanomaterial to reach the liver, it will be exposed to numerous proteins along the way. In 
addition, the C3A cells require 10% serum to survive in vitro.  
 
The ability of NMs to compromise the viability of the C3A was investigated using both the 
WST-1 and Alamarblue assays. Although data gathered revealed both assays were very 
similar across the ten nanomaterials, WST-1 was more sensitive over the steepest part of the 
curve when compared to the Alamarblue assay.  
 
Hepatocytes are responsible for the manufacture of important serum proteins. They play a 
substantial role in the metabolism of lipids (Kmiec, et al., 2001) and synthesize many 
hormones and cytokines including IL8 (Dong, et al., 1998), IL6 (Saad, et al., 1995) TNF-α 
(Saad, et al., 1995) and CRP (Vermeire, et al., 2005). IL8 is a chemokine mediating the 
activation and migration of a wide variety of inflammatory cells including macrophages and 
mast cells into tissue, hence playing a pivotal role in initiation of an inflammatory response 
(Puthothu, et al., 2006). As described above there was a significant increase in the levels of 
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IL8 produced by the C3A cells in the presence of nanomaterials, with these levels peaking 
around the LC50 mark for the highly toxicity materials (Ag and the two ZnO NMs). The 
decrease in cytokine production at concentrations above the LC50 in the presence of the toxic 
concentrations of NMs is likely due to the fact the cells were dying preventing cytokine 
production. In the presence of low toxicity NMs (TiO2 and MWCNT), C3A cells produced 
increased levels of IL8 peaking only at the highest concentrations suggesting that they cause 
a lower pro-inflammatory response than Ag and ZnO. These experiments seem to suggest 
that the in vitro hepatocyte nanomaterial-induced inflammation seems to include IL8 
production from the cells. It is interesting to note that exposure of the liver cell line HepG2 to 
microorganisms (Brucella) in vitro also results in an increase of IL8 secretion from the cells 
(Delpino, et al., 2010). These findings suggest that IL8 seems to mediate hepatocyte 
inflammation in response to a number of stress factors, including NMs.  
 
There was no change in the levels of IL6, TNF-α or CRP following exposure of the C3A cells 
to any of the investigated nanomaterials suggesting that the inflammatory response is limited. 
There is a real possibility that for a more realistic representation of cytokine secretion in the 
liver incorporation of other cells (i.e. Kupffer cells) into the in vitro system might be essential 
(Sadauskas, et al., 2007) (Chapter 9). 
 
Both urea and albumin were quantified as measures of liver function. Following exposure of 
C3A cells to the panel of nanomaterials. It was discovered that there was no significant 
decrease or increase in the levels of urea production. There was no change in the levels of 
albumin following nanomaterial exposure, with the exception of both ZnO NMs. These 
results suggest that with the exception of ZnO, despite varying degrees of cell death, none of 
the nanomaterials investigated affected hepatocyte function in vitro in terms of albumin and 
urea production. It is interesting that although silver was the most toxic nanomaterial 
investigated in terms of viability, this did not translate into the effect on cell function at sub 
lethal concentrations. 
 
4.8 Conclusions 
 
In conclusion, the in vitro hepatocyte model demonstrated that Ag and ZnO NMs were 
consistently more potent with respect to cytotoxicity and cytokine production. In comparison 
the MWCNT and TiO2 nanomaterials investigated revealed relatively lower toxicity. The 
89 
 
cytotoxicity of ZnO may be related to its solubility, but this is less likely for the Ag NMs. 
Urea and albumin production were measured as indicators of hepatic function. These markers 
were only altered by the coated and uncoated ZnO, which significantly decreased albumin 
production. 
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Chapter Five 
Assessing oxidative stress and genotoxicity following 
exposure of C3A cells to the ENPRA panel of 
engineered nanomaterials  
 
 
 
 
 
 
 
Based on publication: Kermanizadeh A, Gaiser BK, Hutchison GR, Stone V. (2012). An in 
vitro liver model – assessing oxidative stress and genotoxicity following exposure of 
hepatocytes to a panel of engineered nanoparticles. Particle and Fibre Toxicology 9:28 DOI: 
10.1186/1743-8977-9-28. 
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5.1 Aims and chapter outline 
 
To investigate the ability of NMs with diffrent physicochemical characteristics to induce 
ROS production and oxidative stress in hepatocytes in vitro, in order to relate this oxidative 
stress to pro-inflammatory protein production and genotoxicity. 
 
In order to determine whether oxidative stress is induced by the different nanomaterials in the 
C3A cell line, the levels of cellular antioxidant glutathione (GSH) was measured. The effects 
of the overall oxidative stress depends upon the size of these changes, with a cell being able 
to overcome small perturbations (small to medium changes can induce cell signalling leading 
to activation of genes e.g. via NFkB signalling - control inflammation) and regain its original 
state. However, more severe oxidative stress can cause cell death. Even moderate oxidation 
can trigger apoptosis, while more intense stress may cause necrosis.   
 
Furthermore, the levels of intracellular hydrogen peroxide (H2O2) was measured using the 
DCFH-DA assay - fluorogenic probes convenient and sensitive to monitor oxidative activity.  
 
Finally, the short term genotoxic properties of the panel of materials was investigated using 
the widely utilised FPG modified comet assay. 
 
5.2 Impact of the nanomaterials on depletion of GSH in C3A hepatocytes 
 
Analysis of the total glutathione contents of C3A cells revealed a dose dependant decrease 
compared to the control cells at 24 hr following exposure to five of the ten nanomaterials 
investigated. These NMs were NM 110 (ZnO uncoated), NM 111 (ZnO coated), NM 300 
(Ag), NM 400 and NM 402 (MWCNTs) (Figure 5.1b, c, d, e and f). The three NMs 
previously shown to be the most cytotoxic to C3A cells as measured by the WST-1 assay (Ag 
NM 300, ZnO NM 110 and 111) (Chapter 4) (Kermanizadeh, et al., 2012c) also proved to 
induce relatively greater glutathione depletion than the other investigated NMs (Figure 5.1b, 
c and d - the LC50 is indicated). 
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Figure 5.1. Effects of NM exposure on reduced GSH and total glutathione levels in C3A cells. The cells were 
exposed to cell medium (control) and increasing concentrations of selected NMs for 24 hr. Values represent 
mean ± SEM (n=3), significance indicated by *= p<0.05 and **= p<0.005 compared to the control. A) NM 101 
B) NM 110 C) NM 111 D) NM 300 E) NM 400 F) NM 402 G) NRCWE 001 H) NRCWE 002 I) NRCWE 003 
J) NRCWE 004. LC50 values are indicated for NMs where this value was measurable. For all other NMs the 
LC50 was not reached following exposure up to 80 µg/cm
2
 after a 24 hr incubation. 
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5.3 Measurement of intracellular ROS 
 
The 2',7'-dichlorfluorescein-diacetate assay is based on the principle of DCFH being oxidized 
to fluorescent dichlorofluorescein (DCF) in the presence of intracellular ROS. Six different 
exposure time points were chosen (2, 4, 6, 8, 12 and 24 hr). It was noted that the 6 hr 
exposure was optimal for the highest levels of intracellular ROS production (data not shown). 
We noted a dose dependent increase in the levels of DCF fluorescence after exposure to the 
low toxicity nanomaterials (TiO2 and MWCNT NMs - Figure 5.2a, e, f, g, h and j). Following 
exposure to the highly toxic ZnO (NM 110) and Ag (NM 300) NMs, there was no significant 
increase in intracellular ROS levels. After exposure of the cells to coated ZnO (NM 111) 
there was a small but significant increase of fluorescence up to the LC50 value before a sharp 
drop at the higher concentrations. The levels of DCF fluorescence after the exposure to the 
highly toxic NMs were markedly lower than those witnessed after exposure to the low 
toxicity nanomaterials (Figure 5.2b, c and d). 
 
In order to investigate whether an antioxidant could prevent the NM-induced ROS production 
within the hepatocytes – the cells were pre-treated with the vitamin E derivative – Trolox for 
1 hr before the addition of the nanomaterials. Trolox prevented the NM induced DCF 
fluorescence with the inhibition most evident for the two MWCNTs (Figure 5.3). 
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Figure 5.2. Effects of increasing concentration of NMs on the oxidation of DCFH to DCF in the C3A cells. 
The cells were exposed to cell medium (control) or NMs for 24 hr. Results are shown as mean fluorescence 
intensity minus corresponding control traces (± SEM) from three experiments (n=3), significance indicated by * 
= p<0.05 and ** = p<0.005, when NM treatments are compared to the control. A) NM 101 B) NM 110 C) NM 
111 D) NM 300 E) NM 400 F) NM 402 G) NRCWE 001 H) NRCWE 002 I) NRCWE 003 J) NRCWE 004. 
LC50 values are indicated for NMs where this value was measurable. For all other NMs the LC50 was not 
reached following exposure up to 80 µg/cm
2
 after a 24 hr incubation. 
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Figure 5.3. Effect of 20 µg/cm2 of ENPRA nanomaterials on the oxidation of DCFH to DCF in C3A cells 
with and without Trolox pre-treatment. The cells were exposed to cell medium (control) or NMs for 6 or 24 hr. 
Results are exposed as mean fluorescence intensity minus corresponding control traces (±SEM) from three 
experiments (n=3), significance indicated by * = p<0.05 and ** = p<0.005, when decrease in fluorescence is 
compared to cells not treated with Trolox (T) before exposure to the NMs.  
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5.4 The effect of Trolox pre-treatment on cytotoxicity and IL8 production from C3A 
cells 
 
As shown in chapter 4, three of the ENPRA panel of nanomaterials were highly cytotoxic 
(Ag, coated and uncoated ZnO). As shown there was also an increase in levels of IL8 
production following exposure to the NMs investigated while no change in the levels of IL6, 
TNF-α or C reactive protein were observed. Therefore the aim was to investigate the effects 
of the pre-treatment with an external antioxidant on cytotoxicity and IL8 production from the 
C3A cells. The hepatocytes were pre-treated with Trolox for 1 hr before being exposed to 
four of the highest concentrations of the nanomaterials used previously (5 µg/cm
2
 to 80 
µg/cm
2
).   
 
The pre-treatment with Trolox prevented the cytotoxicity induced by five of the ten 
nanomaterials investigated (NM 110 (ZnO uncoated), NM 111 (ZnO coated), NM 300 (Ag), 
NRCWE 001 (TiO2 rutile 10 nm) and NRCWE 004 (TiO2 rutile 94 nm)) (Figure 5.4c, e, g, m 
and s). We also observed that Trolox reduced IL8 secretion for all NMs with the exception of 
Ag, whereas IL8 secretion appeared increased, however these changes were not significant 
(Figure 5.4h).    
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Figure 5.4. The cell viability and induction of IL8 production in C3A cells treated with the ENPRA NMs for 
24 hr. Cells pre-treated with the antioxidant Trolox (100 µM, 1 hr) are show in grey, while cells not pre-treated 
are shown in black. Values represent mean ± SEM (n=3), significance indicated by * = p<0.05 and **= 
p<0.005, when nanomaterial treatments are compared to the control. ∞ = p<0.05 and ∞∞ p<0.005 is 
representative of significant difference between values signifying absence and presence of Trolox pre-treatment 
at each given concentration. A) NM 101 cytotoxicity B) NM 101 IL8 secretion C) NM 110 cytotoxicity D) NM 
110 IL8 secretion E) NM 111 cytotoxicity F) NM 111 IL8 secretion G) NM 300 cytotoxicity H) 300 IL8 
secretion I) NM 400 cytotoxicity J) NM 400 IL8 secretion K) NM 402 cytotoxicity L) NM 402 IL8 secretion 
M) NRCWE 001 cytotoxicity N) NRCWE 001 IL8 secretion O) NRCWE 002 cytotoxicity P) NRCWE 002 IL8 
secretion Q) NRCWE 003 cytotoxicity R) NRCWE 003 IL8 secretion S) NRCWE 004 cytotoxicity T) NRCWE 
004 IL8 secretion.  
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5.5 DNA damage in C3A cells  
 
In order to investigate the possible DNA damage caused by the panel of nanomaterials, C3A 
cells were exposed to the NMs for 4 hr. In this study the LC20 value for each individual NM 
plus one concentration above (2x LC20) and one below (0.5x LC20) were chosen (The LC50 
and LC20 values have been previously described) (Chapter 4) (Kermanizadeh, et al., 2012c). 
 
DNA damage was most evident following exposure to NM 101 (TiO2 - 7 nm) and NRCWE 
002 (TiO2 - 10 nm positively charged) (Figure 5.5a, h). There was also a small but significant 
increase in percentage tail DNA following exposure to seven of the other eight NMs 
investigated (NRCWE 003 - negatively charged TiO2 10 nm being the exception) (Figure 
5.5i). 
 
Long term 8 week NM 300 (Ag) exposed cells resulted in a small but significant increase in 
tail moment compared to our cell only control, however there was no significant difference 
between short and long term exposure to LC20 of Ag (Figure 5.6).  
 
Addition of the FPG enzyme to the samples resulted in increased percentage of tail DNA 
following treatment with the NMs. This indicates that the damage witnessed is partially due 
to oxidative DNA damage. 
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Figure 5.5. DNA damage expressed as percent of tail DNA following exposure of the C3A cells to LC20 ± 
one serial dilution to the ENPRA panel of engineered nanomaterials. The cells were exposed to cell medium 
(control), 60 µM H2O2 or NMs for 4 hr. Values represent mean ± SEM (n=3), significance indicated by * = 
p<0.05 and ** = p<0.005, when material treatments are compared to the control. ∞ = p<0.05 and ∞∞ p<0.005 is 
representative of significant difference between values signifying absence and presence of FPG enzyme at each 
given concentration. A) NM 101 B) NM 110 C) NM 111 D) NM 300 E) NM 400 F) NM 402 G) NRCWE 001 
H) NRCWE 002 I) NRCWE 003 J) NRCWE 004. 
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Figure 5.6. DNA damage expressed as percent of tail DNA following exposure of the C3A cells to LC20 of 
silver (NM 300). The cells were exposed to cell medium (control), 60 µM H2O2 (for 4 hr) or NMs for a period 
of 8 weeks. Values represent mean ± SEM (n=3), significance indicated by * = p<0.05. 
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5.6 Discussion 
 
In the previous chapter it was demonstrated that the panel of nanomaterials investigated could 
be divided into a high toxicity group (two ZnO and one Ag) and a low toxicity group (five 
TiO2 and two MWCNTs) according to their ability to induce cytotoxicity in the C3A cell line. 
The discussion below is therefore structured to allow comparison between the low toxicity 
and high toxicity materials in order to ascertain whether this pattern is retained across a wider 
array of sub-lethal endpoints (Table 5.1). 
 
NM Composition LC50 (WST-1) GSH 
Depletion 
Increase in 
intracellular ROS 
levels 
DNA damage 
compared to 
control 
NM 101 TiO2 > 80 µg/cm
2
 No Large Yes 
NM 110 ZnO 5 - 10 μg/cm
2
 Yes None Yes 
NM 111 ZnO 10 - 20 μg/cm
2
 Yes Small Yes 
NM 300 Ag 1.25 - 2.5 μg/cm
2
 Yes None Yes 
NM 400 MWCNT > 80 µg/cm
2
 Yes Large Yes 
NM 402 MWCNT > 80 µg/cm
2
 Yes Large Yes 
NRCWE 
001 
TiO2 > 80 µg/cm
2
 No Large Yes 
NRCWE 
002 
TiO2 (+) > 80 µg/cm
2
 No Large Yes 
NRCWE 
003 
TiO2 (-) > 80 µg/cm
2
 No Large No 
NRCWE 
004 
TiO2  > 80 µg/cm
2
 No Large Yes 
Table 5.1. Summary of the observed effects on C3A hepatocytes following exposure to the ENPRA panel of 
nanomaterials. 
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Initially the ability of the chosen NMs to induce glutathione depletion in C3A cells was 
examined. Exposure to the Ag and the two ZnO NMs resulted in significant GSH depletion 
following a 24 hr exposure. For these highly toxic NMs glutathione depletion at the higher 
concentrations might be associated with cell death rather than a specific oxidative stress 
response. In contrast, MWCNTs were also able to significantly deplete glutathione at doses 
which did not influence cell viability, suggesting that MWCNTs induced oxidative stress in 
these cells. The TiO2 materials had no significant effect on the glutathione content of the cells 
suggesting that they are unable to induce oxidative stress in liver cells in dark experimental 
conditions. 
 
Next, the intracellular ROS levels following exposure of the ENPRA panel of NMs was 
investigated. Interestingly the Ag and uncoated ZnO NMs did not generate detectable 
intracellular ROS according to the DCFH-DA assay at 24 hr, although small yet significant 
levels could be detected for coated ZnO (NM 111). This assay is dependent on intact viable 
cells therefore exposure to highly toxic nanomaterials could result in lower levels of 
fluorescence from the DCFH-DA assay. Furthermore, investigations into earlier exposure 
time-points (6 hr) revealed higher levels of DCF fluorescence for all of the NMs tested. We 
therefore suggest that the DCFH assay is not suitable for investigating the cellular ROS 
response to highly toxic NMs, or that it should be limited to relatively low concentrations and 
early time points for such materials.  
 
In contrast a concentration dependant increase in ROS levels following exposure to the low 
toxicity nanomaterials (five TiO2 and two MWCNT NMs) was observed indicating firstly 
that these low toxicity materials are able to generate intracellular ROS and secondly that the 
assay is suitable for these lower toxicity NMs. It is interesting to note that the ROS 
production by MWCNT translated into a GSH depletion at 24 hr, but the same was not true 
for the TiO2 NMs. Either the cells were sufficiently protected with antioxidant defence 
mechanisms to prevent GSH depletion by the TiO2 NM, or a longer time point might be 
required to assess such an effect. Another explanation for the ROS generation by the 
MWCNT might be that the iron residues within the nanotubes may contribute to the oxygen 
species generation (e.g. via Fe
2+
 fenton reaction). 
 
A recent study investigated a rat derived liver cell line (BRL 3A) and 10 nm Ag NMs (up to 
50 μg/ml – 24 hr exposure) and reported a significant GSH depletion (Hussain, et al., 2005). 
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In a contradictory study however the effects of silver NMs (220 µg/ml) on primary mice 
hepatocytes in vitro revealed a small increase in intracellular GSH levels subsequent to a 24 
hr exposure to the particles (Arora, et al., 2004). Studies in which human Chang liver cells 
were exposed to Ag NMs also induced intracellular ROS generation (Piao, et al., 2011) 
which was contrary to findings in this study. However it is important to note that these 
finding were after much shorter exposure times (Piao, et al., 2011) which could therefore 
mean that viability of these cells was sufficient to allow ROS to be detected. Exposure of 
HepG2 cell to a 100 nm ZnO NMs resulted in high toxicity associated with reactive oxygen 
species and oxidative stress (Akhtar, et al., 2012).  
 
We could not identify any studies in which the impacts of MWCNTs on hepatocytes was 
reported, but intraperitoneal injection of functionalized SWCNTs into Swiss-Webster mice 
resulted in increased ROS levels within liver cells and enhanced the activities of serum 
amino-transferases (Patlolla, et al., 2011). 
 
In a recent set of trials the use of nanoparticulate TiO2 (intragastric administration) resulted in 
mice liver damage with the authors suggesting oxidative stress as the mechanism of 
cytotoxicity (Wang, et al., 2011b). In another study exposure of mice (intragastric 
administration) to TiO2 NMs for 60 days resulted in hepatocyte apoptosis associated by 
increased reactive oxygen species accumulation and decreased stress-related gene expression 
levels of superoxide dismutase and glutathione peroxidise (Cui, et al., 2010). These studies 
add support to our observations for MWCNT and TiO2 with respect to ROS production in 
liver cells.  
 
The lipophilic antioxidant Trolox decreased the Ag and ZnO induced cytotoxicity as well as 
the ZnO induced IL8 production. With respect to Ag, Trolox appeared to enhance IL8 
production although this was not statistically significant. This might seem counter-intuitive, 
as it could be interpreted as protection of the cells from particle induced cytotoxicity by the 
antioxidant, thereby enhancing their ability to induce a pro-inflammatory response at doses 
that were toxic in previous experiments without the addition of Trolox (Chapter 4) 
(Kermanizadeh, et al., 2012c). The pre-treatment of the C3A cells with Trolox prevented the 
low toxicity nanomaterials from increasing DCF fluorescence, confirming that the DCFH 
assay was measuring oxidative activity. The pre-treatment with Trolox also resulted in 
protection against cytotoxicity following exposure to relatively high concentrations of TiO2 
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NMs (NRCWE 001, NRCWE 004). In addition, Trolox pre-treatment decreased the IL8 
secretion following exposure to these NMs. Taken together these results suggest that ROS 
play a key role in the up regulation of cytokines in hepatocytes following exposure to ZnO, 
TiO2 and the MWCNT NMs. 
 
To our knowledge there have been no nanotoxicological studies that have pre-treated liver 
cells with Trolox in vitro, however Trolox pre-treatment of human macrophages significantly 
reduced the toxicity of superparamagnetic iron oxide (Lunov, et al., 2010) and TiO2 NMs 
(Miller, et al., 2007). The authors of two other studies in which human monocytes were pre-
treated with Trolox before exposure to fine carbon black also noted a decrease in the pro 
inflammatory cytokine TNF-α (Brown, et al., 2002; Brown, et al., 2007). Contrary to these 
findings, pre-treatment with Trolox of J774.A1 macrophages (Clift, et al., 2010), PC 12 cells 
(cell line derived from a pheochromocytoma of the rat adrenal medulla) (Lovric, et al., 2005), 
N9 (murine microglial cell line) (Lovric, et al., 2005) followed by exposure to quantum dots 
did not prevent toxicity or cytokine production by the cells. 
 
We also investigated any possible genotoxic effects following exposure to the NMs at sub-
lethal concentrations. Short term exposure (4 hr) of C3A cells to the ENPRA panel of 
nanomaterials resulted in a small but significant increase in percent tail DNA for nine of the 
ten NMs investigated (the negatively charged TiO2 - NRCWE 003 being the exception). 
Exposure of the C3A cells to LC20 of Ag NM for 8 weeks resulted in a marginal yet 
significant increase in tail moment compared to the control, however there was no significant 
difference between short and long term exposure to this particular particle. A small but 
significant increase in DNA damage following exposure to both ZnO and the two MWCNT 
NMs was also noted. Genotoxicity was most evident following exposure to NM 101 (TiO2 7 
nm) and NRCWE 002 (positively charged TiO2 10 nm). The relative genotoxicity of the NM 
panel is therefore strikingly different to their ranking with respect to cytotoxicity. This 
therefore indicates the importance of assessing sub-lethal effects and the need for further 
chronic in vivo studies to assess the validity of these short term in vitro observations. 
 
It is important to emphasis the role of FPG enzyme in the comet assay. The enzyme measures 
specific oxidative DNA mediated strand breaks so it is not surprising to see increased tail 
length in the presence of the enzyme following exposure to one of the MWCNTs (NM 402) 
and three of the TiO2 NMs (NM 101, NRCWE 001 and NRCWE 002). As seen from the data 
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in the DCFH-DA assay there was a significant increase in intracellular ROS following 
exposure of the hepatocytes to these materials. Therefore these findings suggest that ROS 
plays an important role in the genotoxicity witnessed for the MWCNTs and TiO2 NM 
investigated in this study.  
 
In a recent study exposure of human epidermal cell line A431 to TiO2 resulted in significant 
oxidative stress related DNA damage (Shukla, et al., 2011). Our short-term exposure findings 
are similar in part to a study in which low concentration exposures of 90 nm TiO2 NMs to 
human embryo hepatocytes did not induce DNA breaks or chromosome damage (Shi, et al., 
2010b). Another study using A549 cells alveolar epithelial cells, HepG2 hepatocytes and 
NRK-52E kidney cells were exposed to a panel of NMs including TiO2, Al2O3, gold and 
MWCNTs discovered that genotoxicity was weak and that DNA damage was limited to 
single-strand beaks and/or alkali-labile sites (Simon, et al., 2007).  
 
5.7 Conclusion 
 
In conclusion, utilising this particular in vitro hepatocyte model showed that the NM which 
induced a low cytotoxicity (TiO2 and MWCNTs), generated intracellular ROS, induced 
oxidative stress (GSH depletion), and that an oxidative mechanism was involved in both the 
induction of IL8 protein production and genotoxicity according to the Comet assay. The 
highly toxic Ag and ZnO NMs appeared to work by different mechanisms. Silver did not 
generate ROS measurable by the DCFH-DA assay, although pre-treatment with an 
antioxidant may marginally enhance IL8 production by the hepatocytes suggesting that the 
toxic mechanisms might be partially mediated by ROS. In addition the data indicates that Ag 
particles are capable of enhancing a pro-inflammatory response, providing that they are not 
too toxic.  
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Chapter Six 
Primary human hepatocytes vs. hepatic cell line: 
suitability for in vitro nanotoxicology testing 
 
 
 
 
 
 
 
 
Based on publication: Kermanizadeh, A, Gaiser BK, Ward MB, Stone V. (2012b). Primary 
human hepatocytes vs. hepatic cell line – assessing their suitability for in vitro 
nanotoxicology. Nanotoxicology DOI: 10.3109/17435390.2012.734341. 
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6.1 Aims and chapter outline 
 
The use of hepatocyte cell lines as a replacement for animal models have been heavily 
criticised mainly due to low expression of metabolism enzymes. This study compares 
primary human hepatocytes to the C3A cell line and with respect to their response to a panel 
of nanomaterials. 
 
Here the potential of engineered NMs to induce cytotoxicity, measured by mitochondrial 
function using the WST-1 assay, and to induce an inflammatory response in the C3A and 
primary human cells, measured by the release of pro-inflammatory cytokines (IL6, IL8 and 
TNF-α) was measured. Furthermore albumin was measured following exposure of the cells to 
the panel of nanomaterials as a good indicator of hepatic functionality. Finally, the interaction 
of the NMs with the cells was investigated by the use of transmission and scanning electron 
microscopy (TEM and SEM).  
 
In this study six of the ten NMs in the panel of ENPRA nanomaetrials were utilised (selected 
as the priority NMs by the ENPRA consortium). 
 
6.2 Characteristics of nanomaterials and exposure media 
 
Investigated nanomaterials were characterised by a combination of analytical techniques in 
order to infer primary physical and chemical properties useful to understand their 
toxicological behaviour and described in chapter 4 (Kermanizadeh, et al., 2012c). In order to 
investigate if the nanomaterials behaved differently in William’s E medium, the 
hydrodynamic size distributions of the NMs was measured by DLS after the nanomaterials 
were dispersed in the complete medium between 1 - 128 µg/ml (Table 6.1). 
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ENM code ENM type  Size in MEM (DLS) Ψ Size in William’s E medium (DLS) Ψ 
NM 110 ZnO 306 393.3 
NM 111 ZnO 313 322.1 
NM 300 Ag 114 137.7 
NM 400 MWCNT * * 
NM 402 MWCNT * * 
NRCWE 002 TiO2 287 314.9 
$
 wet XRD in capillary tube 
£
 dried samples 
* Not detectable by DLS due to the very large aspect ratio 
Ψ Intensity based size average in biological media after 15 mins. 
 
Table 6.1. Main physical and chemical properties of tested NMs in MEM and William’s E medium. 
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6.3 Impact of the selected panel of NMs on C3A and human primary cell viability 
 
From the WST-1 data it was evident that there was a dose dependent decrease in cell viability 
at 24 hr across the entire nanomaterial panel for both C3A and primary human hepatocytes 
(Figure 6.1). Overall the toxicity following exposure to the panel of engineered NMs was 
fairly similar for both the C3A and primary cells, although small differences were witnessed 
for the uncoated ZnO NM between the cell types which were significant at the higher 
exposures (Figure 6.1a). An LC50 was reached following exposure to Ag (NM 300), uncoated 
ZnO (NM 110) and coated ZnO (NM 111) after a 24 hr exposure (Figure 6.1a, b and c). All 
of the TiO2 and MWCNT NMs were considered to be low toxicity materials as the LC50 was 
not reached after a 24 hr exposure to the C3A and primary cells at the range investigated 
(Table 6.2). 
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 Figure 6.1. Cytotoxicity of C3A cells and human primary hepatocytes in the presence of a panel of 
engineered nanomaterials. The cells were exposed to cell medium control and NMs for 24 hr with cytotoxicity 
measured via the WST-1 assay. Values represent mean ± SEM (n=3). A) NM 110 B) NM 111 C) NM 300 D) 
NM 400 E) NM 402 F) NRCWE 002. Significance difference between C3A and primary cells indicated by ∞ = 
p<0.05. 
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 C3A - LC50 (WST-1), µg/cm
2 
Primary hepatocytes LC50 (WST-1), 
µg/cm
2
 
NM 110 LC50 between 5 and 10 μg/cm
2
 LC50 between 5 and 10 μg/cm
2
 
NM 111 LC50 is between 10 and 20 μg/cm
2
 LC50 around 5 μg/cm
2
 
NM 300 LC50 is between 1.25 and 2.5 
μg/cm2 
LC50 around 2.5 μg/cm
2
 
NM 400 LC50 not reached up to 80 µg/cm
2 
  LC50 not reached up to 80 µg/cm
2
   
NM 402 LC50 not reached up to 80 µg/cm
2  
 LC50 not reached up to 80 µg/cm
2
   
NRCWE 002 LC50 not reached up to 80 µg/cm
2 
  LC50 not reached up to 80 µg/cm
2
   
Table 6.2. WST-1 cytotoxicity following 24 hr exposure of C3A hepatocytes and human primary hepatocytes 
to NM 110 (ZnO - uncoated 100 nm), NM 111 (ZnO - coated 130 nm), NM 300 (Ag - < 20 nm) and NM 400 
(MWCNT), NM 402 (MWCNT) and NRCWE 002 (TiO2 - rutile 10 nm with positive charge) NMs. 
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6.4 Impact of the engineered NMs on C3A and human hepatocyte IL8 production 
 
Changes in cytokine production as a consequence of NM exposure were assessed within the 
supernatant of exposed hepatocytes and quantified via ELISA. For the low toxicity TiO2 and 
MWCNT samples (NRCWE 002, NM 400 and NM 402) the IL8 production increased in a 
dose dependent manner, reaching statistical significance compared to the control at high 
exposure concentrations (Figure 6.2d, e and f). However, in the presence of the highly toxic 
materials Ag and ZnO (NM 300, NM 110 and NM 111) there was a significant increase in the 
level of IL8 protein production, followed by a decrease in the amounts of the cytokine 
produced as the toxicity increased (Figure 6.2a, b and c). A similar pattern of IL8 secretion 
from both the cell line and primary cells following exposure to the panel of ENPRA NMs 
was noted. However, there were small but significant differences between the two cell types 
on certain exposures. These differences included one low exposure for NM 111, two low 
exposures for NM 300, one exposure for both MWCNTs and the four highest exposures for 
the TiO2 NM. Following the exposure to the ZnO and the Ag at these mentioned 
concentrations IL8 secretion was higher from the primary hepatocytes while exposure to the 
MWCNT and the TiO2 at the above mentioned concentrations resulted in greater cytokine 
production from the C3A cells. The cells treated with LPS produced significant amounts of 
IL8 (primary cells – 662.3±71.0 pg/ml; C3A cells – 682.5±30.6 pg/ml). 
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Figure 6.2. IL8 secretion by C3A cells and primary human hepatocytes in the presence of a panel of 
engineered nanomaterials. The cells were exposed to cell medium control and NMs for 24 hr. IL8 production 
within cell supernatants was measured by ELISA. Values represent mean ± SEM (n=3). A) NM 110 B) NM 111 
C) NM 300 D) NM 400 E) NM 402 F) NRCWE 002. Significance between C3A and primary hepatocytes  
indicated by ∞ = p<0.05. 
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6.5 Impact of the NMs on C3A and primary hepatocyte in terms of IL6 and TNF-α 
production 
 
Secretion of IL6 and TNF-α into the supernatant of exposed hepatocytes was quantified using 
ELISA analysis. There was no significant increase or decrease in the production of IL6 or 
TNF-α compared to the negative control after the exposure of the C3A cells or primary cells 
to any of the selected nanomaterials (data not shown). As a positive control both cell types 
were treated with LPS for 24 hr. This resulted in IL6 production by both cell types (primary 
hepatocytes 650±250 pg/ml; C3A cells 530±286 pg/ml. LPS treatment of both cell types did 
not result in any TNF-α production from the hepatocytes above the back ground levels. 
 
6.6 Impact of engineered NMs on albumin production by primary hepatocytes 
 
In order to establish whether any of the NMs affected albumin production, four exposure 
concentrations were chosen for each material. These concentrations included the LC50 and 
three subsequently lower concentrations for the highly toxic particles (NM 110, NM 111 and 
NM 300) and four highest concentrations for the low toxicity nanomaterials (80, 40, 20 and 
10 µg/cm
2
). There was a significant decrease in levels of albumin secreted at LC50 
concentrations for the NM 110 ZnO NM (compared to the control) (Figure 6.3a). However, 
none of the other five NMs were capable of affecting albumin production by primary 
hepatocytes. As shown in chapter 4 sub-lethal exposures to the nanomaterials did not impact 
albumin production from C3A cells with the exception of the two ZnO NMs at LC50. 
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Figure 6.3. Albumin production from primary human hepatocytes following exposure to sub-lethal 
concentrations of the panel of engineered nanomaterials. Cells were exposed to medium (control) or NMs for 24 
hr. Values represent mean ± SEM (n=3), significance indicated by * = p<0.05, compared to the control. A) NM 
110 B) NM 111 C) NM 300 D) NM 400 E) NM 402 F) NRCWE 002.  
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6.7 Interaction of cells and the nanomaterials 
 
In order to observe the interaction between the cells and the nanomaterials we utilised TEM 
(Figures 6.4-10) and SEM (Figures 6.11-17). It was noted that both the C3A cells and 
primary human cells were capable of uptake of nanomaterials (Figure 6.4-10). This alone was 
quite an interesting finding as hepatocytes are not intrinsically phagocytic cells. Four of the 
nanomaterials were observed in the cytoplasm of the investigated cells (NM 300, NM 400, 
NM 402 and NRCWE 002). Additionally, one of the MWCNT (NM 402) was also found in 
the nucleus of both the cell line and the primary cells (Figure 6.9). The two ZnO NMs 
investigated in this study are extremely soluble in the chosen media (Chapter 4) 
(Kermanizadeh, et al., 2012c) and as a result no individual particles were observed, nor was 
any high local concentration of Zn present for detection via EDX. Therefore only damage 
caused by these NMs is shown (Figure 6.5 and 6.6). 
 
Furthermore, we investigated the surface interaction of the cells with the NMs utilising SEM. 
It is evident that the highly toxic NMs (Ag and ZnO) cause relatively large amounts of 
surface damage to both the C3A and the primary cells (Figures 6.12, 13 and 14). The 
MWCNT are clearly visible as thin fibres on the surface of the cells and they tended to 
agglomerate around the cells (Figure 15 and 16). The TiO2 NMs were evident on the surface 
of the cells (Figure 6.17). Once again there were no distinguishable differences between the 
C3A cell line and the primary human hepatocytes. 
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Figure 6.4. TEM images of C3A (a) and primary human hepatocytes (b) from the control samples. 
 
 
 
 
 
 
 
Figure 6.5. TEM images of C3A (a) and primary human hepatocytes (b) exposed to NM 110 – uncoated 
ZnO.  Cell death is clearly evident in both samples; however no elemental Zn was detected, suggesting complete 
dissolution within the cell culture medium in the investigated samples. 
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Figure 6.6. TEM images of C3A (a) and primary human hepatocytes (b) exposed to NM 111 – coated ZnO.  
Cell death is clearly evident in both samples; however no elemental Zn was detected, suggesting complete 
dissolution within the cell culture medium in the investigated samples. 
 
 
 
 
 
 
 
Figure 6.7. TEM images of C3A (a) and primary human hepatocytes (b) exposed to NM 300 – Ag.  Cell 
damage was observed in both samples, and concentrations of Ag were detected using EDX (spectra inset in (a) 
and (b), with X-ray energy in keV shown on the scale bar). The Ag concentrations existed as both fine dispersed 
particles (comparable in size and contrast to the heavy metal stain particles) as shown in (a), and also as large 
defined polycrystalline particles, as shown in (b). 
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Figure 6.8. TEM images of C3A (a) and primary human hepatocytes (b) exposed to NM 400 – MWCNT.  In 
both samples MWCNTs were identified throughout the cells.  They were easily identified by their long filament-
like morphology, and characteristic 0.335 nm (0001) basal plane spacing (see images inset).  
 
 
 
 
 
 
 
Figure 6.9. TEM images of C3A (a) and primary human hepatocytes (b) exposed to NM 402 – MWCNT.  In 
both samples MWCNTs were identified throughout the cells.  They were easily identified by their long filament-
like morphology, and characteristic 0.335 nm (0001) basal plane spacing (see images inset).  
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Figure 6.10. TEM images of C3A (a) and primary human hepatocytes (b) exposed to NRCWE002 – 
positively charged TiO2.  The strong contrast exhibited by the clusters of needle-like particles makes them 
clearly visible in both samples.  EDX also confirms the particles to be composed from Ti (spectra inset in (a) 
and (b), with X-ray energy in keV shown on the scale bar). 
 
 
 
 
 
 
 
Figure 6.11. Scanning electron microscopy pictures of a) C3A and b) primary human hepatocytes. 
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Figure 6.12. Scanning electron microscopy pictures of interaction of ZnO (NM 110) NMs with the cells 
following a 4 hr exposure a) C3A cell b) human primary hepatocyte.  
 
 
 
 
 
 
 
Figure 6.13. Scanning electron microscopy pictures of interaction of ZnO (NM 111) NMs with the cells 
following a 4 hr exposure a) C3A cell b) human primary hepatocyte. 
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Figure 6.14. Scanning electron microscopy pictures of interaction of Ag (NM 300) NMs with the cells 
following a 4 hr exposure a) C3A cell b) human primary hepatocyte. 
 
 
 
 
 
 
 
Figure 6.15. Scanning electron microscopy pictures of interaction of MWCNT (NM 400) NMs with the cells 
following a 4 hr exposure a) C3A cell b) human primary hepatocyte. 
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Figure 6.16. Scanning electron microscopy pictures of interaction of MWCNT (NM 402) NMs with the cells 
following a 4 hr exposure a) C3A cell b) human primary hepatocyte. 
 
 
 
 
 
 
 
Figure 6.17. Scanning electron microscopy pictures of interaction of TiO2 (NRCWE 002) NMs with the cells 
following a 4 hr exposure a) C3A cell b) human primary hepatocyte. 
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6.8 Cytochrome P450 levels 
 
Hepatic cytochrome P450 activities (CYP 3A4, 2B4 and 2D6) were simultaneously examined 
in the C3A cell lines and primary human hepatocytes. Unsurprisingly we found greater levels 
of CYP450 activity in the untreated primary cells compared to the C3A cell line (Figure 
6.18). Furthermore, exposure of the cells to the panel of engineered NMs at the low sub-lethal 
concentration of 0.31 µg/cm
2 
did not affect cytochrome CYP450 levels in either cell type 
(Figure 6.18). 
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Figure 6.18. Hepatic cytochrome P450 (3A4, 2B4 and 2D6) measured from both untreated primary human 
hepatocytes and C3A cells. Both cells types were also treated with a sub-lethal concentration of the panel of 
nanomaterials at 0.31 µg/cm
2
 quantified via DetectX
®
 P450 demethylating fluorescent activity kit. 
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6.9 Discussion 
 
This particular chapter focused on the impacts of the investigated nanomaterial panel on 
human primary hepatocytes and C3A hepatic cell line with respect to cytotoxicity, pro-
inflammatory cytokine production, albumin production and nanomaterial uptake. The data 
shows that although there are small variations between the primary cells and the cell line, the 
overall responses are very similar from both cell types following acute exposure (24 hr) to the 
investigated nanomaterials in vitro. 
 
The use of in vitro hepatocyte models have been extremely useful in both fundamental 
research and various application areas. Primary hepatocytes appear as the closest model for 
the human liver. However, these cells are phenotypically unstable, they can be very 
expensive and have an extremely limited life span. In addition they exhibit large variability 
between different human donors (Liguori, et al. 2008; Sahi, et al. 2010). Hepatocyte cell lines 
on the other hand are cheap and much easier to maintain. Hence they are often utilised as 
surrogates for human primary hepatocytes. However their use in absorption, metabolism, 
excretion and toxicity studies have been questioned as the basal levels of their metabolizing 
enzymes is greatly reduced compared to primary cells (Hansson, et al., 2004).  
 
Similar to previous studies it was found that that the ENPRA panel of NMs panel can be 
segregated into a low (TiO2 and MWCNT) and a high toxicity group (Ag and coated and 
uncoated ZnO) as investigated using the WST-1 assays. The most interesting finding was that 
the toxicity pattern was similar for both hepatocyte cell types, with the silver NMs being the 
most toxic followed by the uncoated and the coated ZnO NMs. While the TiO2 and 
MWCNTs were not considered as highly cytotoxic to the hepatocytes as the LC50 was not 
reached following a 24 hr exposure. To our knowledge no studies have investigated the NM 
induced toxicity to primary human hepatocytes however previous studies have shown that 
ZnO (Sharma, et al., 2011) and Ag (Piao, et al., 2011) NMs are highly toxic to hepatocyte 
cell lines in vitro while TiO2 NMs (Wang, et al., 2011b) were of relatively low toxicity. 
Exposure of HepG2 cells to MWCNTs for 48 hr resulted in an LC50 of around 40 µg/ml 
(Anreddy, et al., 2011).  
 
IL8 is a chemokine mediating the activation and migration of a wide variety of inflammatory 
cells including neutrophils into tissue, hence playing a pivotal role in initiation of an 
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inflammatory response (Puthothu, et al., 2006). Both primary hepatocytes and the hepatic cell 
line produced significant levels of the chemokine following exposure to the nanomaterials. 
The pattern of cytokine production witnessed was similar for both hepatocyte cell models. 
Our findings suggest that the in vitro hepatocyte nanomaterial-induced inflammation seems 
to include IL8 production from both the primary and C3A hepatocytes. These particular 
findings are similar to previous studies in which it has been shown that primary hepatocytes 
(Wanninger, et al., 2009) and hepatocyte cell lines (Delpino, et al., 2010) produce IL8 
following exposure to foreign antigens. This being said small differences in IL8 secretion was 
observed following exposure to certain concentrations of five of the NMs investigated in this 
study. Although statistically significant these distinctions do not influence the conclusions 
made above. It is also worth noting that it would be impossible to produce identical 
replication of ELISA results even if the exact same cell type were being utilised. 
 
Furthermore no change in the levels of IL6 or TNF-α compared to the control following 
exposure of the primary hepatocytes or C3A cells to any of the investigated nanomaterials 
was noted suggesting that the cytokine production from these cells is limited.  
 
Albumin is the most abundant protein produced from the liver and was quantified as a 
measure of liver function. Previously it was shown that exposure of C3A cells to the panel of 
nanomaterials resulted in very little change in the levels of albumin with the exception of the 
two ZnO NMs at LC50 concentrations (Chapter 4) (Kermanizadeh, et al., 2012c). In this study 
exposure of the primary human hepatocytes to sub-lethal levels of the ENPRA NMs once 
again resulted in a very similar outcome to the results seen with the C3A cell line with one 
exception. Exposure of the primary cells to one of the ZnO NMs (NM 111) at the LC50 did 
not result in a significant decrease in albumin as previously witnessed. These results suggest 
that despite varying degrees of cell death, none of the nanomaterials investigated (at sub-
lethal concentrations) affected hepatocyte function in vitro in terms of albumin production.  
 
Next the interaction of the nanomaterials with both cell types was investigated. Both the 
primary hepatocytes and the C3A cells were capable of nanomaterial uptake. Four of the 
nanomaterials were found in the cytoplasm of the cells (Ag – NM 300, TiO2 - NRCWE 002 
and MWCNTs – NM 400 and NM 402), while one of the carbon nanotubes (NM 402) was 
also observed within the nucleus of the cells. It is important to note however that our TEM 
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study had its limitations. It was extremely difficult to identify any of the ZnO NMs due to 
their high solubility in the chosen culture media (Chapter 4) (Kermanizadeh, et al., 2012c). 
 
As the SEM and TEM pictures demonstrate cell death is evident following exposure of the 
hepatocytes to the Ag and two ZnO NMs. Although we suspect apoptosis to be the 
mechanism of death in this in vitro model, this has not been checked or validated so there is a 
real possibility that other mechanisms could be involved in the liver cells dying. 
 
Apoptosis is a form of programmed cell death in which cells die without release of their 
intracellular contents (no damage to neighbouring cells). Apoptosis is characterised by 
appearance of morphological changes including membrane blebbing, chromatin condensation 
and the fragmentation of the nucleus and externalisation of phosophatidylserine residues 
(very important in the clearance of apoptotic bodies by phagocytes) (Beere, et al., 2001). 
 
Apoptosis is orchestrated by a number of cysteine proteases generally termed as caspases. 
These proteases are synthesised as inactive precursors that are cleaved in order to become 
active prior to apoptosis (Ola, et al., 2011). Interior caspases contain protein-protein 
interaction domains or the related death effector domains. Binding of specific adaptor 
molecules to these domains promotes the activation of the caspase (Ola, et al., 2011). 
Caspase activation is regulated by a number of cytosolic events one of the most important is 
the formation of the apoptosome (Ola, et al., 2011). This complex comprises of several 
proteins including apoptotic protease activating factor-1 (APAF-1), cytochrome c and 
procaspase 9 (Ola, et al., 2011). The release of cytochrome c from the mitochondria into the 
cytosol in particular is crucial for both apoptosome formation and caspase activation in 
response to the apoptotic stimuli (Ola, et al., 2011). The APAF-1 complex sequesters 
procaspase-9, which then autoactivates, recruits and cleaves procaspase-3. Catalytically 
active caspase-3 is then able to cleave its target substrates to induce apoptosis (Ola, et al., 
2011). It is important to note that abnormalities in apoptosis can lead to  a variety of diseases 
including cancer and a number of degenerative disorders hence it must be heavily regulated 
through independent signalling pathways that are initiated either from triggering events 
within the cell or on its surface (Beere, et al., 2001).  
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As already mentioned cell death can be classified in many ways mostly distinguished as 
being actively regulated or passive and/or accidental (Beere, et al., 2001). Necrosis in 
contrast to apoptosis is an example of unregulated cell death.  
 
Although a significant proportion of necrotic deaths are passive, recent experimental 
evidence has emerged that necrosis can also be regulated. The relative proportion of 
unregulated versus regulated necrotic death is not currently known (Parone, et al., 2002). The 
archetypal features of necrosis are loss of plasma membrane integrity and depletion of 
cellular ATP (Parone, et al., 2002). As a result of this plasma membrane dysfunction, 
necrotic cells become swollen. There is also swelling of organelles such as the mitochondria. 
These events result in a general collapse of intracellular homeostasis. In contrast to the clean-
up operation that is typical in apoptosis, the release of cellular contents into the extracellular 
space engenders an inflammatory response in necrosis (Parone, et al., 2002). Although the 
exact mechanisms of necrosis signalling are currently unknown it is believed that two 
pathways might be responsible for necrosis of a cell. Firstly, necrosis can be mediated by a 
multi-protein complex including TRADD, RIP1, TRAF2, and cIAP1/2 (i.e. binding of TNF-α 
receptor 1) (Parone, et al., 2002). A second necrosis pathway involves the mitochondrial 
permeability transition pore (MPTP) in the inner mitochondrial membrane and its regulation 
by cyclophilin D. The MPTP may be opened by increased Ca
2+
, oxidative stress or decreased 
ATP (Parone, et al., 2002). 
 
In a contrast to necrosis and apoptosis, autophagy is primarily a survival mechanism. The 
processs is an intracellular recycling process in which organelles, proteins and lipids are 
catabolised by lysosomal degradation (Whelan, et al., 2010). Autophagy provides cells with 
amino acids, free fatty acids and energy in times of nutrient shortage. In addition, it serves to 
regulate protein and organelle abundance and quality. Autophagy can involve a chaperone in 
which it binds a target protein and escorts it to the lysosome, provides a means for the 
degradation of the selected proteins (Whelan, et al., 2010).  
 
In addition to the above mentioned forms of cell death there are many other mechanisms in 
which cells die and tissue homeostasis is maintained (e.g. entosis – a viable cell is 
phagocytosed by a neighbouring cells which then dies (Kroemer, et al., 2009), anoikis – cells 
lose their attachment to neighbouring cells (Kroemer, et al., 2009)).  
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The uptake mechanism of the nanomaterials into the hepatocytes is currently unknown, but 
since hepatocytes are not phagocytic, the uptake is most likely to be via clathrin mediated 
endocytosis as witnessed in other cell types (Passagne, et al., 2012; Smith, et al., 2012; Zhao, 
et al., 2011). 
 
Following an investigation into the surface interaction of the cells with the NMs utilising 
SEM we noted that the highly toxic NMs (Ag and ZnO) cause large amounts of surface 
damage to both the C3A and the primary cells, while the TiO2 and MWCNT were clearly 
evident on or interacting with the surface of the cells.  
 
The Cytochrome P450 levels for the C3A cell lines and the primary hepatocytes was also 
examined. Significantly lower levels of CYP450 (3A4, 2B4 and 2D6) activity from the C3A 
cells compared to their primary counterparts were found. These finding are similar to 
previous studies in which it has been shown that CYP450 isozymes are intrinsically lower in 
hepatocyte cell lines compared to primary cells (Wongkajornslip, et al., 2012). These 
findings are not surprising and have been reported elsewhere however it is worth noting that 
the materials investigated here did not interfere with the metabolic activity of the primary 
cells at low sub lethal concentrations. Furthermore it seems that CYP450 activity does not 
play a role in the adverse effects witnessed following exposure of the cells to the panel of 
engineered nanomaterials. 
 
Finally, reactive oxygen species and oxidative stress have been demonstrated to play a key 
role in the response of many cell types to a range of NMs (Pichardo, et al., 2012; Shvedova, 
et al., 2012). Therefore it would be interesting to know whether the hepatocyte cell line 
responds to these materials via a mechanism involving oxidative stress and whether this is 
comparable to the primary hepatocytes. It was not possible to investigate this question using 
the primary human hepatocytes due to their extremely high cost, and so we have asked the 
same question using liver tissue from exposed animals (Chapters 7 and 8).  
 
6.10 Conclusions 
 
This in vitro study demonstrated that the C3A cells are a very good model to investigate 
nanomaterial induced effects on hepatocytes with regards to the end points investigated 
(cytotoxicity, cytokine secretion, nanonmaterial uptake and functional markers). The results 
147 
 
also suggest that biotransformation enzymes in hepatocytes are not important in terms of 
determining nanotoxicology. Over all the cell line was found to be extremely useful as a 
replacement for a primary model for specific studies (on occasions the use of primary cells is 
often difficult or all together impossible) providing that the limitation for each cell type and 
experiment is thoroughly understood.  
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Chapter Seven 
Nanomaterial impact on liver antioxidant status and 
gene expression following administration via the 
lungs  
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7.1 Aims and chapter outline 
 
To assess the oxidative impact (glutathione depletion) and gene expression (C3, CXCL2, IL6, 
IL10 and TNF-α) response of mice liver tissue 24 hr following intratracheal exposure via the 
lungs. 
 
Mice were exposed via intratracheal instillation to the ENPRA NMs (described in section 
3.29) before the liver was removed to assess for glutathione content (section 3.17) and the 
expression of a range of genes (section 3.30). 
 
7.2 Liver glutathione measurements following intratracheal instillation of 
nanomaterials 
 
Analysis of the changes of total glutathione levels (GSH and GSSG) in mice liver tissue 
revealed that there was a visible dose-dependent decrease in the antioxidant levels compared 
to the control tissue across four of the ten investigated NMs; NM 110 (ZnO uncoated), NM 
111 (ZnO coated), NM 300 (Ag), and NRCWE 002 (positively charged TiO2) (Figure 7.1b, c, 
d and h). The largest depletion was observed following exposure to the coated ZnO and Ag 
NMs. There was no significant impact on liver glutathione following exposure to the 
remaining TiO2 NMs (NM 101, NRCWE 001, NRCWE 003 and NRCWE 004) and 
MWCNTs (NM 400 and NM 402) (Figure 7.1a, e, f, g, i and j).  
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Figure 7.1. Effects of NM intratracheal instillation (24 hr) on the total glutathione content of mouse liver 
tissue. Values represent means ± SEM (n=3), significance indicated by * = p<0.05 and ** = p<0.005, when NM 
treatments are compared to the control. A) NM 101 B) NM 110 C) NM 111 D) NM 300 E) NM 400 F) NM 402 
G) NRCWE 001 H) NRCWE 002 I) NRCWE 003 J) NRCWE 004.      
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7.3 mRNA expression in mice liver following IT exposure of NMs 
 
Analysis of mRNA expression in livers of mice 24 hr post intratracheal instillation showed a 
decrease in C3 following exposure to NM 101, NM 110, NM 111, NM 300, NRCWE 001 
and NRCWE 002 (Table 7.1). There was no large change in the levels of CXCL2 following 
exposure to the ENPRA nanomaterials (Table 7.2). an increase in the IL6 mRNA following 
exposure to NM 110, NM 111, NM 300, NRCWE 001, NRCWE 002, NRCWE 003 and 
NRCWE 004 was noted (Table 7.3). The largest and most significant change of all the genes 
investigated was an increase in IL10 following exposure to NM 101, NM 110, NM 111, NM 
300, NRCWE 001, NRCWE 002, NRCWE 003 and NRCWE 004 (Table 7.4). Finally no 
significant change in TNF-α gene expression was observed following exposure to any of the 
nanomaterials investigated (Table 7.5). 
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NM 1 8 32 64 128 
NM 101 ++++ 0 - --- -- 
NM 110 --- -- -- - - 
NM 111 --- -- ---- -- 0 
NM 300 0 0 -- -- --- 
NM 400 0 0 0 0 0 
NM 402 0 0 0 0 0 
NRCWE 001 0 + 0 -- -- 
NRCWE 002 0 --- 0 -- - 
NRCWE 003 0 0 0 0 -- 
NRCWE 004 0 0 0 0 0 
Table 7.1. mRNA expression of complement component 3 in C57/BL6 mice liver. The animals were exposed 
to increasing doses of NMs via the lungs. The animals were dissected 24 hr after exposure and the mRNA 
expression was analysed by real time PCR with B2m utilised as an endogenous control. – or + is representative 
of 50% change, -- or ++ is representative of 75% change, --- or +++ is representative of 100% change and ---- or 
++++ is representative of ≥ 200% change. (n=3) 
Doses - µg per animal 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
156 
 
NM 1 8 32 64 128 
NM 101 0 - - 0 0 
NM 110 -- -- 0 -- 0 
NM 111 - - -- -- 0 
NM 300 0 0 0 0 0 
NM 400 0 0 0 0 0 
NM 402 0 0 0 0 0 
NRCWE 001 ++ 0 0 0 0 
NRCWE 002 + 0 0 0 0 
NRCWE 003 0 0 0 0 0 
NRCWE 004 0 0 0 0 0 
Table 7.2. mRNA expression of CXCL2 in C57/BL6 mice liver. The animals were exposed to increasing 
doses of NMs via the lungs. The animals were dissected 24 hr after exposure and the mRNA expression was 
analysed by real time PCR with B2m utilised as an endogenous control. – or + is representative of 50% change, 
-- or ++ is representative of 75% change, --- or +++ is representative of 100% change and ---- or ++++ is 
representative of ≥ 200% change. (n=3) 
Doses - µg per animal 
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NM 1 8 32 64 128 
NM 101 0 0 0 0 ++ 
NM 110 -- -- 0 - 0 
NM 111 - + 0 0 + 
NM 300 - 0 ++ ++ ++ 
NM 400 0 0 0 0 0 
NM 402 0 0 0 0 0 
NRCWE 001 0 ++ ++ ++++ ++++ 
NRCWE 002 0 ++ ++ ++++ ++++ 
NRCWE 003 0 ++ ++ ++++ ++++ 
NRCWE 004 0 0 0 0 ++ 
Table 7.3. mRNA expression of IL6 in C57/BL6 mice liver. The animals were exposed to increasing doses of 
NMs via the lungs. The animals were dissected 24 hr after exposure and the mRNA expression was analysed by 
real time PCR with B2m utilised as an endogenous control. – or + is representative of 50% change, -- or ++ is 
representative of 75% change, --- or +++ is representative of 100% change and ---- or ++++ is representative of 
≥ 200% change. (n=3) 
Doses - µg per animal 
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NM 1 8 32 64 128 
NM 101 ---- 0 0 0 ++++ 
NM 110 ++++ ++++ ++++ ++++ ++++ 
NM 111 + 0 ++++ 0 ++++ 
NM 300 ++ 0 +++ ++ ++++ 
NM 400 0 0 0 0 0 
NM 402 0 0 0 0 0 
NRCWE 001 0 0 ++ +++ ++++ 
NRCWE 002 0 0 0 + ++ 
NRCWE 003 0 0 ++ +++ ++++ 
NRCWE 004 0 + + ++ +++ 
Table 7.4. mRNA expression of IL10 in C57/BL6 mice liver. The animals were exposed to increasing doses 
of NMs via the lungs. The animals were dissected 24 hr after exposure and the mRNA expression was analysed 
by real time PCR with B2m utilised as an endogenous control. – or + is representative of 50% change, -- or ++ 
is representative of 75% change, --- or +++ is representative of 100% change and ---- or ++++ is representative 
of ≥ 200% change. (n=3) 
Doses - µg per animal 
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NM 1 8 32 64 128 
NM 101 0 0 0 0 0 
NM 110 0 - 0 0 0 
NM 111 0 -- -- 0 0 
NM 300 -- 0 0 0 0 
NM 400 0 0 0 0 0 
NM 402 0 0 0 0 0 
NRCWE 001 0 0 0 0 0 
NRCWE 002 0 0 0 0 0 
NRCWE 003 0 0 0 0 0 
NRCWE 004 0 0 0 0 0 
Table 7.5. mRNA expression of TNF-α in C57/BL6 mice liver. The animals were exposed to increasing doses 
of NMs via the lungs. The animals were dissected 24 hr after exposure and the mRNA expression was analysed 
by real time PCR with B2m utilised as an endogenous control. – or + is representative of 50% change, -- or ++ 
is representative of 75% change, --- or +++ is representative of 100% change and ---- or ++++ is representative 
of ≥ 200% change. (n=3) 
Doses - µg per animal 
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7.4 Discussion 
 
This study shows the intratracheally instilled Ag, ZnO and positively charged TiO2 result in 
acute distal effects on the liver that involved oxidative stress (glutathione depletion), while 
exposure to all nanomaterials with the exception of the MWCNT result in changes in gene 
expression in the liver. 
 
To our knowledge this is the first time that distal effects relating to toxicity or oxidative stress 
in the liver have been demonstrated following exposure via the lung. This is not a uniform 
effect induced by all NMs, but instead it is limited to the highly toxic Ag (NM 300) and ZnO 
NMs (NM 110, NM 111) and the positively charged TiO2 (NRCWE 002) (Chapter 4). These 
in vivo effects are reflected to some extent using the C3A cells, where five of the tested NMs 
also induced glutathione depletion (Chapter 5) (Kermanizadeh, et al., 2012a).  
 
It is important to note that our investigation into glutathione depletion following intratracheal 
instillation of the ENPRA NMs had limitations which have to be taken into account when 
interpreting the findings. Firstly, the source of glutathione is unknown in the in vivo assays as 
the measurements could be potentially from any number of cell populations within the liver 
and not just the hepatocytes as is the case for the in vitro experiments. This could be an 
important factor as 20-25% of the organ is composed of non parenchymal cells (Kmiec, 
2001). Secondly, there were some differences between the levels of intracellular glutathione 
between the vehicle control animals for each nanomaterial. Hence the levels of glutathione 
depletion observed in our experiments are only comparable to the control group for each 
nanomaterial and not uniform for all treatments. 
 
Few studies have investigated the effects of Ag, ZnO, TiO2 or MWCNT on GSH depletion 
within the liver in vivo or in vitro, however in a recent study Sprague Dawley rats were 
exposed to 10 nm cerium oxide NMs via a single dose intratracheal instillation. The authors 
discovered an array of adverse effects in the liver (Nalabotu, et al., 2011). In another study 
the cellular redox state of a human liver cell line (HL7702) was investigated (Gao, et al., 
2011). The authors demonstrate a clear decrease in intracellular GSH levels after exposure to 
8 nm gold nanoparticles for 24 hr (Gao, et al., 2011). The use of a rat derived liver cell line 
(BRL 3A) and 10 nm Ag NMs (up to 50 μg/ml – 24 hr exposure) also resulted in significant 
GSH depletion (Hussain, et al., 2005). In a contradictory study however the effects of silver 
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NMs on primary mice hepatocytes in vitro revealed a small increase in intracellular GSH 
levels subsequent to 24 hr exposure to the NMs (Arora et al., 2009).  
 
The in vivo and in vitro assays therefore produced comparable results for the Ag and ZnO 
nanomaterials, but there were differences for the TiO2 (for which the in vivo system was more 
sensitive) and MWCNT (for which the in vitro system was more sensitive). The difference 
following MWCNT exposure may be related to the shape and size of carbon nanotubes 
compared to the nanoparticles. Since the MWCNTs examined had lengths in the μm-range, it 
is possible that their translocation into the bloodstream, and subsequent exposure of the liver, 
is relatively lower in comparison to the smaller NMs. The difference for the positive TiO2 
particles is less easy to explain. Positively charged particles have been demonstrated to 
penetrate cellular barriers more readily than uncharged or negatively charged particles 
(Orthmann, et al., 2010), and to be more cytotoxic in vitro (Salomon, et al., 2011). However, 
the positive TiO2 particles in this study were not considered to be highly toxic in the C3A cell 
line. Something relating to the respiratory route of exposure might have imparted a 
characteristic to the particles that enhanced their toxicity. Perhaps coating the particles with 
lung lining fluid (LLF) could influence their impact on the liver cells. Other studies 
conducted within our research group have demonstrated that LLF can modulate the 
cytotoxicity and pro-inflammatory nature of gold and silica nanomaterials to hepatocytes and 
macrophages (Brown, et al., 2013a and b). Alternatively the positively charged TiO2 may 
have induced a localised response in the lung generating a response that impacted on the 
liver. 
 
Next it was shown that 24 hr exposure of ENPRA nanomaterials (with the exception of two 
MWCNTs) via the lungs affects gene expression in the liver - with a decrease in C3 and an 
increase in IL6 and IL10 mRNA levels most evident. The data in this study suggest that the 
overall response in the liver is anti-inflammatory, hence tolerance is the mechanism of 
response in the organ following exposure to these NMs. To our knowledge studies into gene 
expression in the liver following exposure of nanomaterials via the lungs are limited in 
number. However in a recent study a significant hepatic response was witnessed in the 
offspring of rats exposed to carbon black at mRNA level (Jackson, et al., 2012). The genes 
investigated in this study, their role in the liver and possible consequences of the route of 
exposure of nanomaterials are comprehensively discussed in chapter 8.  
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7.5 Conclusions 
 
In conclusion, this study shows that instilled Ag, ZnO and positively charged TiO2 result in 
distal effects on the liver in the form of oxidative stress. Furthermore all NMs with the 
exception of the two MWCNTs instilled via the lungs caused changes in gene expression in 
the liver in varying degrees. In the in vitro C3A cell line similar results were generated (GSH 
depletion), with two exceptions, positively charged TiO2 (NRECWE 002) and the MWCNTs 
(NM 400 and NM 402). The animal model was more sensitive to the positive TiO2, while the 
cell line was more sensitive to the MWCNTs, while we observed differences in the 
mechanism of action and response to antioxidants depending on the toxicity of the NMs 
applied.  
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Chapter Eight 
Evaluating the impact of the engineered 
nanomaterials in the liver following exposure via an 
intravenous route – the role of polymorphonuclear 
leukocytes, antioxidant status and gene expression in 
the organ 
 
 
 
 
 
Based on publication: Kermanizadeh A, Brown DM, Hutchison G, Stone V. (2013a). 
Engineered nanomaterial impact in the liver following exposure via an intravenous route – 
the role of polymorphonuclear leukocytes and gene expression in the organ. Nanomedicine 
and Nanotechnology 4: 157. DOI:10.4172/2157-7439.1000157. 
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8.1 Aims and chapter outline 
 
In previous chapters it was demonstrated that the panel of engineered nanomaterials 
investigated could be divided into a high toxicity group and a low toxicity group according to 
their ability to induce cytotoxicity in the C3A cell line (Kermanizadeh, et al., 2012c), primary 
human hepatocytes (Kermanizadeh, et al., 2012b), primary rat co-cultures of hepatocytes and 
Kupffer cells (Filippi, et al., manuscript in preparation) and renal cells (Kermanizadeh, et al., 
2013b). Hence six nanomaterials were chosen - three of which were shown to be highly toxic 
(Ag and two ZnO NMs) and three that were relatively low toxic (positively charged TiO2 and 
two MWCNTs) in the in vitro systems.  
 
The aim of this study was to investigate the potential for NMs to induce neutrophil influx in 
the liver. We investigated the role of neutrophils by looking at the influx of these cells into 
the liver following IV exposure (large percentage of NMs reach the liver very quickly) of 
mice to a panel of NMs. Furthermore the changes in the expression of C3, IL6, CXCL2, 
IL10, TNF-α, Fas ligand, albumin and intracellular adhesion molecule 1 (ICAM-1) in the 
liver following nanomaterial exposure to gain a better understanding of how the organ 
responds following a NM (NM 110, NM 111, NM 300, NM 400, NM 402 and NRCWE 002) 
challenge were investigated. Finally we examined the total glutathione (GSH and GSSG) 
levels in the liver to ascertain any changes in the organ’s antioxidant status following IV 
exposure to the NMs.  
 
8.2 Myeloperoxidase quantification in liver tissue 
 
MPO is a lysosomal protein stored in granules of all granulocytes, and hence it is found in 
largest quantities in neutrophils. In order to quantify PMN infiltration into the liver we 
measured MPO in the tissue samples. A modest but statistically significant increase in MPO 
in the liver as early as 6 hr following intravenous injection of four of the six NMs (NM 110, 
NM 300, NM 400 and NRCWE 002) was noted (Figure 8.1) (p<0.05). MPO content of the 
liver tissue had subsided back to control levels by 48 hr (all NMs) (Figure 8.2). Multiple 
doses of Ag and TiO2 NMs (one high and one low toxicity materials) did not enhance the 
MPO up-regulation further (Figure 8.3).  
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Figure 8.1. MPO measured in the liver tissue following 6 hr IV exposure to 100 µl 128 µg/ml of the panel of 
NMs (NM 110 – ZnO uncoated; NM 111 – ZnO coated; NM 300 – Ag; NM 400 – MWCNT; NM 402 
MWCNT; NRCWE 002 – positively charged TiO2. A positive control of LPS (50 µl - 100 µg/ml) was also 
employed. The negative control is representative of animals injected with 100 µl of PBS. (n=3±SEM) * P<0.05, 
** P<0.005 compared to negative control. 
 
 
Figure 8.2. MPO measured in the liver following 24, 48 and 72 hr exposure to 100 µl of 128 µg/ml the NM 
300 – Ag and NRCWE 002 – positively charged TiO2. A positive control of LPS (50 µl - 100 µg/ml) was also 
employed. The negative control is representative of animals injected with 100 µl of PBS. (n=3±SEM) * P<0.05, 
** P<0.005compared to negative control. 
 
Figure 8.3. MPO measured in the liver following 3 repeated doses of NMs over three days (3 doses of 100 µl 
of 64 µg/ml every 24 hr). The animals were dissected 72 hr following the initial dose. The negative control is 
representative of animals injected with three doses of 100 µl of PBS while the positive control animals were 
injected with three doses of LPS (50 µl - 50 µg/ml per injection). (n=3±SEM) * P<0.05, ** P<0.005compared to 
negative control. 
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8.3 Immunohistochemistry 
 
As already mentioned MPO is found in all granulocytes including basophils and eosinophils 
all be it in smaller quantities compared to neutrophils. Therefore to ascertain whether the 
increase in MPO witnessed previously (Figure 8.1, 2 and 3) was indeed associated with 
neutrophils, the tissues were labelled using a specific neutrophil cell surface marker (Ly-
6B.2). Staining of the sections showed neutrophils in the tissues exposed to the positive 
control and the nanomaterials 6 hr post exposure which were not evident in the negative 
control (Figure 8.4). Furthermore the relative numbers of neutrophils stained in the tissues 
were comparable to results obtained from the MPO experiments for the time course in that 
the staining decreased with time (Figure 8.5). Multiple dose experiments also reflected the 
MPO results, in that repeated exposures did not further enhance the neutrophil influx into the 
tissue (Figure 8.6). 
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Figure 8.4. Ly6B.2 staining of mouse liver tissue by immunohistochemistry 6 hr post intravenous exposure to 
ENPRA panel of engineered nanomaterials (100 µl - 128 µg/ml of NMs). A positive control of LPS (50 µl - 100 
µg/ml) was also employed. The negative control is representative of animals injected with 100 µl of PBS. A) 
PBS B) LPS C) NM 110 D) NM 111 E) NM 300 F) NM 400 G) NM 402 H) NRCWE 002. 
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Figure 8.5. Ly6B.2 staining of mouse liver tissue by immunohistochemistry representing samples from 
animals 24, 48 or 72 hr post intravenous exposure to ENPRA panel of engineered nanomaterials (100 µl - 128 
µg/ml of NMs). A) NM 300 – 24 hr B) NRCWE 002 – 24 hr C) NM 300 – 48 hr D) NRCWE 002 – 48 hr E) 
NM 300 – 72 hr F) NRCWE 002 – 72 hr. 
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Figure 8.6. Ly6B.2 staining of mouse liver tissue by immunohistochemistry following three repeated doses 
over three days (3 doses of 100 µl of 64 µg/ml of NMs every 24 hr). The animals were dissected 72 hr following 
the initial dose. A) NM 300 B) NRCWE 002. 
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8.4 Liver glutathione measurements following intravenous injection of nanomaterials 
 
Analysis of the changes of total glutathione levels in mice liver tissue revealed no significant 
changes 24 hr following a intravenous exposure to 100 µl of 128 µg/ml of the Ag (NM 300) 
or positively charged TiO2 (NRCWE 002) nanomaterials (Figure 8.7).  
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Figure 8.7. Effects of NM exposure on total glutathione levels in liver tissue. The animals were exposed to 
the nanomaterials via an intravenous route - 100 µl of 128 µg/ml of the Ag (NM 300) or positively charged TiO2 
(NRCWE 002) for a period of 24 hr before dissection and the removal of the liver. The negative control group 
of animal received 100 µl of PBS. (n=3±SEM) 
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8.5 mRNA expression in mice liver following intravenous exposure of NMs 
 
Analysis of mRNA expression in mice liver 6 hr after intravenous injection of 100 µl of 128 
µg/ml of panel of nanomaterials showed a decrease in C3 following exposure to ZnO (NM 
110 and NM 111), MWCNT (NM 400 and NM 402) (Table 8.1). A decrease in IL6 mRNA 
levels following exposure to ZnO (NM 110, NM 111) and Ag NMs (NM 300) (Table 8.1). 
Increases in IL10 was witnessed following exposure to ZnO (NM 110) and TiO2 (NRCWE 
002) (Table 8.1) was observed. Finally a large increase in CXCL2 was witnessed following 
exposure to NM 110. No significant changes were detected in the expression of albumin, 
TNF-α, Fas ligand or ICAM-1 following treatment with any of the nanomaterials (Table 8.1). 
 
Repeated exposure of the C57/BL6 mice to three doses of the Ag (NM 300) and positively 
charged TiO2 (NRCWE 002) nanomaterials resulted in a large increase in IL10 levels while 
smaller yet significant decreases in C3 and ICAM-1 mRNA were noted following exposure 
to both NMs (Table 8.2). 
 
Finally, the animals were exposed to a single dose of 100 µl of 64 µg/ml of the Ag and 
positively charged TiO2 NMs by injection via the lateral tail vein. The animals were dissected 
24 hr, 48 hr and 72 hr after the initial injection. We found that in all instances the increase or 
decrease in mRNA was most evident after the 24 hr exposure. For all the genes investigated 
in this study resolution to control levels had occurred 72 hr post exposure (Tables 8.3 and 4).  
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Gene 
Expression 
NM 110 NM 111 NM 300 NM 400 NM 402 NRCWE 
002 
IL6 ---- - ---- 0 0 0 
IL10 ++ 0 0 0 + ++++ 
C3 - -- -- - -- 0 
CXCL2 ++++ 0 0 0 0 0 
TNF-α 0 0 0 0 0 0 
Fas ligand 0 0 0 0 0 0 
ICAM-1 0 0 0 0 0 0 
Albumin 0 0 0 0 0 0 
Table 8.1. mRNA expression of inflammatory cytokines and receptors, FasL and albumin in C57/BL6 mice 
liver. The animals were exposed to 100 µl of 128 µg/ml of panel of nanomaterials for 6 hr by injection via the 
lateral tail vein. mRNA expression was analysed by real time PCR with B2m utilised as an endogenous control. 
– or + is representative of 50% change, -- or ++ is representative of 75% change, --- or +++ is representative of 
100% change and ---- or ++++ is representative of ≥ 200%  change. (n=3) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
179 
 
Gene Expression NM 300 NRCWE 002 
IL6 0 0 
IL10 ++++ ++++ 
C3 -- -- 
CXCL2 0 0 
TNF-α + 0 
Fas Ligand 0 0 
ICAM-1 -- -- 
Albumin 0 0 
Table 8.2. mRNA expression of inflammatory cytokines and receptors, FasL and albumin in C57/BL6 mice 
liver. The animals were exposed three times (0 hr, 24 hr and 48 hr) to 100 µl of 64 µg/ml of the Ag (NM 300) 
and the positively charged TiO2 NM (NRCWE 002) by injection via the lateral tail vein. The animals were 
dissected 72 hr after the first injection and the mRNA expression was analysed by real time PCR with B2m 
utilised as an endogenous control. – or + is representative of 50% change, -- or ++ is representative of 75% 
change, --- or +++ is representative of 100% change and ---- or ++++ is representative of ≥ 200%  change. (n=3) 
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Gene Expression 
(NM 300) 
Day 1 Day 2 Day 3 
IL6 ++ + 0 
IL10 ++++ ++ 0 
C3 -- - 0 
CXCL2 0 0 0 
TNF-α 0 0 0 
Fas Ligand ++ 0 0 
ICAM-1 ++ 0 0 
Albumin 0 0 0 
Table 8.3. mRNA expression of inflammatory cytokines and receptors, FasL and albumin in C57/BL6 mice 
liver. The animals were exposed to a single dose of 100 µl of 128 µg/ml of the Ag NM (NM 300) by injection 
via the lateral tail vein. The animals were dissected 24 hr, 48 hr and 72 hr after the initial injection and the 
mRNA expression was analysed by real time PCR with B2m utilised as an endogenous control. – or + is 
representative of 50% change, -- or ++ is representative of 75% change, --- or +++ is representative of 100% 
change and ---- or ++++ is representative of ≥ 200%  change. (n=3) 
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Gene Expression 
(NRCWE 002) 
Day 1 Day 2 Day 3 
IL6 0 0 0 
IL10 ++++ ++++ 0 
C3 -- 0 0 
CXCL2 0 0 0 
TNF-α 0 0 0 
Fas Ligand ++ 0 0 
ICAM-1 ++ 0 0 
Albumin 0 0 0 
Table 8.4. mRNA expression of inflammatory cytokines and receptors, FasL and albumin in C57/BL6 mice 
liver. The animals were exposed to a single dose of 100 µl of 128 µg/ml of the TiO2 NM (NRCWE 002) by 
injection via the lateral tail vein. The animals were dissected 24 hr, 48 hr and 72 hr after the initial injection and 
the mRNA expression was analysed by real time PCR with B2m utilised as an endogenous control. – or + is 
representative of 50% change, -- or ++ is representative of 75% change, --- or +++ is representative of 100% 
change and ---- or ++++ is representative of ≥ 200%  change. (n=3) 
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8.6 Discussion 
 
Numerous studies have demonstrated that NMs entering the body via the lungs, ingestion or 
direct injection accumulate in the liver (Chen, et al., 1999; Diesen, et al., 2009; Sadauskas, et 
al., 2009b). In previous studies it has been shown that hepatocytes are capable of producing 
potent neutrophil chemoattractants (human – IL8) (Delpino, et al., 2010; Kermanizadeh, et 
al., 2012a; b and c) (rat - CINC-3) (Ding, et al., 2008; Filippi, et al., manuscript in 
preparation) following exposure to foreign materials or disease models. We therefore 
investigated neutrophil infiltration into the liver following intravenous exposure of mice to a 
panel of engineered nanomaterials. 
 
Here it was shown that all six NMs (NM 110, NM 111, NM 300, NM 400, NM 402 and 
NRCWE 002) were able to induce a neutrophil influx into the liver as early as 6 hr post IV 
injection. It is extremely important to note that the doses which the animals were exposed to 
were very low doses mirroring realistic possible human (i.e. less than 15 µg of nanomaterials 
per animal) - suggesting neutrophils are involved in the organs immunity to the foreign 
nanomaterials. To our knowledge the role of neutrophils in the liver following nanomaterial 
exposure has not been addressed previously however it has been shown that neutrophils can 
accumulate within hepatic microvasculature following an increase in inflammatory mediators 
such as TNF-α, IL1, MIP-2, and PAF (Bajt, et al., 2001; Ramaiah, et al., 2007). Furthermore 
in a recent study an increase in numbers of neutrophils in the liver of BALB/c mice was 
observed during casein induced anaphylaxis (Krishnamurthy, et al., 2012).  
 
It appears that the neutrophils are only involved in the initial phases of the immune response 
against the NMs. The initial increase of neutrophil numbers in tissue was resolved by 48 hr 
post exposure. It is possible that after the initial infiltration of the neutrophils into the tissue 
the resident macrophages (Kupffer cells) take over the immune response to the 
nanomaterials. It was also very interesting to note that repeated doses of the nanomaterials 
did not result in further accumulation of the polymorphonuclear leukocytes into the tissue 
suggesting once again that after their role in initiating the immune response in the liver the 
neutrophils play no further part in the maintenance or the continuation of the inflammatory 
response. 
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It has been shown that the most common neutrophil mediated response in the liver is 
governed by the adhesion of the cells to hepatocytes (via ICAM-1 binding Mac-1) (Bautista, 
2002; Ramaiah, et al., 2007). This adhesion triggers the formation of reactive oxygen species 
(ROS) by NADPH oxidase and release of proteases through the degranulation of the PMNs. 
This process could lead to neutrophilic hepatitis characterised by self aggravating 
mechanisms resulting in chronic disease (Bautista, 2002). However a prolonged neutrophil 
response does not happen following exposure to the nanomaterials utilised in this study. As 
already mentioned the neutrophils decrease in number with time after the initial exposure. In 
addition the up-regulation of ICAM-1 mRNA was only noted after the 24 hr and had returned 
to normal background levels 48 hr post IV NM exposure.  
 
Next it was noted that there was no significant impact on liver total glutathione following IV 
exposure of the mice to the Ag or positively charged TiO2 NMs after 24 hr. These findings 
are contradictory to our previous studies in which both materials were shown to deplete total 
GSH in the liver following intratracheal instillation (IT) into the lungs (Chapter 7) (Gosens, 
et al., 2013a and b - manuscript in preparation) and in a hepatocyte cell line model (Chapter 
5) (Kermanizadeh, et al., 2012a) after a 24 hr time point. One explanation for this could be 
that the doses administrated within this study are just not high enough to induce an effect on 
the antioxidant levels in the liver (these particular doses were chosen to mirror realistic 
exposure scenarios). It is also possible that 24 hr is too long for the analysis of the antioxidant 
status in the liver. It has been shown that MWCNT/Fe3O4 NM reached the liver as early as 2 
hr following intravenous exposure (Wu, et al., 2011), while single walled carbon nanotubes 
injected into mice were found in the liver after 3 hr (McDevitt, et al., 2007). Hence it is 
possible that following this small NM challenge any antioxidant fluctuation could have taken 
place at earlier time points, with the cells being able to recover after 24 hr. The third 
hypothesis for the differences between the IT and IV routes is that passage through the lungs 
might impart a specific toxicity to the NMs that results in an impact on the liver. This may 
involve either the formation of a specific protein corona on the NM surface derived from the 
lung lining fluid or a humoral mediated effect initiated by cells in the lung.  
 
Next the expression of a range of genes related to inflammation, oxidative stress and 
apoptosis was analysed in livers of mice exposed to the panel of engineered nanomaterials. 
Analysis of mRNA expression in mice livers 6 hr after intravenous injection of panel of 
nanomaterials resulted in a decrease in C3 following exposure to ZnO (NM 110 and NM 
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111), Ag (NM 300) and MWCNT (NM 400 and NM 402) NMs. Repeated exposure of the 
mice to three doses of the Ag (NM 300) and positively charged TiO2 (NRCWE 002) 
nanomaterials also resulted in small yet significant decrease in C3. Complement component 3 
is one of the most abundant and important protein in the complement cascade. C3 activation 
is essential for all the functions of the complement system. It is crucial in promoting 
phagocytosis, supporting the local immune response against foreign agents and instructing 
the adaptive immune responses to select the appropriate antigens for any eventual antibody 
response (Sahu, et al., 2002). Moreover C3 might be capable of interaction with the 
coagulation system and contributing to pro-coagulation and ultimately a prothrombotic state 
(Hertle, et al., 2012). The decrease in C3 expression might suggest that exposure to low doses 
of NMs in this study results in overall tolerance in the liver rather than a fully developed 
immune response.  
 
Furthermore there was a decrease in IL6 mRNA levels following exposure to the ZnO and 
Ag NMs after 6 hr of exposure. IL6 is a multifunctional cytokine that acts on a number of cell 
types including B and T lymphocytes, hepatocytes, hematopoietic progenitor cells and 
neuronal cells (Kishimoto, et al., 1995). Under different circumstances the cytokine can be 
both pro and anti-inflammatory. In the liver IL6 is a potent inducer of acute phase proteins 
which are in most part pro-inflammatory proteins (including C reactive protein, complement 
factors and serum amyloid A) (Poli, et al., 1989). Once again the decrease in IL6 expression 
suggests that exposure to low doses of these NMs results in tolerance in the liver. 
 
IL10 is a multifunctional cytokine with diverse effects on a wide range of hemopoietic cells. 
The cytokine’s principle function is to terminate inflammatory responses (Moore, et al., 
2001). IL10 also regulates growth or differentiation of B and T lymphocytes, NK cells, mast 
cells, most granulocytes, dendritic cells, keratinocytes, and endothelial cells (Mocellin, et al., 
2004). IL10 also plays a key role in differentiation of regulatory T cells, which figure 
prominently and importantly in the control of immune responses and developing a tolerant 
immune state (Mocellin, et al., 2004). Analysis of IL10 mRNA showed an increase following 
exposure to exposure to NM 110, NM 300, NM 402 and NRCWE 002. The increase in IL10 
mRNA was the largest and the most significant of all the genes investigated in this study once 
again suggesting tolerance as being the overall response in the organ following acute low 
exposure to NMs. 
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CXCL2 also known as macrophage inflammatory protein 2 alpha (MIP-2) is a chemokine 
secreted from a number of cells in particular monocytes and macrophages (Zamjahn, et al., 
2011). MIP-2 is a potent chemoattractant for neutrophils and hematopoetic stem cells 
(Zamjahn, et al., 2011). A large increase in CXCL2 was witnessed following exposure to NM 
110 (uncoated ZnO) following 6 hr exposure. It is important to note that increases compared 
to base levels of CXCL2 were also witnessed following the 6 hr exposure to other 
nanomaterials however due to large fluctuations in the control group of animals these 
changes could not be regarded as significant. Up regulation of CXCL2 could be associated 
with the short term acute recruitment of neutrophils into the liver. 
 
No significant changes were detected in the expression of albumin, TNF-α, Fas ligand or 
ICAM-1 following 6 hr of any of the nanomaterials utilised in this study. The fact that there 
was no change in the levels of TNF-α would again suggest that there is no significant pro-
inflammatory response following exposure to the NMs. FasL (also referred to as CD95L) is a 
homotrimeric type II transmembrane protein signalling through trimerisation with CD95 on 
the target cells leading to death by apoptosis (McIntyre., 2012). The findings here would 
suggest that there is no apoptosis following exposure to these particular nanomaterials and 
time points however it is very possible that FasL might be up-regulated at later time points in 
relation of PMN clearance from the organ. Finally there was no change in albumin gene 
expression suggesting that the NM challenge at these low doses does not affect liver function. 
Repeated exposure of the C57/BL6 mice to three doses of the Ag (NM 300) and positively 
charged (NRCWE 002) nanomaterials again resulted in large increases in IL10 levels while 
smaller yet significant decreases in C3 and ICAM-1 mRNA were noted following exposure 
to both NMs. ICAM-1 (intracellular adhesion molecule 1) is a molecule involved in attraction 
and adhesion of inflammatory cells to endothelial and epithelial cells, and its soluble form, 
sICAM-1, is linked to activation of these cells in pathological responses (Yang, et al., 2005). 
It is up-regulated in liver associated diseases such as in hepatitis C (Yang, et al., 2005). As 
already mentioned binding of ICAM-1 to Mac-1 on hepatocytes is crucial to neutrophil 
mediated response in the liver. The overall decrease in ICAM-1 mRNA suggests that 
neutrophils are not involved at the latter stages of the liver immunity despite fresh foreign 
nanomaterial challenges.   
 
Finally, a group of animals were exposed to a single dose of 100 µl of 64 µg/ml of the Ag 
and positively charged TiO2 NMs. The animals were dissected 24 hr, 48 hr and 72 hr after the 
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initial injection. We found that in all instances the changes in mRNA were most evident after 
the 24 hr exposure. These alterations resolved and all the genes investigated returned to 
background levels after 72 hr post exposure.  
 
It is important to state that this study has some limitations. It might be important to look at 
earlier time points to gain a better understanding of the role of neutrophils in the liver 
following a NM challenge. We would suggest investigating early time points could be 
advantageous into gaining a better insight into the antioxidant status of liver tissue following 
intravenous nanomaterial exposure. Future studies might include the utilisation of microarray 
analysis for a more comprehensive gene expression profile in the liver. Any potential changes 
in a large number of genes including the likes of the cytochrome P450 family, heat shock 
proteins and IL1 family of proteins could be invaluable indicators of NM impact on the liver.  
 
8.7 Conclusions 
 
Overall the findings in this study seem to suggest that intravenous exposure of mice to the 
ENPRA panel of engineered nanomaterials results in acute effects in the liver. However the 
low doses used here are not sufficient to cause any long term inflammation or damage to the 
liver tissue. Any changes that were observed after 24 hr post exposure in terms of leukocyte 
infiltration into the tissue, antioxidant status and changes in gene expression related to 
inflammation, oxidative stress and apoptosis had resolved 72 hr post exposure. 
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Chapter Nine 
The role of Kupffer cells in the hepatic response 
to nanomaterials 
 
 
 
 
 
 
 
 
 
 
 
 
Based on publication: Filippi C, Kermanizadeh A, Stone V. (2013). Kupffer cell contribution 
to the hepatic response to nanomaterials – Manuscript in preparation. 
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9.1 Aims and chapter outline 
 
In previous chapter it has been shown that the ENPRA panel of NMs chosen for this study 
affect a hepatocyte cell line (Chapters 4 and 5) and human primary hepatopcytes (Chapter 6). 
In this chapter we are investigating the role of resident liver macrophages (Kupffer cells) co-
cultured with hepatocytes in an attempt to gain a better understanding of the liver response 
following exposure to engineered nanomaterials. The liver cells were thoroughly 
characterised before different end-points including cytotoxicity, intracellular glutathione 
levels and in particular cytokine secretion were measured.  
 
Primary rat liver cells were isolated as described in section 3.23.  The isolated cells were 
characterised by Dr Celine Filippi.  The primary cell preparation was enriched for Kupffer 
cells using the protocol described in (section 3.25).  The primary co-culture and the enriched 
Kupffer cell populations were exposed to NM 110, NM 111, NM 300, NM 400, NM 402 and 
NRCWE 002 with viability, cytokine secretion and antioxidant depletion quantified. 
 
9.2 Characteristics of nanomaterials and exposure media 
 
A list of the measured physical and chemical properties of selected nanomaterials was 
previously described (Chapter 4) (Kermanizadeh, et al., 2012c). In order to investigate if the 
nanomaterials behaved differently in HepatoZYME medium compared to C3A complete 
medium, the hydrodynamic size distributions of the NMs was measured by DLS after the 
nanomaterials were dispersed in this medium between 1 - 128 µg/ml (Table 9.1). 
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ENM code ENM type Manufacturer 
Size 
[nm] 
Known coating  Size in HepatoZYME 
(DLS) Ψ 
NM110 ZnO 100 none 134.9 
NM111 ZnO 130 Trie-othoxy-capry-
lsilane 130 
149.9 
NM300 Ag < 20 Polyoxylaurat-Tween 
20 
34.0 
NM400 MWCNT - none * 
NM402 MWCNT - none * 
NRCWE 002 TiO2 10 Positive charged  128.0 
* Not detectable by DLS due to the very large aspect ratio 
Ψ Intensity based size average in biological media after 15 mins. 
 
Table 9.1. Physical and chemical properties of tested ENMs in HepatoZyme medium. 
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9.3 Liver cell characterisation 
 
All the cells utilised in this study were from the second pass (section 3.23) and had a viability 
of over 90%. The characterisation work was carried out by Dr Celine Filippi and described in 
detail in Filippi, et al., 2013 (including percentage of endothelial cells present in each 
fraction). The fraction of cells used in subsequent toxicity studies will be termed the primary 
liver cell culture. This fraction was further purified by MACS column. 
 
Briefly, we noted that Kupffer cell enrichment resulted in an increased in liver macrophages 
numbers from 3% to 30-40% (Figure 9.1). This preparation is termed the kupffer cell 
enriched liver cell culture.   
 
 
 
 
 
 
 
 
 
 
 
 
 
191 
 
 
Figure 9.1. Flow cytometry images representative of Kupffer cells numbers prior and post enrichment using 
the MACS magnetic column. CD163 was used to specifically target and select Kupffer cells. 
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9.4 Impact of the selected panel of NMs on the primary liver cell co-culture viability 
 
From the WST-1 data it is evident that following exposure of the primary liver cell co-culture 
to the ENPRA NMs there was a dose dependent decrease in cell viability at 24 hr across the 
entire nanomaterial panel (Figure 9.2). The two ZnO (NM 110 and NM 111) and the Ag (NM 
300) NMs were highly toxic with an LC50 reached after a 24 hr exposure (Figure 9.2a, b and 
c). While the TiO2 (NRCWE 002) and MWCNT (NM 400 and 402) NMs were considered to 
be low toxicity materials as the LC50 was not reached after a 24 hr exposure (Figure 9.2d, e 
and f). 
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Figure 9.2. Cytotoxicity following exposure to a panel of engineered nanomaterials to the co-culture of 
primary rat liver cells before Kupffer cell enrichment. The cells were exposed to cell medium (control)/medium 
and NMs for 24 hr with cytotoxicity measured via WST-1 assay. A) NM 110 B) NM 111 C) NM 300 D) NM 
400 E) NM 402 F) NRCWE 002.  
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9.5 Impact of the engineered NMs on cytokine secretion from the liver cells before 
Kupffer cell enrichment    
 
Changes in cytokine production as a consequence of NM exposure to the standard primary 
hepatocye culture (without enrichment) were assessed within the supernatant of exposed liver 
cells and was quantified via FACSArray and ELISA. We found a dose dependent increase in 
the levels of TNF-α and IL10 from the liver cells with statistical significance being reached at 
the higher concentrations of all NMs (Figure 9.3a and b). For the low toxicity TiO2 and 
MWCNT samples (NM 400, NM 402 and NRCWE 002) the CINC-3 production increased in 
a dose dependent manner, reaching statistical significance compared to the control at high 
exposure concentrations (Figure 9.3c). However, in the presence of the highly toxic particles 
Ag and ZnO (NM 110, NM 111 and NM 300) there was a significant increase in the level of 
CINC-3 protein production that peaked around the LC50 values, followed by a decrease in the 
amounts of the cytokine produced as the toxicity increased (Figure 9.3a, b and c). 
Additionally we found no change in the levels of IL6 or IFN-γ (a cytokine that has crucial 
importance in macrophage activation so we regarded it as being important with regards to the 
role of liver Kupffer cells) secreted from these cells following the 24 hr exposure to any of 
the selected NMs (data not shown).  
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Figure 9.3. Cytokine secretion by primary liver co-culture cells following exposure to the panel of engineered 
nanomaterials. The cells were exposed to the NMs for 24 hr with cytokine secretion measured utilising the 
FACS array and ELISA. Values represent mean ± SEM (n=3), significance indicated by * = p<0.05 and ** = 
p<0.005, when material treatments are compared to the control. A) TNF-α B) IL10 C) CINC-3. 
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9.6 Impact of the engineered NMs on cytokine secretion from the liver cells after 
Kupffer cell enrichment    
 
Liver cells harvested from the Sprague Dawley rats were put through a magnetic bead based 
cell purification system as described in section 3.24. This typically increased the Kupffer cell 
content from 3% to 40% of the cell suspension (Section 9.4). The cells were then treated with 
three concentrations (0.32, 5 and 40 µg/cm
2
) of the highly toxic Ag and the low toxicity 
positively charged TiO2. The changes in cytokine production from the Kupffer enriched cells 
in terms of TNF-α, IFN-γ, IL6, IL10 and CINC-3 were measured and compared to those 
obtained from cells without the macrophage enrichment (section 9.5).  
 
A dose dependent increase in the levels of TNF-α and IL10 from the Kupffer cell enriched 
liver cells following exposure of the silver NMs was found. Exposure of the cells to NRCWE 
002 (TiO2) also resulted in significant TNF-α, IL10 and IL6 (Figure 9.4 and 5). There was no 
change in the levels of IFN- γ produced from the cells relative to the Kupffer cell enrichment 
(data not shown). 
 
Comparison of the cytokine profiles from cells before and after Kupffer cell enrichment were 
not as different as expected. There was a significant increase in TNF-α and IL6 levels from 
Kupffer cell enriched liver cells following exposure to the NMs (Figure 9.6 and 7). IL10 and 
CINC-3 secretion on the other hand was decreased with some of these alterations significant 
between the two groups (Figure 9.6 and 7). 
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Figure 9.4. Cytokine secretion by rat liver cells (KC enriched) exposed to NM 300. The cells were exposed to 
the NMs for 24 hr with cytokine secretion measured utilising the FACS array and ELISA. Values represent 
mean ± SEM (n=3), significance indicated by * = p<0.05 and ** = p<0.005, when material treatments are 
compared to the control.  
 
 
Figure 9.5. Cytokine secretion by rat liver cells (KC enriched) exposed to NRCWE 002. The cells were 
exposed to the NMs for 24 hr with cytokine secretion measured utilising the FACS array and ELISA. Values 
represent mean ± SEM (n=3), significance indicated by * = p<0.05 and ** = p<0.005, when material treatments 
are compared to the control.  
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Figure 9.6. Cytokine secretion by rat liver cells before and after Kupffer cell enrichment exposed to NM 300. 
The cells were exposed to the NMs for 24 hr with cytokine secretion measured utilising the FACS array and 
ELISA. Values represent mean ± SEM (n=3), ∞ = p<0.05 and ∞∞ p<0.005 is representative of significant 
difference between values before and after Kupffer cell (KC) enrichment. 
 
 
Figure 9.7. Cytokine secretion by rat liver cells before and after Kupffer cell enrichment exposed to NRCWE 
002. The cells were exposed to the NMs for 24 hr with cytokine secretion measured utilising the FACS array 
and ELISA. Values represent mean ± SEM (n=3), ∞ = p<0.05 and ∞∞ p<0.005 is representative of significant 
difference between values before and after Kupffer cell (KC) enrichment. 
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9.7 Impact of the nanomaterials on depletion of total GSH in primary rat liver cells 
 
Analysis of the total glutathione contents of the liver cells (without Kupffer cell enrichment) 
revealed a dose dependant GSH depletion compared to the control cells at 24 hr following 
exposure to the highly toxic NMs with these effects most evident as the higher doses (Ag and 
the two ZnO NMs) (Figure 9.8a, b and c). Also a small but significant decrease following 
exposure to one of the MWCNT (NM 400) was found (Figure 9.8d). While there was no 
significant change in intracellular total GSH content following exposure to the other two 
NMs (NM 402 and NRCWE 002) (Figure 9.8e and f).  
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Figure 9.8. Effects of NM exposure on total glutathione levels in primary rat liver co-culture (before Kupffer 
cell enrichment). The cells were exposed to cell medium (control), and increasing concentrations of selected 
NMs for 24 hr. Values represent mean ± SEM (n=3), significance indicated by * = p<0.05 and ** = p<0.005 
compared to the control. A) NM 110 B) NM 111 C) NM 300 D) NM 400 E) NM 402 F) NRCWE 002. 
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9.8 Discussion  
 
As already mentioned NMs entering the blood stream will accumulate within the liver (Chen, 
et al., 1999; Diesen, et al., 2009; Sadauskas, et al., 2009b). In previous chapters we have 
looked at how the ENPRA NMs affect liver hepatocytes (Chapter 4, 5 and 6). However, to 
gain a more accurate representation of how NMs impact on the liver as a whole, 
incorporation of other cell types in the test system is a necessity. In this chapter the focus was 
on the liver resident macrophages. Kupffer cells represent the largest portion of resident 
tissue macrophages in any organ and constitute up to 25% of the total cell populations of a 
healthy liver (Seki, et al., 2011).  
 
Kupffer cells are indispensible in the liver immunity against gut derived antigens and are 
known to produce a large array of cytokines including IL1, IL6, IL12 and TNF-α but to name 
a few which can further activate hepatic T cells, in turn activating phagocytosis and cytokine 
production by Kupffer cells in a positive feedback loop (Bottcher, et al., 2011; Seki, et al., 
2011). However it is believed that Kupffer cells in a non diseased liver are in a constant semi 
activated state and are crucial in maintaining organ tolerance to food antigens in everyday life 
(Bottcher, et al., 2011). Hence the liver offers a unique scenario in which the resident 
macrophages can both initiate an immune response or play an active role in retaining an 
immnuno tolerant state (Bottcher, et al., 2011; Nemeth, et al., 2009).  
 
Here, the acute exposure of co-culture of primary liver cells to the priority ENPRA NMs 
resulted in similar cytotoxicity outcome as previously witnessed in the C3A cell line (Chapter 
4), primary human hepatocytes (Chapter 6) and HK-2 cell line (Chapter 10). The NMs were 
segregated into a high toxicity group (the Ag - NM 300) and the two ZnO - NM 110, NM 111 
and a low toxicity groups (TiO2 - NRCWE 002 and MWCNT - NM 400 and NM 402). These 
findings are not very surprising because the Kupffer cells only formed 3% of the overall 
population with the hepatocytes still constructing the majority of the cells. 
 
We investigated the cytokine secretion from the primary liver co-culture before and after 
Kupffer cell enrichment following a 24 hr exposure to the panel of NMs in terms of TNF-α, 
CINC-3, IL10, IL6 and IFN-γ release from the cells. Interestingly exposure of the co-culture 
with the 3% Kupffer cell population to the ENPRA NMs resulted in a completely different 
cytokine profile as previously perceived following hepatocyte only exposures (Chapters 4, 5 
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and 6). Incorporation of macrophages into the in vitro system resulted in a dose dependant 
release of significant amounts of TNF-α and IL10. There was also substantial secretion of the 
chemokine CINC-3 (rat equivalent of human IL8) with the same pattern of release as detected 
for the human hepatocytes models (increase up to the LC50 with a gradual drop at the higher 
most cytotoxic concentration for the highly toxic NMs, while a dose dependant increase was 
observed for the low toxicity NMs). A very important observation from all co-culture data 
was the high levels of IL10 being released from the cells. It is possible that IL10 acts as 
antagonistic against the pro-inflammatory cytokines.  
 
Furthermore no change in the levels of IL6 or IFN-γ compared to the control following 
exposure of the liver co-culture to any of the investigated nanomaterials was found. The 
hypothesis is that the Kupffer cell (or potentially any other cytokine producing cells) numbers 
were not high enough for the secretion of these cytokines.  
 
Next it was shown that the use of a MACS magnetic column is an effective method of 
enriching liver Kupffer cells. A typical increase in macrophage numbers from 3% to around 
40% was observed. To our knowledge this the first time the column is utilised for liver cell 
enrichment, however the column is frequently used for positive selection of numerous 
immune cells (Grutzkau, et al., 2010). Interestingly the positively selected cells were healthy 
and viable once they had passed through the column, hence we suggest that the MACS 
column can be beneficial in Kupffer selection and isolation. However a disadvantage of this 
system is that the number of the positively selected cells is not very high.  
 
The cytokine analysis of the enriched co-culture population of cells showed significantly 
higher secretion of TNF-α from the cells, while IL10 and CINC-3 levels had appreciably 
dropped. We also observed small amounts of IL6 produced from the cells while no IFN-γ was 
detectable following exposure to any of the NMs in this study. Before any conclusion can be 
drawn from this data it is important that the limitation of the study is acknowledged. As the 
liver is composed of more than two cell types it is impossible to pin point which cells are 
synthesising the cytokines. Although great effort was taken into characterising each cell 
population it is impossible to completely eliminate all the undesired cell types from the 
population hence the conclusions made here are based on the theory that the co-culture is 
principally composed of two cell types (namely hepatocytes and Kupffer cells).   
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This data suggests that Kupffer cells secrete IL6 and TNF-α following exposure of these 
NMs. Although other cells in the liver (i.e. endothelial cells (Crisp., 2009)) are capable of 
cytokine production. Additionally it appears that the principle source of IL10 and CINC-3 is 
paranchymal cells although it has been shown that Kupffer cells are also capable of 
producing small levels of IL10 under certain conditions (Tiegs, et al., 2009). Once again 
there was no IFN-γ secreted from the Kupffer cell enriched population. It has been shown 
that NKT cells and lymphocytes are the main source of IFN-γ production within the liver 
(Shono, et al., 2011) indicating that either these cells were not present in large enough 
numbers for the cytokine to be detected or exposure to these NMs does not result in IFN-γ 
secretion from the cells.  
 
In future experiments will include the complete depletion of liver Kupffer cells will be 
attempted and whole tissue ELISAs inducted to resolve the unanswered queries in this study. 
 
Finally, the ability of the chosen NMs to induce glutathione depletion in the co-culture of the 
primary liver cells was tested. Exposure to the Ag, two ZnO NMs and one of the MWCNTs 
(NM 400) resulted in significant GSH depletion following a 24 hr exposure. Similar to the 
depletion observed in the hepatocyte cell line the GSH reduction following exposure to the 
highly toxic NMs could be attributed to cell death rather than a specific oxidative stress 
response. In contrast, MWCNTs were also able to significantly deplete glutathione at doses 
which were not considered as highly cytotoxic, suggesting that MWCNTs induced oxidative 
stress in these cells. The TiO2 NMs had no significant effect on the glutathione content of the 
liver co-culture. Similarly to the toxicity data the GSH depletion observations in the co-
culture model was comparable to the antioxidant levels with the hepatocytes models 
described previously (Chapter 5) suggesting incorporation of 3% resident macrophages does 
not play a major role in this in vitro oxidative stress model following exposure of the ENPRA 
NMs.    
 
9.9 Conclusions 
 
It appears that Kupffer cells are crucial in the overall liver response to NMs that reach the 
organ. Data from the last two chapters allows to hypothesis that neutrophils are the organs 
first line of defence against NMs, however the resident macrophages take over the immune 
response after this initial short lived influx. These macrophages secrete a variety of cytokines 
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which orchestrate the nature of the response. The high levels of IL10 in the in vitro system 
(primary liver co-culture) and IL10 mRNA in the in vivo systems (liver tissue following IT 
and IV exposure of NMs) would suggest that tolerance is favoured over immunity however 
this can be easily distorted in disease models (animals or humans) or long tem repeated 
exposure to NMs (even at very small doses).  
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Chapter Ten 
In vitro assessment of panel of engineered NMs 
following exposure of a human renal cell line in 
terms of cytotoxicity, pro-inflammatory response, 
oxidative stress and genotoxicity 
 
 
 
 
 
 
Based on publication: Kermanizadeh A, Vranic S, Boland S, Moreau K, Squiban AB, Gaiser 
BK, Andrzejczuk
 
LA, Stone V. (2013b). An in vitro assessment of panel of engineered 
nanomaterials using a human renal cell line: Cytotoxicity, pro-inflammatory response, 
oxidative stress and genotoxicity - Submitted to BMC Nephrology. 
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10.1 Aims and chapter outline 
 
To investigate the effcts on the human renal proximal tubule epithelial cells (HK-2) treated 
with the panel of engineered nanomaterials in terms of cytotoxicity (WST-1), pro-
inflammatory cytokine secretion (IL6, IL8, TNF-α and MCP-1), intracellular reactive oxygen 
species (HE oxidation assay) and genotoxicity (FPG modified comet assay). 
 
10.2 Characteristics of nanomaterials and exposure media 
 
Investigated nanomaterials were characterised by a combination of analytical techniques in 
order to infer primary physical and chemical properties useful to understand their 
toxicological behaviour. A list of the measured physical and chemical properties is described 
(Table 10.1). In order to investigate if the nanomaterials behaved differently in K-SFM or 
complete RPMI, the hydrodynamic size distributions of the NMs dispersed in the two media 
was measured between a 1 - 128 µg/ml concentration range by dynamic light scattering 
(DLS) (Table 10.1). It is widely accepted that DLS is not a suitable method of ascertaining 
the size of carbon nanotubes (due to the fact that the machine measures size based on the 
principle that particles are spherical and well dispersed), hence we examined how the two 
MWCNTs behave in our two chosen media utilising light microscopy. We found that the 
MWCNTs agglomerated into larger clusters in the complete RPMI which contained higher 
levels of FCS in comparison to the K-SFM (data not shown). 
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ENM code ENM 
type 
Phase Known 
coating 
 Size in K-
SFM (DLS) 
Ψ 
Size in 
complete RPMI 
(DLS) Ψ 
NM 101 TiO2 Anatase none 221 358 
NM 110 ZnO Zincite none 393 453.6 
NM 111 ZnO Zincite Trieothoxy-
capryl-silane 
130 
332 362.4 
NM 300 Ag - Polyoxylaurat-
Tween 20 
87 51.59 
 
NM 400 MWCNT - none * * 
NM 402 MWCNT - none * * 
NRCWE 001 TiO2 Rutile none 349 337.5 
NRCWE 002 TiO2 Rutile Positive 
charge 
314 378.8 
NRCWE 003 TiO2 Rutile Negative 
charge 
384 423.6 
NRCWE 004 TiO2 Rutile none 396 482.6 
* Not detectable by DLS due to the very large aspect ratio 
Ψ Intensity based size average in biological media after 15 mins. 
 
Table 10.1. Physical and chemical properties of tested ENMs in K-SFM and complete RPMI. 
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10.3 Impact of the selected panel of NMs on HK-2 cell viability 
 
Our toxicity data show a dose dependent decrease in cell viability at 24 hr across the entire 
nanomaterial panel (Table 10.2). The Ag and the two ZnO NMs were shown to be highly 
toxic (NM 110 LC50 2.5 µg/cm
2
 – K-SFM, LC50 0.64 µg/cm
2
 – complete RPMI; NM 111 
LC50 2.5 µg/cm
2
 – K-SFM, LC50 1.25 µg/cm
2
 – complete RPMI; NM 300 10 µg/cm2 – K-
SFM, LC50 5 µg/cm
2
 – complete RPMI) after a 24 hr exposure. All of the TiO2 and MWCNT 
NMs were considered to be low toxicity materials as the LC50 was not reached after a 24 hr 
exposure to the HK-2 cells at the range investigated. We observed slightly higher toxicity 
(not significant) to the cells in complete RPMI exposed to the Ag and ZnO NMs. The toxicity 
of the ENPRA dispersants namely NM 300 dispersant termed (NM 300 DIS) and 0.5% 
ethanol in complete medium was also investigated. No cytotoxicity of either dispersant to the 
HK-2 cells (data not shown) so we conclude that all observed toxicity is due to exposure to 
the NMs investigated was found. LC20 are shown as these values were utilised for the FPG 
modified comet assay (Table 10.2).  
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NM K-SFM Complete RPMI 
LC20 LC50 LC20 LC50 
NM 101 Not reached up to 
80 µg/cm
2
 
Not reached up to 
80 µg/cm
2 
80 µg/cm
2 Not reached up to 
80 µg/cm
2 
NM 110 0.64 µg/cm2 2.5 µg/cm2 0.64 µg/cm2 Between 0.32 – 
0.64 µg/cm
2 
NM 111 Between 0.64 – 
1.25 µg/cm
2
 
2.5 µg/cm2 Between 0.32 – 
0.64 µg/cm
2 
Between 0.64 – 
1.25 µg/cm
2 
NM 300 1.25 µg/cm
2 10 µg/cm2 1.25 µg/cm2 Between 2.5 – 5 
µg/cm
2 
NM 400 2.5 µg/cm2 Not reached up to 
80 µg/cm
2 
20 µg/cm
2 Not reached up to 
80 µg/cm
2 
NM 402 Between 2.5 – 5 
µg/cm
2 
Not reached up to 
80 µg/cm
2 
20 µg/cm
2 Not reached up to 
80 µg/cm
2 
NRCWE 001 40 µg/cm
2 Not reached up to 
80 µg/cm
2 
Between 40 – 80 
µg/cm
2 
Not reached up to 
80 µg/cm
2 
NRCWE 002 20 µg/cm
2 Not reached up to 
80 µg/cm
2 
Not reached up to 
80 µg/cm
2 
Not reached up to 
80 µg/cm
2 
NRCWE 003 Between 40 – 80 
µg/cm
2 
Not reached up to 
80 µg/cm
2 
Not reached up to 
80 µg/cm
2 
Not reached up to 
80 µg/cm
2 
NRCWE 004 40 µg/cm
2 Not reached up to 
80 µg/cm
2 
Not reached up to 
80 µg/cm
2 
Not reached up to 
80 µg/cm
2 
Table 10.2. Cytotoxicity following exposure of the HK-2 cells in two different media to a panel of engineered 
nanomaterials. The cells were exposed to the NM for 24 hr with cytotoxicity measured via WST-1 assay.  
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10.4 Cytokine secretion by HK-2 cells following exposure to the panel of NMs 
 
Changes in cytokine production as a consequence of NM exposure were assessed within the 
supernatant of exposed renal cells and quantified via FACS Array. We found a dose 
dependent (exposure to sub-lethal concentrations of the NMs) increase in the levels of IL8 
and IL6 from the kidney cells with statistical significance being reached at the higher 
concentrations following exposure to nine of the ten nanomaterials (TiO2 - NM 101 being the 
exception) (Figure 10.1a). Additionally we found no change in the levels of MCP-1 or TNF-α 
secreted from the HK-2 cells following the 24 hr exposure to any of the selected NMs (data 
not shown).  
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Figure 10.1. IL6 (black bars) and IL8 (grey bars) production by HK-2 cells following exposure to the panel 
of engineered nanomaterials. The cells were exposed to the sub-lethal concentrations of the NMs for 24 hr with 
cytokine secretion measured utilising the FACS array. Values represent mean ± SEM (n=3), significance 
indicated by * = p<0.05 and **= p<0.005, when material treatments are compared to the control. A) NM 101 B) 
NM 110 C) NM 111 D) NM 300 E) NM 400 F) NM 402 G) NRCWE 001 H) NRCWE 002 I) NRCWE 003 J) 
NRCWE 004.  
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10.5 HE Oxidation 
 
This work was carried out by partners in Paris. Briefly, a significant increase in HE positive 
cells following exposure to ZnO and Ag NMs. A very small yet significant increase was also 
observed to all the TiO2 NM with the exception of NRCWE 003. However no change in 
intracellular reactive oxygen species was noted following exposure to either of the MWCNTs 
(data not shown).  
 
10.6 DNA damage in the HK-2 cells  
 
In order to investigate the possible DNA damage caused by the panel of nanomaterials, HK-2 
cells were exposed to the NMs for 4 hr. In this study we chose the LC20 value for each 
individual NM plus one concentration above (2x LC20) and one below (0.5x LC20). We 
observed that DNA damage was most evident following exposure to NM 300 (Ag) and 
NRCWE 002 (TiO2 - 10 nm positively charged) (Figure 10.2c, h). We also noted a small but 
significant increase in the percentage of tail DNA following exposure to five of the other 
eight NMs investigated (ZnO - NM 111, NRCWE 001 and 003 TiO2 NMs being the 
exception) (Figure 10.2). 
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Figure 10.2. DNA damage expressed as percent of tail DNA following exposure of the HK-2 cells to LC20 ± 
one serial dilution to the ENPRA panel of engineered nanomaterials. The cells were exposed to cell medium 
(control), 60 µM H2O2 and NMs for 4 hr. Values represent mean ± SEM (n=3), significance indicated by * = 
p<0.05 and ** = p<0.005, when material treatments are compared to the control. A) NM 101 B) NM 110 C) 
NM 111 D) NM 300 E) NM 400 F) NM 402 G) NRCWE 001 H) NRCWE 002 I) NRCWE 003 J) NRCWE 
004. 
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10.7 Discussion 
 
To date human kidneys have received relatively little attention in terms of nanotoxicological 
studies. Due to high blood supply level and ability to concentrate toxins, this organ could be 
potentially affected by any nanomaterial that reaches the circulatory system. During active or 
passive transport of molecules and during re-absorption across the nephral proximal tubule, 
this part of the nephron may be at high risk of potential damage from NMs. It has been shown 
previously that the proximal renal tubule is more susceptible to gold NM toxicity than the 
distal tubule (Abdelhalim, et al., 2011). In a recent study it was shown that a high 
concentration of orally administrated Ag NMs accumulated in kidney tissues at a higher wet 
mass than any other organ (Kim, et al., 2010). This observation suggests that kidneys are 
important organs in clearing the NMs from the mammalian system and at potential risk of 
being damaged by NM exposure. Hence we have chosen an immortalized proximal tubule 
epithelial cell line from adult human kidney (HK-2) as a well differentiated cell line 
representing an alternative to primary kidney cells (Ryan, et al., 1994). This study has 
focused on the impacts of the investigated panel of nanomaterials on cell cytotoxicity, pro-
inflammatory cytokine production, intracellular ROS and DNA damage.  
 
Here we have shown that following acute in vitro exposure of the cells to the panel of the 
NMs, they can be segregated into a low (TiO2 and MWCNT) and a high toxicity group (Ag 
and coated and uncoated ZnO) (Table 10.1). This complements our previous data for a 
hepatocyte cell line (Chapters 4 and 5) and primary human hepatocytes (Chapter 6) and rat 
liver co-culture (Chapter 9). We observed slightly higher toxicity (not significant) to the cells 
in RPMI-FCS exposed to the Ag and ZnO NMs (higher amounts of protein within the media 
compared to the K-SFM) utilised in this study. One theory offering an explanation for this 
could be that the serum interaction with the NMs might make the materials more bio-
available to the cells. It is also possible that the cells might be healthier in the K-SFM 
compared to RPMI with FCS under the conditions in this study. 
 
We noted that the Ag NM (NM 300) was highly toxic to the HK-2 cells (LC50 between 2.5 - 
10 µg/cm
2
). To our knowledge no study has investigated the toxicity of Ag nanomaterials and 
human kidney cells in vitro however a number of studies have demonstrated that Ag NMs 
can be highly toxic in other organs and systems both in vivo and in vitro (Gaiser, et al., 2012; 
Kermanizadeh, et al, 2012c; Kim, et al., 2011c). Oxidative stress is often proposed as a 
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mechanism of toxicity (Piao, 2011; Kim, et al., 2011). Our HE oxidation data show an 
increase in intracellular ROS levels following exposure to the NM 300. Furthermore we 
noted that there was an increase in IL6 and IL8 levels following exposure of the cells to the 
Ag NMs (highest release at intermediated doses – suggesting cytotoxicity inhibits cytokine 
production at the highest doses), as well as a significant increase in genotoxicity following 
exposure to sub-lethal concentrations of the nanomaterial. This indicates that Ag NMs are 
highly genotoxic to human kidney cells. So far a number of other studies have confirmed 
dose dependent DNA damage after Ag NM treatment to a liver cell line (Kermanizadeh, et 
al., 2012a) or genotoxicity in testicular cells (Asare, et al., 2012).  
 
Next we have shown that the two ZnO NMs were highly toxic (with the LC50 around 0.64 - 
2.5 µg/cm
2
) to the renal cells. Our findings are similar to a previous study in which HK-2 
cells were shown to be highly susceptible to exposure to ZnO NMs (LC50 - 2.4 µg/cm
2
) 
(Pujalté, et al., 2011). The toxicity was associated with increased intracellular ROS 
production which is very similar to our findings here (Pujalté, et al., 2011). We chose sub-
lethal concentrations based on data obtained from our cytotoxicity assays. Notably, exposure 
to the NM 110 zinc oxide NMs showed a small but significant increase in percentage of tail 
damage however no significant genotoxicity was witnessed following exposure to NM 111. It 
is possible that the 4 hr exposure time for genotoxicity was not sufficient to cause larger 
effects from the two ZnO NMs in this study. Next, we noted a dose dependant increase in IL6 
and IL8 secretion from the cells following NM exposure. It has been shown previously that 
there is an increase of these pro-inflammatory mediators from the kidney following exposure 
to various antigens (Shing, et al., 2011; Dudas, et al., 2011). In a similar theme exposure of 
human embryonic kidney cell line HEK 293 to 100 nm ZnO NMs resulted in up-regulation of 
IL6 and IL8 genes from the cells in vitro (Dua, et al., 2011). 
 
We had previously shown that the two ZnO NMs used in this study are highly soluble (40-
50%) while less than 1% of Ag (NM 300) was soluble after 24 hr of incubation in complete 
medium (Chapter 4). Therefore there is a real possibility that the high toxicity (all be much 
smaller amount of DNA damage) of the two ZnO materials are in part due to the release of 
ions, with this scenario being very unlikely following exposure to the Ag NMs. 
 
It has been shown previously that in sufficient doses TiO2 can cause damage to cells and 
tissue (Chen, et al., 2008; Hu, et al., 2011; Jin, et al., 2008). Furthermore other studies have 
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shown that after translocation from the primary site of exposure, the TiO2 NMs can induce 
oxidative stress - mediated toxicity in many cell types by producing large amounts of free 
radicals (Jin, et al., 2008; Kang, et al., 2008; Wang, et al., 2007). In this study we found all 
five TiO2 were of relatively low toxicity to the HK-2 cells (LC50 was not reached in the 
presence of any of the NMs up to 80 µg/cm
2
) with only small increases of oxidative stress 
presenting cells following exposure to four of the five TiO2 NMs. Our findings are similar to 
a previous study in which exposure of HK-2 cells to a 12 nm TiO2 resulted in low toxicity 
(Pujalte, et al., 2011). Similarly, in a study using Caco2 cells it was found that there was low 
cytotoxicity following 24 hr exposure to TiO2 NMs (Jin, et al., 2008). In addition the data 
presented here indicate that relatively high TiO2 exposure concentrations can induce 
production of the pro-inflammatory cytokine IL6 and IL8. In a recent study exposure of mice 
to 6 nm TiO2 NM via an intragastric route promoted the expression of IL2, IL4, IL6, IL8, 
IL10, IL18, IL1-β, TGF-β and IFN-γ from the kidney (Gui, et al., 2011). Furthermore 
exposure of C3A cell line in vitro also resulted in IL8 secretion at high TiO2 concentrations 
(Kermanizadeh, et al., 2012c; Monteiller, et al., 2007). Finally we show a significant increase 
in genotoxicity following a 4 hr exposure to two of the five TiO2 NMs investigated in this 
study (NM 101 and NRCWE 004). Our findings are similar to a recent study in which 
exposure of Cos-1 monkey kidney fibroblasts to TiO2 NMs resulted in significant DNA 
damage as measured via the comet assay (Magdolenova, et al., 2012).  
 
We found that the MWCNTs tested were relatively non-toxic to the HK-2 cells at the times 
and concentrations tested. The toxicity of MWCNTs is widely documented, with adverse 
effects observed in pulmonary (Ji, et al., 2009), hepatic (Kermanizadeh, et al. 2012c), renal 
(Barillet, et al., 2010), dermal cells (Kishore, et al., 2009) as well as monocyte (De Nicola, et 
al., 2009) and macrophage cells (Hirano, et al., 2008). It has been shown that exposure of 
NRK-52E cells (an in vitro renal model) to MWCNT resulted in low toxicity (LC25 following 
24 hr exposure) (Simon, et al., 2008) which is similar to our findings in this study. Exposure 
of the HK-2 cells to the two MWCNTs in this study resulted in a dose dependant increase in 
both IL6 and IL8 following a 24 hr exposure. Our findings are similar to a recent study in 
which exposure of HEK 293 cells to two types of MWCNTs (80 and 150 nm) resulted in 
increased production of IL8 (Reddy, et al., 2010). The HE oxidation assay showed no 
intracellular ROS following exposure to either of two MWCNTs. This is contradictory to 
findings from Reddy and colleagues in which cytotoxicity was associated with oxidative 
stress (Reddy, et al., 2010). Finally we show that short term (4 hr) exposure of the HK-2 cells 
225 
 
to the two carbon nanotubes at sub-lethal concentrations resulted in significant DNA damage. 
Barillet et al also witnessed small but significant genotoxicity following exposure of NRK-
52E cells to 100 nm MWCNT which is similar to our findings in this study (Barillet, et al., 
2010). 
 
Finally no TNF-α or MCP-1 production was observed following exposure to ENPRA panel 
of NMs. It has been shown that under certain disease models that kidney cells produce TNF-α 
(Zuo, et al., 2011) and MCP-1 (Wittlinger, et al., 2010; Zehnder, et al., 2008). Here we show 
that exposure to these particular nanomaterials even at very high (in some cases cytotoxic) 
doses are not sufficient for MCP-1 or TNF-α secretion from the cells. 
 
10.8 Conclusions 
 
This in vitro renal model demonstrated that ZnO and Ag NMs were consistently more potent 
with respect to cytotoxicity, cytokine production (IL6 and IL8) and intracellular reactive 
oxygen species production. In comparison the MWCNT and TiO2 nanomaterials investigated 
revealed relatively lower toxicity. We noted that short term sub-lethal exposure to eight of the 
ten nanomaterials (coated ZnO and 10 nm TiO2 NMs being the exception) resulted in DNA 
damage to the cells (most evident following exposure to the Ag, 10 nm positively charged 
TiO2 and 94 nm TiO2).  
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Chapter Eleven 
General Discussion 
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11.1 Summary of findings in this study 
 
This thesis was able to demonstrate the ability of the human C3A cell line to distinguish 
between different NM in terms of cytotoxicity and sub-lethal effects. The relevance of this 
data was supported by the comparable data obtained from primary human and rodent 
hepatocytes with regards to a number of relevant investigated end points. While most or all of 
the NMs were able to induce glutathione depletion and IL8 protein production in this in vitro 
system, this reflected the hepatic response following instillation for only a sub-population of 
the nanomaterials. This suggests that the in vitro system is useful but not sufficient as 
currently used to predict in vivo hepatic responses following inhalation. The in vitro system 
provided a false positive for MWCNT which might be explained by a lack of translocation of 
MWCNT from the lung due to agglomeration of particle shape. The in vitro system provided 
a false negative for positively charged TiO2 NMs which might be explained by the ability of 
positively charged materials to more efficiently penetrate cell barriers compared to neutral or 
negatively charged materials (Roblegg, et al., 2012). In addition, the positively charged TiO2 
may have acquired a coating from the lung that rendered them more active than if suspended 
in serum. Alternatively the positively charged materials, because of their ability to penetrate 
lung cells might have induced a humoral or neural stimulus to active a hepatic response. 
 
The dose response data generated by this study correlated well with the different partners 
across Europe for the ENPRA project and clearly demonstrated that despite the use of 
different cell lines, media and different systems (pulmonary, cardio-vascular, hepatic, renal 
and developmental) that the NMs can be divided into a highly toxic (Ag and ZnO) and low 
toxicity (TiO2 and MWCNT) group with respect to cytotoxicity in vitro. This data allowed 
for the identification of a sub-lethal dose range for each target system to investigate the 
molecular/cellular mechanism driving the toxicity of the NMs chosen in this study.  
 
The next important observation made in this project was the fact that in addition to the 
cytotoxicity observations, that sub-lethal exposure of the nanomaterials were not without 
effect in terms of oxidative, pro-inflammatory, genotoxic effects and gene expression. There 
appears to be differences between the cell types with respect to their sensitivities to the sub-
lethal effects of the materials and differences between each NM. These differences in toxicity 
and the sub-lethal effects between each nanomaterial could be attributed to their 
physicochemical characteristics. As discussed previously the solubility of NMs is extremely 
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important in the associated toxicity (Kwok, et al., 2012).  Therefore an unqualified 
understanding of the dissolution kinetics of partially soluble compounds in both the test 
material preparation and in the cell media is crucial for further understanding of the 
toxicology of these nanomaterials.  
 
Another explanation for material toxicity and reactive oxygen species generation might be 
contaminants in the materials i.e. iron residues within the nanotubes in study may contribute 
to their toxicity (e.g. via Fe
2+
 fenton reaction). 
 
Next is the importance of presence or the absence of proteins in the test system contributing 
to the toxicity of NMs. Some nanomaterials can adsorb proteins and form a protein corona 
(Montes-Burgos, et al., 2010) which could influence uptake and fate of the NM. It is believed 
that the amount and the nature of protein could and does influence the toxicity of the NM in 
question (Brown, et al., 2013a; McCormack, et al., 2012).  
 
A deeper analysis of the data in other work packages of the ENPRA project is required to 
pick out a more detailed picture of how the NM properties relate to their impacts on different 
cell types. 
 
We also show that neutrophils and Kupffer cells are very important in the overall immune 
response of the organ following low acute dose exposure to these particular engineered NMs. 
We also believed that these NMs at the low doses administered cause a toleregenic response 
which is in all probability IL10 orchestrated. 
 
11.2 In vitro vs. in vivo systems and limitations 
 
The potential of NMs to translocate to the liver is a realistic prospect (Nalabotu, et al., 2011; 
Nemmar, et al., 2001). Therefore there is a necessity that the threat of nanomaterial exposure 
to normal liver function is thoroughly investigated. In this study the toxicity of the NMs to 
the liver was assessed using both in vitro and in vivo models. The use of primary cells and 
tissues were critical to determine if the response witnessed in the in vitro systems was indeed 
mirrored and representative of cells in vivo. 
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Through this study and numerous other experiments elsewhere major advances have been 
made in identifying the potential nanotoxicological effects on the liver, however there are still 
large gaps in what is needed to fully understand the adverse effects of realistic NM exposure.  
 
Very few studies have attempted to make a direct comparison between in vitro and in vivo 
liver models. However this European funded project (ENPRA) has investigated the toxicity 
of a panel NMs to the liver, assessed using a hepatocyte cell line, primary human hepatocytes 
and liver tissues to determine if the response witnessed in the in vitro systems was indeed 
mirrored and representative of cells in vivo. The results show that there are some comparisons 
between certain end points of a hepatocyte cell line (C3A), primary human hepatocytes and 
primary mice and rat liver cells to the ENPRA NMs (Table 1) (not the case for all end points 
and NMs – e.g. instilled Ag, ZnO and positively charged TiO2 result in distal effects on the 
liver in the form of oxidative stress. In the C3A cell line similar results were generated, with 
two exceptions, positively charged TiO2 and the two MWCNTs. The animal model was more 
sensitive to the positive TiO2, while the cell line was more sensitive to the MWCNTs).  
 
End point C3A cells Primary human 
hepatocytes 
Rat liver tissue Mice liver tissue 
Cytotoxicity YES YES NA NA 
Antioxidant 
depletion 
YES NA YES NO (IV exposure) 
/ YES (IT 
exposure) 
Changes in gene 
expression 
YES NA YES YES 
DNA damage YES NA NA NO  
Cytokine 
production 
YES YES NA NA 
 
NM Uptake YES YES YES YES 
Functional 
markers 
YES YES NO NA 
Table 11.1. General similarities for certain investigated end points between test systems in the ENPRA 
projects (responses were not uniform for all NMs – table offers a simplified summary). 
 
It is often very difficult to make a direct comparison between in vitro and in vivo tissue 
responses. At best, in vitro findings can act as an indicator of possible in vivo responses. One 
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principle reason for this is that the comparisons between the systems are rarely like with like, 
i.e. cytotoxicity in an in vitro system is not inflammation in vivo, and using doses that would 
cause liver cells to die in vivo would be unethical and, in addition, disguise any sub-lethal 
effects. The limitations continue as an organ is never comprised of only a single cell type, and 
cross-talk between both different cell types and different organs is essential to responding to a 
toxic challenge in vivo. Sophisticated new in vitro models such as three-dimensional culture, 
tissue slices and fluidic models as used in the InLiveTox have been developed in order to 
improve in vitro risk assessment of any number of substances, with a view to reducing, 
refining and replacing animal studies.  
 
In an in vitro system, soluble NMs remain trapped in the well, whereas soluble material 
constituents can disperse in an in vivo model. Likewise, many NMs can be removed from the 
site of deposition by macrophages and other phagocytes and excreted via a number of 
different routes. As already mentioned it is very unlikely that any NM will reach the liver 
without a protein coating which will no doubt influence its overall toxicity to the organ. It is 
often very difficult to reproduce the exact protein corona in any in vitro studies, however the 
route of exposure and translocation can be used to inform the preparation and dispersion of 
nanomaterials.  
 
Overall, although some attempts have been made to improve in vitro testing systems (i.e. 
InLiveTox project) the use of animal models are still in all probability the most reliable 
representation of a whole organ/body response to foreign materials i.e. NMs. This being said, 
the high cost and ethical implications of any in vivo study must be considered.  
 
The findings obtained in this study will provide hazard data for the ENPRA panel of 
nanomaterials that will be used for risk assessment purposes conducted by partners within the 
project to hopefully determine any health implications associated with these NMs. Finally the 
knowledge of the extent of NM exposure is imperative as this will impact on their toxicity, as 
risk is dictated by the hazard associated with the extent of NM exposure. 
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11.3 Risk assessment and future studies 
 
As with many toxicological studies it would be very interesting to investigate some of the 
endpoints in more detail to provide further verification of the findings within this study. Of 
particular importance would be an investigation into ROS levels within the hepatocytes 
utilising a more suitable method than the one used in this study i.e. HE oxidation assay (the 
DCFH-DA assay requires viable intact cells, therefore is not entirely suitable for highly 
cytotoxic NMs). To fully validate the findings in this study it would be interesting to 
investigate the primary human hepatocyte response to these materials in order to establish the 
mechanism of toxicity and whether this is comparable to the hepatocyte cell line. It was not 
possible to investigate this question using the primary human hepatocytes due to their 
extremely high cost. The ENPRA nanomaterials were found within the hepatocytes hence 
identifying the mechanisms of uptake and fate of these NMs would be extremely interesting 
and warrant further investigation. The use of fluorescent non toxic NMs would allow for a 
better understanding of the potential role of endocytosis by hepatocytes (Johnston, et al., 
2010). Investigations into the role of bile in elimination of these nanomaterials, as well as 
accumulation and localisation of ENPRA NMs within organelles of the cells would also be 
fascinating (Johnston, et al., 2010).  
 
Evaluating the impact of the nanomaterial exposure on hepatocytes could be expanded upon. 
Hepatocytes are polarized epithelial cells that fulfil a lot of different tasks to contribute to the 
liver physiology such as storage of glycogen, lipid and serum protein synthesis, 
biotransformation, bile secretion, as well as detoxification of xenobiotics by phase I and 
phase II metabolic pathways.  It would be interesting to investigate markers of differentiated 
hepatocytes (especially in the primary model) to gain a better understanding of NM 
modification of liver function. 
 
In this study it was revealed that several materials were able to compromise cell vitality and it 
is of great interest to determine the mechanism by which this cell death occurs specifically 
via necrosis (premature cell death) or apoptosis (programmed cell death). One assay that 
would have been utilised if time was not an issue is the Annexin V Propidium iodide assay.  
 
Taking into account the financial and time restraints of this project all the avenues in the in 
vivo experiments were exhausted however there are a few questions that could still be 
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addressed. Firstly it would be interesting to investigate earlier time points following 
intravenous exposure of nanomaterials. Although we looked at mRNA levels following IT 
and IV exposure of animals to NMs, to gain a more accurate and comprehensive of gene 
expression profile in the liver the utilisation of microarray analysis would be greatly 
advantageous. 
 
All of the experiments in this study were carried out after acute exposures, with the longest 
exposure time being 72 hr. It would be very interesting to repeat the in vivo experiments after 
long term exposure to the NMs. In all probability any nanomaterial mediated adverse effects 
to humans would be following small, yet multiple dose exposures, therefore long term 
exposure of animals would give more accurate representation of any potential human health 
issues. 
 
In this study we showed that Kupffer cells play a crucial role in the liver immunity in 
response to the ENPRA panel of nanomaterials. However we did not manage to isolate a pure 
population of Kupffer cells. An effective approach that could be pursued in the future would 
be the complete depletion of the liver macrophage population utilising Clodrosome 
(liposomal clodronate) (Chen, et al., 2012; Niebel, et al., 2012). Comparisons made between 
models in which the Kupffer cells have been depleted and wild type animals will allow to 
better demonstrate the role of liver macrophages in the immune response of the liver against 
NMs.   
 
Finally, the rheological behaviour of ENPRA NMs and interactions with human blood 
proteins would be very interesting. An investigation of NM interaction with blood is 
imperative in gaining a better understanding of NM toxicity to the liver (for a NM to have 
any impact on the liver it must pass through blood).  
 
As a note a suggestion for any future study design might to reduce the number of 
nanomaterials utilised in the study as this would allow for a more realistic and detailed 
investigation into the mechanism of the NM toxicity.  
 
With the advances in the fields of nanotechnology and nanomedicine, the potential for public 
and occupational exposure is likely to increase, so that there is an urgent necessity to consider 
the possibility of any detrimental health consequences associated with this increased 
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exposure to nanomaterials. This can be achieved in the form of a critical risk assessment. 
Engineered nanomaterials are manufactured from a diverse group of substances and can have 
a very diverse range of physicochemical characteristics such as size, shape, surface charge, 
surface reactivity, crystalline phase, polarity, solubility or impurities, hence a varied range of 
materials with different characteristics need to be evaluated for a comprehensive toxicity 
profile allowing for structure activity relationships to be generated. Likewise, standardisation 
of methods such as particle preparation and exposure conditions are essential to be able to 
compare studies carried out in different laboratories and ensure that any differences in 
toxicological responses are due to the materials only and not the methodology. 
 
Therefore one of the most important reasons for conducting nanotoxicological studies is to 
provide a knowledge base towards assessing the risks associated with realistic NM exposures. 
The findings obtained in such studies should provide hazard data for the nanomaterials that 
will be used for risk assessment purposes and determine any health implications associated 
with these NMs. For this purpose there are areas in liver nanotoxicology in which knowledge 
is severely lacking 
 
To our knowledge there have been very few studies if any that have investigated the effects 
of nanomaterials on the liver following inhalation exposure (in all reality the most prominent 
route of nanomaterial exposure). It is important to note that inhalation and instillation are not 
always comparable, since for example the deposition patterns of the particles in the lung can 
vary between the two methods. Adverse effects observed following an IT exposure might not 
necessarily be seen following an inhalation study.  
 
One of the most important paradigms of risk assessment is exposure. From the literature it is 
evident that there is a clear lack of studies in which low realistic relevant exposure scenarios 
have been employed that can be used for risk assessment purposes concentrating on the liver. 
There is a real need for long term studies in which animals are exposed to low and repeated 
doses of different NMs via different routes (i.e. inhalation, ingestion and intravenous routes). 
This will be the only way a realistic and reliable liver risk assessment model can be 
formulated.  
 
 
 
234 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
References 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
235 
 
Abdelhalim MAK, Jarrar BM. (2011). The appearance of renal cells cytoplasm   degeneration 
and nuclear destruction might be an indication of GNPs toxicity. Lipids in Health and 
Disease 10, 147-153. 
 
Acalovschi M, Buzas C, Radu C, Grigorescu M. (2009). Hepatitis C infection is a risk factor 
for gallstone disease: a prospective hospital-based study of patients with chronic viral C 
hepatitis. Journal of Viral Hepatitis 16, 860-866.  
 
Aitken RJ, Chaudhry MQ, Boxall AB, Hull M. (2006). Manufacture and use of 
nanomaterials: current status in the UK and global trends. Occupational Medicine 56, 300-
306. 
 
Akhtar MJ, Ahamed A, Kumar S, Khan MAM, Ahmad J, Alrokayan SA. (2012) Zinc oxide 
nanoparticles selectively induce apoptosis in human cancer cells through reactive oxygen 
species. International Journal of Nanomedicine 7, 845-857. 
 
Al-Nasiry S, Geusens N, Hanssens M, Luyten C, Pijnenborg R. (2007). The use of 
Alamarblue assay for quantitative analysis of viability, migration and invasion of 
choriocarcinoma cells. Human Reproduction 22, 1304-1309. 
 
Anreddy RNR, Devarakonda RK, Vurimindi H, Yellu NR. (2011). In vitro cytotoxicity of 
carbon nanoparticles against HepG32 cells. Latin American Journal of Pharmacy 30, 177-
180. 
 
Arora S, Jain J, Rajwade JM, Paknikar KM. (2009). Interactions of silver nanoparticles with 
primary mouse fibroblasts and liver cells. Toxicology and Applied Pharmacology 236, 310-
318. 
 
Asare N, Instanes C, Sandberg WJ, Refsnes M, Schwarze P, Kruszewski M, Brunborg G. 
(2012). Cytotoxic and genotoxic effects of silver nanoparticles in testicular cells. Toxicology 
291, 65-72. 
 
Avedisian CT, Cavicchi RE, McEuen PL, Zhou X. (2009). Nanoparticles for cancer 
treatment: role of heat transfer. Annals of New York Academy of Sciences 1161, 62-73. 
236 
 
Baffy G. (2009). Kupffer cells in non-alcoholic fatty liver disease: the emerging view. 
Journal of Hepatology 51, 212-223. 
 
Bajt ML, Farhood A, Jaeschke H. (2001). Effects of CXC chemokines on neutrophil 
activation and sequestration in hepatic vasculature. American Journal of Physiology: 
Gastrointestinal and liver Physiology 281, 1188-1195. 
 
Banerjee R. (2001). Liposomes: applications in medicine. Journal of Biomaterial 
Applications 16, 3-21. 
 
Baniyash M. (2006). Chronic inflammation, immunosuppressant and cancer: New insights 
and outlook. Seminars in Cancer Biology 16, 80-88. 
 
Barillet S, Simon-Deckers A, Herlin-Boime N, Mayne-L’Hermite M, Reynaud C, Cassio D, 
Gouget B, Carriere M. (2010). Toxicological consequences of TiO2, SiC nanoparticles and 
multi-walled carbon nanotubes exposure in several mammalian cell types: an in vitro study. 
Journal of Nanoparticle Research 12, 61-73. 
 
Bautista A. (2002). Netrophilic infiltration in alcoholic hepatitis. Alcohol 27, 17-21.  
 
Beere HM, Green DR. (2001). Stress management – heat shock protein-70 and the regulation 
of apoptosis. Trends in Cell Biology 11, 6-10. 
 
Beliveau-Carey G, Cheung CW, Cohen S, Brusilow S, Raijman L. (1993). Regulation of urea 
and citrulline synthesis under physiological conditions. Biochemical Journal 292, 241–247. 
 
Benn TM, Westerhoff P. (2008). Nanoparticle silver released into water from commercially 
available sock fabrics. Environmental Science and Technology 42, 4133-4139. 
 
Berry JP, Arnoux B, Stanislas G, Galle P, Chretien J. (1977). A microanalytic study of 
particle transport across the alveoli: Role of blood platelets. Biomed Central 27, 354-357. 
 
Beutler B. (2004). Innate immunity: an overview. Molecular Immunology 40, 845-859. 
237 
 
Birlouez-Aragon I, Tessier FJ. (2003). Antioxidant vitamins and degenerative pathologies. A 
review of vitamin C. The Journal of Nutrition, Health and Aging 7, 103-109. 
 
Black S, Kushner I, Samols D. (2004). C reactive protein. The Journal of Biological 
Chemistry 279, 48487-48490. 
 
Bottcher JP, Knolle PA, Stabenow D. (2011). Mechanisms Balancing Tolerance and 
Immunity in the Liver. Digestive Diseases 29, 384-390. 
 
Boyle TJ, Bunge SD, Alam TM, Holland GP, Headley TJ, Avilucea G. (2005). Cadmium 
Amido Alkoxide and Alkoxide Precursors for the Synthesis of Nanocrystalline CdE (E = S, 
Se, Te). Inorganic Chemistry 44, 1309-1318. 
 
Brody AR, Hill LH, Warheit DB. (1985). Induction of early alveolar injury by inhaled 
asbestos and silica. Federation Proceedings 44, 2596-2601. 
 
Brown DM, Donaldson K, Brom PJ, Schins P, Dehnhardt M, Gilmour P, Jiminez LA, Stone 
V. (2004). Calcium and ROS mediated activation of transcription factors and TNF-α cytokine 
gene expression in macrophages exposed to ultrafine particles. American Journal of Lung 
Physiology 286, 344-353. 
 
Brown DM, Hutchison L, Donaldson K, Stone V. (2007). The effects of PM10 particles and 
oxidative stress on macrophages and lung epithelial cells: modulating the effects of calcium 
signalling antagonists. American Journal of Lung Physiology 292, 1444-1451. 
 
Brown DM, Johnston H, Gubbins E, Stone V. (2013a). Cytotoxicity and cytokine release in 
rat hepatocytes and macrophages exposed to gold nanoparticles – effect of biological 
dispersion media or corona. Manuscript in preparation. 
 
Brown DM, Johnston H, Gubbins E, Stone V. (2013b). Size and surface charge effects of 
silica nanoparticles on J774 cells are influenced by the dispersant medium. Manuscript in 
preparation. 
 
238 
 
Brunauer PH, Emmet H, Teller E. (1938). Adsorption of gases in multi-molecular layers. 
Journal of American Chemical Society 60, 309-315. 
 
Buzea C, Pacheco II, Robbie K. (2007). Nanomaterials and nanoparticles: Sources and 
toxicity. Biointerpahses 2, 18-67. 
 
Carlson C, Hussain SM, Schrand AM, Braydich-Stolle LK, Hess KL, Jones RL, Schlager JJ. 
(2008). Unique cellular interaction of silver nanoparticles: Size-dependent generation of 
reactive oxygen species. Journal of Physical Chemistry 112, 13608-13619.  
 
Carneiro LA, Magalhaes JG, Tattoli L, Philpott DJ, Travassos LH. (2008). NOD-like proteins 
in inflammation and disease. Journal of Pathology 214, 136-148. 
 
Carreo JS, Yilmaz MI, Lindholm B, Stenvinkel P. (2008). Cytokine dysregulation in chronic 
kidney disease: How can we treat it? Blood Purification 26, 291-299. 
 
Cartiera MS, Johnson KM, Rajendran V, Caplan MJ. (2009). The uptake and intracellular 
fate of PGLA nanoparticles in epithelial cells. Biomaterials 30, 2790-2798. 
 
Caruthers SD, Wickline SA, Lanza GM. (2007). Nanotechnological applications in medicine. 
Current Opinion in Biotechnology 18, 26-30. 
 
Chappell MA, Miller LF, George AJ, Pettway BA, Prince CL, Porter BE, Bednar AJ, Seiter 
JM, Kennedy AJ. (2011). Simultaneous dispersion-dissolution behaviour of concentrated 
silver nanoparticle suspensions in the presence of model organic solutes. Chmosphere 84, 
1108-1116.  
 
Chen BX, Wilson SR, das M, Coughlin DJ, Erlanger BF, Erlanger BF. (1998). Antigenicity 
of fullerenes: antibodies specific for fullerenes and their characteristics. Proceedings of 
National Academy of Sciences of the United States of America 95, 10809-10813. 
 
Chen C, Zhang P, Hou X, Chai Z. (1999). Sub-cellular distribution of selenium and Se-
containing proteins in human liver. Biochemica et Biophysica Acta-General Subjects 1427, 
205-215. 
239 
 
Chen E, Ruvalcaba M, Araujo L, Chapman R, Chin WC. (2008a). Ultrafine titanium dioxide 
nanoparticles induce cell death in human bronchial epithelial cells. Journal of Experimental 
Nanoscience 3, 171-183. 
 
Chen LL, Ye HY, Zhao XL, Miao Q, Li YM, Hu RM. (2012). Selective depletion of hepatic 
Kupffer cells significantly alleviated hepatosteatosis and intrahepatic inflammation induced 
by high fat diet. Hepato-Gastroenterology 59, 1208-1212. 
 
Chen X, Schluesener HJ. (2008b). Nanosilver: A nanoproduct in medical application. 
Toxicology Letters 176, 1-12. 
 
Chen Z, Meng H, Xing G, Chen C, Zhao Y, Jia G, Wang T, Yuan H, Ye C, Zhao F, Chai Z, 
Zhu C, Fang X, Ma B, Wan L. (2006). Acute toxicological effects of copper nanoparticles in 
vivo. Toxicology Letters 163, 109-120. 
 
Chuang YH, Lan RY, Gershwin ME. (2009). The immunopathology of human biliary cell 
epithelium. Seminars in Immunopathology 31, 323-331. 
 
Clift MJ, Boyles MS, Brown DM, Stone V. (2010). An investigation into the potential for 
different surface coated quantum dots to cause oxidative stress and affect macrophage cell 
signalling in vitro. Nanotoxicology 4, 139-149. 
 
Cohen MP. (2003). Intervention strategies to prevent pathogenetic effects of glycated 
albumin. Archives of Biochemistry and Biophysics 419, 25–30. 
 
Coussens LM, Werb Z. (2002). Inflammation and cancer. Nature 420, 860-866. 
 
Crisp IN. (2007). The liver as a lymphoid organ. Annual review of Immunology 27, 147-163.  
 
Crosera M, Bovenzi M, Maina G, Adami G, Zanette C, Florio C, Filon Larese F. (2009). 
Nanoparticle dermal absorption and toxicity: a review of the literature. International archives 
of Occupational and Environmental Health 82, 1043-1055. 
240 
 
Cui Y, Gong X, Duan Y, Li N, Hu R, Liu H, Hong M, Zhou M, Wang L, Wang H, Hong F. 
(2010). Hepatocyte apoptosis and its molecular mechanisms in mice caused by titanium 
dioxide nanoparticles. Journal of Hazardous Materials 183, 874-880 
 
Delpino MV, Barrionuevo P, Scian R, Fossati CA, Balsi PC. (2010). Brucella-infected 
hepatocytes mediate potentially tissue-damaging immune responses. Journal of Hepatology: 
53, 145-54. 
 
Deng X, Luan Q, Chen W, Wang Y, Wy M, Zhang H, Jiao Z. (2009). Nanosized zinc oxide 
paticles induce neural stem cell apoptosis. Nanotechnology 20, 1-7. 
 
De Nicola M, Nuccitelli S, Gattia DM, Traversa E, Magrini A, Bergamaschi A, Ghibelli L. 
(2009). Effects of carbon nanotubes on human monocytes. Natural compounds and their role 
in apoptotic cell signalling pathways 1171, 600-605. 
 
Diesen DL, Kuo PC. (2009). Nitric Oxide and redox regulation in the liver: Part I. General 
considerations and redox Biology in Hepatitis. Journal of Surgical Research 162, 95-109. 
 
Donaldson K, Aitken R, Tran L, Stone V, Duffein R, Forrest G, Alexander A. (2006). Carbon 
nanotubes: a review of their properties in relation to pulmonary toxicology and workplace 
safety. Toxicological Sciences 92, 5-22. 
 
Donaldson K, Macnee W. (1998). The Mechanism of lung injury caused by PM10. Issues in 
Environmental Science and Technology 10, 21-32. 
 
Donldson K, Murphy F, Schinwald A, Duffin R, Poland CA. (2011). Identifying the 
pulmonary hazard of high aspect ratio nanoparticles to enable their safety-by-design. 
Nanomedicine 6, 143-156.   
 
Donaldson K, Tran CL. (2002). Inflammation caused by particles. Inhalation Toxicology 14, 
4-27. 
 
241 
 
Dong BW, Liang P, Yu XL, Zeng XQ, Wang PJ, Su L, Wang XD, Xin H, Li S. (1998). 
Sonographically guided microwave coagulation treatment of liver cancer: an experimental 
and clinical study. American Journal of Roentgenology 171, 449-454. 
 
Drake PL, Hazlewood KJ. (2005). Exposure-related health effects of silver and silver 
compounds: a review. Annals of Occupational Hygiene 49, 575-585. 
 
Dreher KL. (2004). Health and environmental impact of nanotechnology: Toxicological 
assessment of manufactured nanoparticles. Toxicological Sciences 77, 3-5. 
 
Dua P, Chaudhari KN, Lee CH, Chaudhari NK, Hong SW, Yu JS, Kim S, Lee DK. (2011). 
Evaluation of toxicity and gene expression changes triggered by oxide nanoparticles. Bulletin 
of Korean Chemical society 32, 2051-2057. 
 
Dubrovinsky LS, Dubrovinskaia NA, Swamy V, Muscat J, Harrison NM, Ahuja R, Holm B, 
Johansson B. (2001). Materials science: The hardest known oxide. Nature 410, 653-654. 
 
Du Clos TW, Mold C. (2004). C-reactive protein: an activator of innate immunity and a 
modulator of adaptive immunity. Immunological Research 30, 261-277.  
 
Dudas PL, Sague SL, Elloso MM, Farrell FX. (2011). Proinflammtory/Profibiotc effects of 
interlukin 17A on human proximal tubule epithelium. Nephron Experimental Nephrology 
117, 114-123.   
 
Edwards-Jones V. (2009). The benefits of silver in hygiene, personal care and healthcare. 
Letters in Applied Microbiology 49, 147-152. 
 
Ellinger-Ziegelbauer H, Pauluhn J. (2009). Pulmonary toxicity of multi-walled carbon 
nanotubes (Baytubes(R)) relative to alpha-quartz following a single 6 h inhalation exposure 
of rats and a 3 months post-exposure period. Toxicology 266, 16-29. 
 
Eom HJ, Choi J. (2009). Oxidative stress of CeO2 nanoparticles via p38 - Nrf2 signalling 
pathway in human bronchial epithelial cell, Beas-2B. Toxicology Letters 187, 77-83. 
 
242 
 
European Union official recommendation – Nanomaterials. – Accessed – 3-3-2012 
http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2011:275:0038:0040:EN:PDF. 
 
Fabrega J, Luoma SN, Tyler CR, Galloway TS, Lead R. (2011). Silver nanoparticles: 
behaviour and effects in the aquatic environment. Environment International 37, 517-531. 
 
Fainboim L, Chernavsky A, Paladino N, Flores AC, Arruvito L. (2007). Cytokines and 
chronic liver disease. Cytokine and Growth Factor Reviews 18, 143-157.  
 
Ferin J, Oberdorster G, Penny DP, Soderholm SC, Gelein R, Piper HC. (1990). Increased 
pulmonary toxicity of ultrafine particles? Particle clearance, translocation, morphology. 
Journal of Aerosol Science 21, 381-384. 
 
Ferin J, Oberdorster G, Penny DP. (1992). Pulmonary retention of ultrafine and fine particles 
in rats. American Journal of Respiratory Cell and Molecular Biology 6, 535-542. 
 
Fernandez-Martinez AB, Jimenez MIA, Cazana FJL. (2012). Retionic acid increases 
hypoxia-inducible factor-1 alpha through intracrine prostaglandin E-2 signalling in renal 
proximal tubular cells HK-2. Biochemica et Biophysica Acta - Molecular and Cell Biology of 
Lipids 4, 672-683.  
 
Ferrari M. (2005). Cancer nanotechnology: opportunities and challenges. Nature Review 
Cancer 9, 343-346. 
 
Filippi C, Kermanizadeh A, Stone V. (2013). Kupffer cell contribution to the hepatic 
response to nanomaterials – manuscript in preparation. 
 
Fischer NO, Verma A, Goodman CM, Simard JM, Rotello VM. (2003). Reversible 
"irreversible" inhibition of chymotrypsin using nanoparticle receptors. Journal of American 
Chemical Society 125, 13387-13391. 
 
Fitzgerald JP, Nayak B, Shanmugasundaram K, Friedrichs W, Sudarshan S, Eid AA, De 
Napoli T, Parekh DJ, Gorin Y, Block K. (2012). Nox4 mediated renal cell carcinoma cell 
invasion through hypoxia-induced interleukin 6 and 8 production. Plos One 7, e30712. 
243 
 
Foldbjerg R, Dang DA, Autrup H. (2011). Cytotoxicity and genotoxicity of silver 
nanoparticles in human lung cancer line, A549. Archives of Toxicology 85, 743-750.  
 
Gabay C, Kushner I. (1999). Acute-phase proteins and other systemic responses to 
inflammation. The New England Journal of Medicine 340, 448-454. 
 
Gaiser BK, Biswas A, Rosenkranz P, Jepson MA, Lead JR, Stone V, Tyler CR, Fernandes, 
TR. (2011). Effects of silver and cerum oxide micro and nano sized particles on Daphnia 
magna. Journal of Environmental Monitoring 13, 1227-1235. 
 
Gaiser BK, Fernandes TF, Jepson MA, Lead JR, Tylor CR, Baalousha M, Biswas A, Britton 
GJ, Cole PA, Johnston BD, Ju-Nam Y, Rosenkranz P, Scown TM, Stone V. (2012). 
Interspecies comparison on the uptake and toxicity of silver and cerium dioxide 
nanoparticles. Environmental Toxicology and Chemistry 31, 144-154. 
 
Gao W, Csu K, Jib L, Tang B. (2011).  Effect of gold nanoparticles on glutathione depletion-
induced hydrogen peroxide generation and apoptosis in HL7702 cells. Toxicology Letters 
205, 86-95. 
 
Gekle M. (2005). Renal tubule albumin transport. Annual Review of Physiology 67, 573-594. 
 
Gilmour PS, Ziesenis A, Morrison ER, Vickers MA, Drost EA, Ford I, Karg E, Mossa C,  
Schroeppel A, Ferron GA, Heyder J, Greaves M, MacNee W, Donaldson K. (2004). 
Pulmonary and systemic effects of short-term inhalation exposure to ultrafine carbon black 
particles. Toxicology and Applied Pharmacology 195, 35-44. 
 
Glantzounis GK, Salacinski HJ, Yang W, Davidson BR, Seifalian AM. (2005). The 
contemporary role of antioxidant therapy in attenuating liver ischemia reperfusion injury: a 
review. Liver Transplantation 11, 1031-1047. 
 
Gojovo A, Guo B, Kota RS, Rutledge JC, Kennedy IM, Barakat AI. (2007). Induction of 
inflammation in vascular endothelial cells by metal oxide nanoparticles: effect of particle 
composition. Environmental Health Perspectives 115, 403-409.   
244 
 
Gosens I, Kermanizadeh
 
A, Jacobson NR,
 
Stoeger T, Bokkers
 
B, de Jong
 
WH, Stone V, Tran
 
L, Cassee
 
FR. (2013a). Hazard identification of zinc oxide and silver nanomaterials based on 
acute lung and systemic toxicity in mice. Manuscript in preparation.  
  
Gosens I, Kermanizadeh
 
A, Jacobson NR,
 
Stoeger T, Bokkers
 
B, de Jong
 
WH, Stone V, Tran
 
L, Cassee
 
FR. (2013b). Hazard identification of titanium dioxide and multi-walled carbon 
nanotubes nanomaterials based on acute lung and systemic toxicity in mice. Manuscript in 
preparation. 
 
Grill AE, Johnston NW, Sadhukha T, Panyam J. (2009). Reversible "irreversible" inhibition 
of chymotrypsin using nanoparticle receptors. Journal of American Chemical Society: Recent 
Patents on Drug Delivery and Formulation 3, 137-142. 
 
Grutzkau A, Radbruch A. (2010). Small but mighty: How the MACS – technology based on 
nanosized supermagnetic particles helped to analyze the immune system within the last 20 
years. Chemistry parts A77, 643-647. 
 
Guengerich FP. (2001). Common and uncommon cytochrome P450 reactions related to 
metabolism and chemical toxicity. Chemical Research in Toxicology 14, 611-650. 
 
Gui S, Zhang Z, Zheng L, Cui Y, Liu X, Li N, Sang X, Sun Q, Gao G, Cheng Z, Wang L, 
Tang M, Hong F. (2011). Molecular mechanism of kidney injury of mice caused by exposure 
to titanium dioxide nanoparticles. Journal of Hazardous Materials 195, 365-370. 
 
Gutsch A, Muhlenweg H, Krumerm H. (2005). Tailor-made nanoparticles via gas-phase 
synthesis. Small 1, 1-46.  
 
Hagens WI, Oomen AG, de Jong WH, Casee FR, Sips AJAM. (2007). What do we (need to) 
know about the linetic properties od nanoparticles in the body? Regulatory Toxicology and 
Pharmacology 49, 217-229. 
 
Hamerman JA, Ogasawara K, Lanier LL. (2005). NK cells in innate immunity. Current 
Opinions in Immunology 17, 29-35. 
245 
 
Hamilton Jr RF, Thakur SA, Holian A. (2008). Silica binding and toxicity in alveolar 
macrophages. Free Radical Biology 44, 1246-1258. 
 
Handy RD, Owen R, Valsami-Jones E. (2008). The ecotoxicology of nanoparticles and 
nanomaterials: current status, knowledge gaps, challenges, and future needs. Ecotoxicology 
17, 315-325.  
 
Hansson PK, Asztely AK, Clapham JC, Schreyer SA. (2004). Glucose and fatty acid 
metabolism in McA-RH7777 hepatoma cells vs. rat primary hepatocytes: responsiveness to 
nutrient availability. Biochemica et Biophysica Acta 1684, 54-62.   
 
Hardman R. (2006). A toxicologic review of quantum dots: toxicity depends on 
physicochemical and environmental factors. Environmental Health Perspectives 114, 165-
172. 
 
Häussinger D, Lamers WH, Moorman AFM. (1993). Metabolism of amino acids and 
ammonia. Enzyme 46, 72–93. 
 
Häussinger D, Schliess F. (2008).  Pathogenetic mechanisms of hepatic encephalopathy. Gut 
57, 1156-1165. 
 
Hertle E, van Greevenbroek MMJ, Stehouwer CDA. (2012). Complement  C3: an emerging 
risk factor in cardiometabolic disease. Diabetologica 55, 881-884.  
 
Heyder J, Gebhart J, Rudolf G, Schiller CF, Stahloffen W. (1986). Deposition of particles in 
the human respiratory tract in the size range 0.005-15 μm. Journal of aerosol science 17, 811-
825. 
 
Hirano S, Kanno S, Furuyama A. (2008). Multi-walled carbon nanotubes injure the plasma 
membrane of macrophages. Toxicology and Applied Pharmacology 232, 244-251. 
 
Hirano S. (2009). A current overview of health effect research on nanoparticles. 
Environmental Health and Preventative Medicine 14, 223-225. 
 
246 
 
Hoet PHM, Hohlfeld IB, Salata O. (2004). Nanaoparticles – known and unknown health 
risks. Journal of Nanobiotechnology 2, 12-27. 
 
Hu RP, Zheng L, Zhang T, Gao GD, Cui YL, Cheng Z, Cheng J, Hong MM, Tang M, Hong 
FS. (2011). Molecular mechanism of hippocampal apoptosis of mice following exposure to 
titanium dioxide nanoparticles. Journal of Hazardous Materials 191, 32-40. 
 
Huang C, Bonroy K, Reekmans G, Laureyn W, Verhaegen K, De Vlaminck I, Lagae L, 
Borghs G. (2009). Localized surface plasmon resonance biosensor integrated with 
microfluidic chip. Biomedical Microdevices 4, 893-901. 
 
Huang Z, Zheng X, Yan D, Yin G, Liao X, Kang Y, Yao Y, Huang D, Hao B. (2008). 
Toxicological effect of ZnO nanoparticles based on bacteria. Langmuir 24, 4140-4144. 
 
Hussain SM, Hes KL, Gearhart JM, Geiss KT, Schlager JJ. (2005). In vitro toxicity of 
nanoparticles in BRL3A rat liver cells. Toxicology in vitro 19, 975-983. 
 
Jackson P, Hougaard KS, Vogel U, Wu DM, Casavant L, Willliams A, Wade M, Yauk CL, 
Wallin H, Halappanavar S. (2012). Exposure of pregnant mice to carbon black by 
intratracheal instillation: Toxicogenomic effects in dams and offspring. Mutation Research – 
Genetic Toxicology and Environmental Mutagenesis 745, 73-83. 
 
Jacobsen NR, Pojano G, Wallin H, Jensen KA. (2010). Nanomaterial dispersion protocol for 
toxicological studies in ENPRA. Internal ENPRA Project Report. The National Research 
Centre for the Working Environment. 6 pp. 
 
Jaeschke H, Hasegawa T. (2006). Role of neutrophils in acute inflammatory liver injury. 
Liver International 26, 912-919. 
 
Jaitovich A, Bartorello AM. (2009). Salt, Na
+
, K
+ 
- ATPase and hypertension. Life Sciences 
86, 73-78. 
 
247 
 
Jani P, Halbert GW, Langridge J, Florence AT. (1990). Nanoparticle uptake by the rat 
gastrointestinal mucosa: quantisation and particle size dependency.  Journal of Pharmacy and 
Pharmacology 42, 821-826. 
 
Janssen YM, van Houten B, Borm PJ, Mossman BT. (1993). Cell and tissue responses to 
oxidative damage. Laboratory investigation 69, 261-274.  
 
Jensen KA, Bilaničová D, Birkedal R, Pojana G, Marcomini A, Wallin H, Jacobsen NR. 
Optimization and evaluation of a generic nanoparticle dispersion protocol for in vitro and in 
vivo toxicity testing using serum-water. Manuscript in preparation. 
 
Ji Z, Zhang D, Li L, Shen X, deng X, Dong L, Wu M, Liu Y. (2009). The hepatotoxicity of 
multi-walled carbon nanotubes in mice. Nanotechnology 20, article no: 445101. 
 
Jia G, Wang H, Yan L, Wang X, Pei R, Yan T. (2005). Cytotoxicity of carbon nanomaterials: 
single-wall nanotube, multi-wall nanotube, and fullerene. Environmental Science and 
Technology 39, 1378-1383. 
 
Jin CY, Zhu BS, Wang XF, Lu QH. (2008). Cytotoxicity of Titanium dioxide nanoparticles 
in mouse fibroblast cells. Chemical Research in Toxicology 21, 1871-1877. 
 
Johnston HJ, Semmler-Behnke M, Brown DM, Kreyling W, Tran L, Stone V. (2009). 
Evaluating the uptake and intracellular fate of polystyrene nanoparticles by primary and 
hepatocyte cell lines in vitro. Toxicology and Applied Pharmacology 242, 66-78. 
 
Kalyanaraman B. (2011). Oxidative chemistry of florescent dyes: implications in the 
detection of reactive oxygen and nitrogen species. Biochemical Society Transactions 39, 
1221-1225. 
 
Kanel G, Korula J. (2005). Atlas of liver pathology. Saunders 2
nd
 Edition., USA. 
 
Kang KJ. (2002). Mechanism of hepatic ischemia/reperfusion injury and protection against 
reperfusion injury. Transplantation Proceedings 34, 2659-2661. 
 
248 
 
Kang SJ, Kim BM, Lee YJ, Chung HW. (2008). Titanium dioxide nanoparticles trigger p53-
mediated damage response in peripheral blood lymphocytes. Environmental and Molecular 
Mutagenesis 49, 399-405. 
 
Karczewski M, Karczewski J, Poniedzialek B, Wiktorowicz K, Glyda M. (2009). Cytometric 
analysis of TH1/TH2 cytokines in the urine of patients undergoing kidney transplantation. 
Annals of Transplantation 14, 25-28. 
 
Kawata K, Osawa M, Okabe S. (2009). In vitro toxicity of silver nanoparticles at 
noncytotoxic doses to HepG2 human hepatoma cells. Environmental Science and Technology 
43, 6046–6051. 
 
Kegan VE, Tyurina YY, Tyruin VA, Konduru NV, Potapovich AI, Osipov AN, Kisin ER, 
Schwegler-Berry D, Mercer R, Castranova V, Shevadova AA. (2006). Direct and indirect 
effects of single walled carbon nanotubeson RAW 264.7 macrophages: role of iron. 
Toxicology Letters 165, 88-100. 
 
Kermanizadeh A, Brown DM, Hutchison G, Stone V. (2013a). Engineered nanomaterial 
impact in the liver following exposure via an intravenous route – the role of 
polymorphonuclear leukocytes and gene expression in the organ. Nanomedicine and 
Nanotechnology 4: 157. DOI:10.4172/2157-7439.1000157. 
 
Kermanizadeh A, Gaiser BK, Hutchison GR, Stone V. (2012a). An in vitro liver model – 
assessing oxidative stress and genotoxicity following exposure of hepatocytes to a panel of 
engineered nanoparticles. Particle and Fibre Toxicology DOI:10.1186/1743-8977-9-28. 
 
Kermanizadeh A, Gaiser BK, Ward MB, Stone V. (2012b). Primary human hepatocytes vs. 
hepatic cell line – assessing their suitability for in vitro nanotoxicology. Nanotoxicology 
DOI: 10.3109/17435390.2012.734341. 
 
Kermanizadeh A, Pojana G, Gaiser BK, Birkedal R, Bilaničová D, Wallin H, Jensen KA, 
Sellergren B, Hutchison GR, Marcomini A, Stone V. (2012c). In vitro assessment of 
engineered nanomaterials using C3A cells: Cytotoxicity, pro-inflammatory cytokines and 
function markers. Nanotoxicology DOI: 10.3109/17435390.2011.653416. 
249 
 
 
Kermanizadeh A, Vranic S, Boland S, Moreau K, Squiban AB, Gaiser BK, Andrzejczuk
 
LA, 
Stone V. (2013b). An in vitro assessment of panel of engineered nanomaterials using a 
human renal cell line: Cytotoxicity, pro-inflammatory response, oxidative stress and 
genotoxicity. Submitted to BMC Nephrology. 
 
Kim BS, Park IK, Hoshiba T, Jiang HL, Choi YJ, Akaike Y, Cho CS. (2011a). Design of 
artificial extracellular matrices for tissue engineering. Progress in Polymer Science 36: 238-
268. 
 
Kim HR, Kim MJ, Lee SY, Oh SM, Chung KH. (2011b). Genotoxic effects of silver 
nanoparticles stimulated by oxidative stress in human bronchial epithelial (BEAS-2B) cells. 
Mutation Research- Genetic Toxicology and Environmental Mutagenesis 726, 129-135. 
 
Kim J, Kim S, Lee S. (2011c). Differentiation of the toxicities of silver nanoparticles and 
silver ions to the Japanese medaka (Oryzias latipes) and the cladoceran Daphnia magna. 
Nanotoxicology 5: 208-214. 
 
Kim JS, Yoon TJ, Yu KN, Kim BG, Park SJ, Kim HW, Lee KH, Park SB, Lee JK, Cho MH. 
(2006). Toxicity and tissue distribution of magnetic nanoparticles in mice. Toxicological 
Sciences 89, 338-347. 
 
Kim YS, Song MY, Park JD, Song KS, Ryu HR, Chung YH, Chang HK, Lee JH, Oh KH, 
Kelman BJ, Hwang IK, Yu IJ. (2010). Subchronic oral toxicity of silver nanoparticles. 
Particle and Fibre Toxicology 7, 20-31.  
 
Kishimoto T, Akira S, Narazaki M, Taga T. (1995). Interleukin 6 family of cytokines and gp 
130. Blood 86, 1243-1254.   
 
Kishore AS, Surekha P, Murthy PB. (2009). Assessment of the dermal and ocular irritation 
potential of multi-walled carbon nanotubes by using in vitro and in vivo methods. Toxicology 
Letters 191, 268-274. 
 
250 
 
Kmiec Z. (2001). Co-operation of liver cells in health and disease. Advances in Anatomy, 
Embryology and Cell Biology 161, 1-151. 
 
Koeneman BA, Zhang Y, Westerhoff P, Chen Y, Crittenden JC, Capco DG. (2010). Toxicity 
and cellular responses of intestinal cells exposed to titanium dioxide. Cell Biology and 
Toxicology 26, 225-238. 
 
Krishnamurphy D, Starkl P, Szalai K, Roth-Walter F, Diesner SC, Mittlboeck, M, 
Mannhalter C, Untersmayr E, Jensen-Jarolim E. (2012). Monitoring neutrophils and platelets 
during casein-induced anaphylaxis in an experimental BALB/c mouse model. Clinical and 
Experimental allergy: Journal of the British Society for Allergy and clinical Immunology 42, 
1119-1128.  
 
Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, 
Blagosklonny MV, El-Deiry WS, Golstein P, Green DR, Hengartner M, Knight RA, Kumar 
S, Lipton SA, Malorni W, Nunez G, Peter ME, Tschopp J, Yuan J, Piacentini M, 
Zhivotovsky B, Melino G. (2009). Classification of cell death: recommendations of 
nomenclature committee on cell death 2009. Cell Death and Differentiation 16, 3-11.  
 
Kwok KWH, Auffan M, Badireddy AR, Nelson CM, Wiesner MR, Chilkoti AL, Marinakos 
SM, Hinton DE. (2012). Uptake of silver nanoparticles and toxicity of early life stages of 
Japanese medaka (Oryzias latipes): Effect of coating materials. Aquatic toxicology 120, 59-
66.  
 
Lakshminarasimhan N, Kim W, Choi W. (2008). Effect of agglomerated state on the 
photocatalytic hydrogen production with in situ agglomeration of colloidal TiO2 
nanoparticles.  Journal of Physical Chemistry 112, 20451-20457. 
 
Lam CW, James JT, McCluskey R, Hunter RL. (2003). Pulmonary toxicity of single wall 
carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicological 
Sciences 77, 117-125. 
 
251 
 
L’azou B, Jorly J, On D, Sellier E, Moisan F, Fleury-Feith J, Cambar J, Brochard P, Ohayon-
Courtes C. (2008). In vitro effects of nanoparticles on renal cells. Particle and Fibre 
Toxicology 5, 22-36.  
 
Lee WB, Weng CH, Cheng FY, Yeh CH, Lei HY, Lee GB. (2009). Biomedical microdevices 
synthesis of iron oxide nanoparticles using a microfluidic system. Biomedical Microdevices 
11, 161-171. 
 
Lieber CS. (1997). Role of oxidative stress and antioxidant therapy in alcoholic and non 
alcoholic liver diseases. Advances in Pharmacology 38, 601-628. 
 
Liguori MJ, Blomme EAG, Waring JF. (2008). Trovafloxacin induced gene expression 
changes in liver derived in vitro systems: Comaprison of primary human hepatocytes to 
HepG2 cells. Drug Metabolism and Disposition 36, 223-233. 
 
Lines MG. (2008). Nanomaterials for practical functional uses. Journal of Alloys and 
Compounds 449, 242-245. 
 
Liu ZC, Zhou QL, Liu ZQ, Li XZ, Zuo XX, Tang R. (2012). Tumour necrosis factor like 
weak inducer of apoptosis (TWEAK) mediates p38 mitogen activated protein kinase 
activation and signal transduction in peripheral blood mononuclear cells from patients with 
lupus nephritis. Inflammation 35, 935-943. 
 
Lovric J, Bazzi HS, Cuie Y, Fortin GR, Winnik FM, Maysinger D. (2005). Differences in 
sub-cellular distribution and toxicity of green and red emitting CdTe quantum dots. Journal of 
Molecular Medicine., 83 377-385.  
 
Lunov O, Syrovets T, Buchele B, Jiang XE, Rocker C, Tron K, Nienhaus GU, Walther P, 
Mailander V, Landfester K, Simmet T. (2010). The effects of carboxydextran-coated 
supermagnetic iron oxide nanoparticles on c-Jun N-terminal kinase-mediated apoptosis in 
human macrophages. Biomaterials 31, 5063-5071. 
 
Luo X, Li W, Bird N, Chin SW, Hill NA, Johnson AG. (2007). On the mechanical behaviour 
of the human biliary system. World Journal of Gastroenterology 13, 1384-1392. 
252 
 
Ma LL, Zhao JF, Wang J, Liu J, Duan YM, Liu HT, Li N, Yan JY, Ruan J, Wang H, Hing 
SF. (2009). The acute liver injury in mice caused by Nano-Anatase TiO2. Nanoscle research 
Letters 4, 1275-1285. 
 
Madolenova Z, Bilanicova D, Pojana G, Fjellsbo LM, Hudecova A, Hasplove K, Marcomini, 
A, Dusinska M. (2012). Impact of agglomeration and different dispersions of titanium 
dioxide nanoparticles on the human related in vitro cytotoxicity and genotoxicity. Journal of 
Environmental Monitoring 14, 455-464. 
 
Mailander V, Landfester K. (2009). Interaction of nanoparticles with cells. 
Biomacromolecules 10, 2379-2400. 
 
Mamalis AG. (2006). Recent advances in nanotechnology. Journal of Materials and 
Processing Technology 181, 52-58. 
 
Martindale JL, Holbrook NJ. (2002). Cellular response to oxidative stress: Signalling for 
suicide and survival. Journal of Cellular Physiology 192, 1-15. 
 
Matsumoto K, Fukuda N, Abe M, Fujita T. (2010). Dendritic cells and macrophages in 
kidney disease. Clinical and Experimental Nephrology 14, 1-11.  
 
Maynard MA. (2007). Nanotechnology: The next big thing, or much ado about nothing? The 
Annals of Occupational Hygiene 51, 1-12. 
 
Mazzola L. (2003). Commercialising nanotechnology. Nature Biotechnology 21, 1137-1143. 
 
McCormack TJ, Clark RJ, Dang MKM, Ma GB, Kelly JA, Veinot JGC, Goss GG. (2012). 
Inhibition of enzyme activity by nanomaterials: Potential and implications for nanotoxicity 
testing. Nanotoxicology 6, 514-525. 
 
McDevitt MR, Chattopadhyay D, Jaggi JS, Finn RD, ZanzonicoPB, Villa C, Rey D, 
Mendenhall J, Batt CA, Njardarson JT, Schienberg DA. (2007). PET imaging of soluble 
Yttrium-86-labelled Carbon nanotubes in mice. PLoS ONE 2, e907. 
 
253 
 
McIntyre TM. (2012). Bioactive activity truncated phospholipids in inflammation and 
apoptosis: Formation, targets and inactivation. Biochimica et biophysica acta  1818, 2456-
2464. 
 
McWilliam S, Riorden A. (2010). How to use: C- reactive protein. Archives of disease in 
childhood 95, 55-58. 
 
Meena R, Paulraj R. (2012). Oxidative stress mediated cytotoxicity of TiO2 nano anatse in 
liver and kidney of Wister rats. Toxicological and Environmental Chemistry 94, 146-163. 
 
Miller TJ, Knapton A, Adeyemo O, Noory LS, Weaver JL, Hanig JP, Honchel R, Zhang J, 
Espandiari P, Benedick MF, Umbreit TH, Tomazic-Jezic VJ, Sadrieh N. (2007). Toxicology 
of Titanium dioxide (TiO2) nanoparticles: in vitro and in vivo evaluation of macrophage 
uptake of TiO2. The Journal of the Federation of American Societies for Experimental 
Biology 6, 812-814. 
 
Mingoia RT, Nabb DL, Yang CH, Han X. (2007). Primary culture of rat hepatocytes in 96 
well plates: Effects of extracellular matrix configuration on cytochrome P450 enzyme 
activity and inducibility and its application in vitro cytotoxicity screening. Toxicology in 
vitro 21: 165-173. 
 
Mitchell LA, Gao J, Wal RV, Gigliotti A, Burchiel SW, McDonald JD. (2007). Pulmonary 
and systemic immune response to inhaled multi-walled carbon nanotubes. Toxicological 
Sciences 10, 203-214. 
 
Mocellin S, Panelli MC, Wang E, Nagorsen D, Marincola FM. (2004). The dual role of IL10. 
Trends in Immunology 24, 36-43. 
 
Moore KW, Malefyt R, Coffman RL, O’Garra A. (2001). Interluekin-10 and the interluekin-
10 receptor. Annual Review of Immunology 19, 683-765. 
 
 
 
254 
 
Monteiller C, Tran L, MacNee W, Faux S, Jones A, Miller B, Donaldson K. (2007). The pro-
inflammatory effects of low toxicity low solubility particles, nanoparticles and fine particles, 
on epithelial cells in vitro: the role of surface area. Occupational and Environmental 
Medicine 64: 609-615. 
 
Montes-Burgos I, Walcyzk D, Hole P, Smith J, Lynch I, Dawaon K. (2010). Characterisation 
of nanoparticle size and state prior to nanotoxicological studies. Journal of Nanoparticle 
Research 12, 47-53.  
 
Morris SM. (2002). Regulation of enzymes of the urea cycle and arginine metabolism. 
Annual Review of Nutrition 22, 87–105. 
 
Mossman B, Landersman J. (1983). Importance of oxygen free radicals in asbestos-induced 
injury to airway epithelial cells. Chest 83, 50-51. 
 
Mossman B, Marsh J, Shatos M. (1986). Alteration of superoxide dismutase activity in 
tracheal epithelial cells by asbestos and inhibition of cytotixicity by anti-oxidants. Laboratory 
Investigation 54, 204-212. 
 
Muhlfeld C, Gehr P, Rothen-Rutishauser B. (2008). Translocation and cellular entering 
mechanisms of nanoparticles in the respiratory tract. Swiss Medical Weekly 138, 387-391. 
 
Muller RH, Keck CM. (2004). Drug delivery to the brain – realisation by novel drug carriers. 
Journal of Neuroscience and nanotechnology 207, 221-231. 
 
Murphy FA, Schinwald A, Poland CA, Donaldson K. (2012). The mechanism of pleural 
inflammation by long carbon nanotubes: interaction of long fibres with macrophages 
stimulates them to amplify pro-inflammatory responses in mesothelial cells, Particle and 
Fibre Toxicology DOI. 10.1186/1743-8977-9-8. 
 
Murr LE, Bang JJ, Esquivel PA, Lopez DA. (2004). Carbon nanotubes, nanocrystal forms, 
and complex nanoparticle aggregates in common fuel gas combustion sources and ambient 
air. Journal of Nanoparticle Research 6, 241-251. 
 
255 
 
Nafee N, Schneider M, Schaefer UF, Lehr C. (2009). Relevance of the colloidal stability of 
chitosan/ PLGA nanoparticles on their cytotoxicity profile. Pharmaceutical Nanotechnology 
381, 130-139. 
 
Nagayama S, Ogawara K, Fukuoka Y, Higaki K, Kimura T. (2001). Time-dependent changes 
in opsonin amount associated on nanoparticles alter their hepatic uptake characteristics. 
International Journal of Pharmaceutics 342, 215-221.  
 
Nalabotu SK, Madhukar BK, Triest WE, Ma JY, Manne NDPK, Katta A, Addagarla HS, 
Rice KM, Blough ER. (2011). Intratracheal instillation of cerium oxide nanoparticles induces 
hepatic toxicity in Sprague-Dawley rats. International Journal of Nanomedicine 6, 2327-
2335. 
 
Nel A, Xia T, Madler L, Li N. (2006). Toxic potential of materials at the nanolevel. Science 
311, 622-627. 
 
Nemeth E, Baird AW, O’Farrelly C. (2009). Microanatomy of the liver immune system. 
Seminars in Immunopathology 31, 333-343. 
 
Nemmer A, Vanibilleion H, Hoylaerts MF, Hoet PH, Verbruggen A, Nemery A. (2001). 
Passage of intratracheally instilled ultrafine particles from the lung into the systemic 
circulation in hamster. American Journal of Respiratory and Critical Care Medicine 164, 
1665-1668. 
 
Niebel W, Walkenbach K, Beduneau A, Pellequer Y, Lamprecht A. (2012). Nanopraticle-
based clodronate delivery mitigates murine experimental colitis. Journal of Controlled 
Release 160, 659-665.  
 
Nohl H, Gille L, Kozlov A, Staniek K. (2003). Are mitochondria a spontaneous and 
permanent source of reactive oxygen species? Redox Report 8, 135-141. 
 
Nohynek GJ, Dufour EK, Roberts MS. (2008). Nanotechnology, Cosmetics and the Skin: Is 
There a Health Risk? Skin Pharmacology and Physiology 21, 136-149. 
 
256 
 
Oberdorster G, Feerin J, Finklestein J, Wade P, Corson N. (1990). Increased pulmonary 
toxicity of ultrafine particles? Lung lavage studies. Journal of Aerosol Sciences 21, 384-387. 
 
Oberdorster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, Carter J, 
Karn B, Kreyling W, Lai D, Olin S, Monteiro-Riviere N, Warheit D, Yang H. (2005). 
Principles for characterizing the potential human health effects from exposure to 
nanomaterials: elements of a screening strategy. Particle and Fibre Toxicology 2, DOI: 
10.1186/1743-8977-2-8. 
 
Oberdorster G, Stone V, Donaldson K. (2007). Toxicology of nanoparticles: A historical 
perspective. Nanotoxicology 1, 2-25. 
 
Ola MS, Nawaz M, Ahsan H. (2011). Role of Bcl-2 family proteins in the regulation of 
apoptosis. Molecular and Cellular Biochemistry 351, 41-58. 
 
Olde Damink S, Deutz N, Dejong C, Soeters PB, Jalan R. (2002). Interorgan ammonia 
metabolism in liver failure. Neurochemistry International 41, 177–188. 
 
Park EJ, Park K. (2009). Oxidative stress and pro-inflammatory responses induced by silica 
nanoparticles in vivo and in vitro. Toxicology Letters 184, 18-25. 
 
Park EJ, Yi J, Kim Y, Choi K, Park K. (2010). Silver nanoparticles induce cytotoxicity by a 
Trojan-horse type mechanism. Toxicology In Vitro 24, 872–878. 
 
Park MVDZ, Neigh AM, Vermeulen JP, de la Fonteyne LJJ, Verharen HW, Briede JJ, van 
Loveren H, de Jong  WH. (2011). The effects of particle size on the cytotoxicity, 
inflammation, developmental toxicity and genotoxicity of silver nanoparticles. Biomaterials- 
ahead of press. 
 
Parone PA, Martinou JJC. (2002). Mitochondria: regulating the inevitable. Biochimie 84, 
105-111. 
 
Passagne I, Morille M, Rousset M, Pujalte I, L’azou B. (2012). Implication of oxidative stress 
in size-dependant toxicity of silica nanoparticles in kidney cells. Toxicology 299, 112-124. 
257 
 
Patlolla A, McGinnis B, Tchounwou P. (2011). Biochemical and histopathological evaluation 
of functionalized single-walled carbon nanotubes in Swiss-Webster mice. Journal of Applied 
Toxicology 31, 75-83. 
 
Peters TJ. (1996). All about albumin. Academic Press San Diego P7. 
 
Petkovic J, Zegura B, Stevanovic M, Drnovsek N, Uskokovic D, Novak S, Filipic M. (2011). 
DNA damage and alterations in expression of DNA damage responsive genes induced by 
TiO2 nanoparticles in human hepatoma HepG2 cells. Nanotoxicology 5, 341-353. 
 
Piao MJ, Kang KA, Lee IK, Kim HS, Kim S, Choi JY, Choi J, Hyun JW. (2011). Silver 
nanoparticles induce oxidative cell damage in human liver cells through inhibition of reduced 
glutathione and induction of mitochondrial involved apoptosis. Toxicology Letters 201, 92-
100. 
 
Pichardo S, Gutierrez-Praena D, Puerto M, Sanchez E, Grilo A, Camean AM, Jos A. (2012). 
Oxidative stress responses to carboxylic acid functionalized single wall carbon nanotubes on 
the human intestinal cell line Caco-2. Toxicology in vitro – ahead of print. 
 
Pisanic II TR, Blackwell JD, Shubayev VI, Finones RR, Jin S. (2007). Nanotoxicity of iron 
oxide nanoparticle internalization in growing neurons. Biomaterials 28, 2572-2581. 
 
Poland CA, Duffin R, Kinloch I, Maynard A, Wallace WA, Seaton A, Stone V, Brown S, 
Macnee W, Donaldson K. (2008). Carbon nanotubes introduced into the abdominal cavity of 
mice show asbestos-like pathogenicity in a pilot study. Nature nanotechnology 3, 423-428. 
 
Poli V, Cortese R. (1989). Interleukin 6 induces a liver specific nuclear protein that binds to 
the promoter of acute phase genes. Proceeding of the National Academy of Sciences 86, 
8202-8206. 
 
Pujalté I, Passagne I, Brouillaud B, Tréguer M, Durand E, Ohayon-Courtès C, L'Azou B. 
(2011). Cytotoxicity and oxidative stress induced by different metallic nanoparticles on 
human kidney cells. Particle and Fibre Toxicology 8, 10-26. 
 
258 
 
Puthothu B, Krueger M, Heinze J, Forster J, Heinzmann A. (2006). Impact of IL8 and IL8-
receptor alpha polymorphisms on the genetics of bronchial asthma and severe RSV 
infections. Clinical and Molecular Allergy 4, 2-8.  
 
Quinlan GJ, Martin GS, Evans TW. (2005). Albumin: biochemical properties and therapeutic 
potential. Hepatology 41, 1211–1219. 
 
Racine-Samson L, Scoazec JY, D’Errico A, Fiorentino M, Christa L, Moreau A, Roda C, 
Grigioni WF, Feldman G. (1996). The metabolic organization of the adult human liver: a 
comparative study of normal, fibrotic, and cirrhotic liver tissue. Hepatology 24, 104–113. 
 
Ramaiah SK, Jaeschke H. (2007). Role of neutrophils in the pathogenesis of acute 
inflammatory liver injury. Toxicologic Pathology 35, 456-766. 
 
Raven PH, Johnson GB, Losos JB, Mason KA, Singer SR. (2008). Biology. Eighth edition - 
McGraw Hill International, 1030. 
 
Ravenzwaay B, Leibold E. (2004). A comparison between in vitro rat and human and in vivo 
skin penetration studies. Human and Experimental Toxicology 23, 412-430.  
 
Reddy ARN, Reddy YN, Krishna DR, Himabindu V. (2010). Multi walled carbon nanotubes 
induce oxidative stress and cytotoxicity in human embryonic kidney (HEK293) cells. 
Toxicology 272, 11-16. 
 
Reich PB, Hungate BA, Luo YQ. (2006). Carbon-nitrogen interactions in terrestrial 
ecosystems in response to rising atmospheric carbon dioxide. Annual review of Ecology 
Evolution and Systematics 37, 611-636. 
 
Rhee SG, Chang TS, Jeong W, Kang D. (2010). Methods for detection and measurement of 
Hydrogen peroxide inside and outside of cells. Molecules and Cells 29, 539-549. 
 
Robblegg E, Frohlich E, Meindl C, Teubl B, Zaversky M, Zimmer A. (2012). Evaluation of a 
physiological in vitro systems to study the transport of nanoparticles through the buccal 
mucosa. Nanotoxicology 6, 399-413. 
259 
 
Roberts M, Reiss M, Monger G. (2000). Advanced Biology. Nelson Publishing, 280. 
 
Roche M, Rondeau P, Singh NR, Tarnus E, Bourdon E. (2008). The antioxidant properties of 
serum albumin. FEBS Letters 582, 1783-1787. 
 
Roduner E. (2006). Size matters: Why nanomaterials are different. Chemical Society 
Reviews 35, 583-592.  
 
Roselli M, Finamore A, Garaguso I, Britti MS, Mengheri E. (2003). Zinc oxide protects 
cultured enterocytes from the damage induced by Escherichia coli. Journal of Nutrition 133, 
4077-4082. 
 
Rothen-Rutishauser BM, Schurch S, Haenni B, Kapp N, Gehr P. (2006). Interaction of fine 
particles and nanoparticles with red blood cells visualised with advanced microscopic 
techniques. Environmental Science and Technology 40, 4353-4359. 
 
Saad B, Frei K, Scholl FA, Fontana A, Maier P. (1995). Hepatocyte-derived interleukin-6 and 
tumor-necrosis factor alpha mediate the lipopolysaccharide-induced acute-phase response and 
nitric oxide release by cultured rat hepatocytes. European Journal of Chemistry 229, 349-355. 
 
Sadauskas E, Danscher G, Stoltenberg M, Vogel U, Larsen A, Wallin H. (2009a). Protracted 
elimination of gold nanoparticles from mouse liver. Nanomedicine 5, 162-169. 
 
Sadauskas E, Jacobson NR, Danscher G, Soltenberg M, Larsen A, Kreyling W, Wallin H. 
(2009b). Bio-disruption of gold nanoparticles in mouse lung following intratracheal 
instillation. Chemistry Central Journal 3: 16-23. 
 
Sadauskas E, Wallin H, Stoltenberg M, Vogel U, Doering P, Larsen A, Danscher G. (2007). 
Kupffer cells are central in the removal of nanoparticles from the organism. Particle and 
Fibre Toxicology 4, 10-17. 
 
Sahi J, Grepper S, Smith C. (2010). Hepatocytes as a tool in drug metabolism, transport and 
safety evaluations in drug discovery. Current Drug Discovery Technologies 7, 188-198. 
 
260 
 
Sahu A, Lambris JD. (2002). Structure and biology of complent protein C3, a connecting link 
between the innate and acquired immunity. Immunological reviews 180, 35-48. 
 
Saini S, Edelman PR, Sharma P, Li W, Mayo-Smith W, Slater GJ, Eisenberg PJ, Hahn PF. 
(1995). Blood-pool MR contrast material for detection and characterisation of focal hepatic 
lesions: initial clinical experience with ultra small superparamagnetic iron oxide (AMI-227). 
American Journal of Roentgenology 164, 1147-1152. 
 
Salomon JJ, Ehrhardt C. (2011). Nanoparticles attenuate P-glycoprotein/MDR1 function in 
A549 human alveolar epithelial cells. European Journal of Pharmaceutics and 
Biopharmaceutics 77, 392-397. 
 
Sanders S, Barnett A, Correa-Valez I, Coulthard M, Doust J. (2008). Systematic review of the 
diagnostic accuracy of C reactive protein to detect bacterial infection in non hospitalized 
infants and children with fever. The Journal of Paediatrics 153, 570-574. 
 
Sandhiya S, Dkhar SA, Surendiran A. (2009). Emerging trends of nanomedicine - an 
overview. Fundamental and Clinical Pharmacology 23, 263-269. 
 
Sands JM. (2003). Mammalian urea transporters. Annual Review of Physiology 65, 543–566. 
Schubert D, Dargusch R, Raitano J, Chan SW. (2006). Cerium and Yttrium Oxide 
nanoparticles are neuroprotective. Biochemical and Biophysical Research Communications 
342, 86-91.  
 
Scott A, Khan KM, Cook JL, Duronio V. (2004). What is Inflammation? Are we ready to 
move beyond Celsius? British Journal of Sports Medicine 38, 248-249. 
 
Seki S, Nakashima H, Nakashima M, Kinoshita M. (2011). Antitumor immunity produced by 
the liver Kupffer cells, NK cells, NKT cells, and CD8 CD122 T cells. Clinical and 
Developmental Immunology 2011, 868345. 
 
Semmler-Behnke M, Wolfgang KG, Lipka J, Fertsch S, Wenk A, Takeneka S, Schmid G, 
Brandau W. (2008). Bio-distribution of 1.4 and 18 nm gold particles in rats. Small 12, 2108-
2111. 
261 
 
Senft AP, Dalton TP, Shertzer HG. (2000). Determining Glutathione and Glutathione 
Disulfide using the fluorescence probe o-Phthalaldehyde. Analytical Biochemistry 280, 80-
86. 
 
Sharma V, Anderson D, Dhawan A. (2011). Zinc Oxide Nanoparticles induce Oxidative 
stress and Genotoxicity in Human Liver Cells (HepG2). Journal of Biomedical 
Nanotechnology 7, 98-99. 
 
Sharma V, Anderson D, Dhawan A. (2012a). Zinc oxide nanoparticles induce oxidative DNA 
damage and ROS-triggered mitochondria mediated apoptosis in human liver cells (HepG2). 
Apoptosis 17, 852-870. 
 
Sharma V, Singh P, Pandey AK, Dhawan A. (2012b). Induction of oxidative stress, DNA 
damage and apoptosis in mouse liver after sub-acute oral exposure to zinc oxide 
nanoparticles. Mutation Research - Genetic Toxicology and Environmental Mutagenesis 745, 
84-91. 
 
Shi XL, Gu JY, Han B, Xu HY, Fang LA, Ding YT. (2010a). Magnetically labelled 
mesenchymal stem cells after autologous transplantation into acutely injured liver. World 
Journal of Gastroenterology 16, 3674-3679.  
 
Shi Y, Zhang JH, Jiang M, Zhu LH, Tan HQ, Lu B. (2010b). Synergistic genotoxicity caused 
by low concentration of Titanium dioxide nanoparticles and p – DDT in human hepatocytes. 
Environmental and Molecular Mutagenesis 51, 192-204. 
 
Shing CM, Adams MJ, Fassett RG, Coombes JS. (2011). Nutritional compounds influence 
tissue factor expression and inflammation of chronic kidney patients in vitro. Nutrition 27, 
967-972. 
 
Shukla RK, Sharma V, Pandey AK, Singh S, Sultana S, Dhawan A. (2011). ROS-mediated 
genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells. Toxicology 
In Vitro 25, 231-241. 
 
262 
 
Shono S, Habu Y, Nakashima M, Sato A, Nakashima H, Miyazaki H, Kinoshita M, 
Tsumatori M, Shinomiya N, Seki S. (2011). The immunological outcome of enhanced 
function of mouse liver lymphocytes and Kupffer cells by high fat and high cholesterol diet. 
Shock 36, 484-493. 
 
Shvedova AA, Kisin ER, Mercer R, Murray AR, Johnson VJ, Potapovich AI, Tyurina YY, 
Gorelik O, Arepalli S, Schwegler-Berry D, Hubbs AF, Antonini J, Evans DE, Ku BK, 
Ramsey D, Maynard A, Kagan VE, Castranova V, Baron P. (2005). Unusual inflammatory 
and fibrogenic pulmonary responses to single walled carbon nanotubes in mice. American 
Journal of Physiology 289, 698-708. 
 
Shvedova AA, Pietroiusti A, Fadeel B, Kagan VE. (2012). Mechanism of carbon nanotube-
induced toxicity: Focus on oxidative stress. Toxicology and Applied Pharmacology – ahead 
of press. 
 
Simon A, Gouget B, Mayne M, Herlin N, Reynaud C, Degrouard J, Carriere M. (2007). In 
vitro investigation of TiO2, Al2O3, Au nanoparticles and multi-walled carbon nanotubes cyto- 
and genotoxicity on lung, kidney cells and hepatocytes. Toxicology Letters 172, 36-36. 
 
Simon A, Reynaud C, Mayne M, Herlin N, Desqueyroux H, Gouget B, Carriere M. (2008). 
Cytotoxicity of metal oxide nanoparticles and multiwalled carbon nanotubes to lung, kidney 
and liver cells. Metal ions in Biology and Medicine 10, 310-314.  
 
Singh R, Pantarotto D, Lacerda L, Pastorin G, Klumpp G, Parto M, Bianco A, Kostarelos K. 
(2006). Tissue bio-distribution and blood clearance rates of intravenously administered 
carbon nanotube radiotracers. Proceedings of the National Academy of Sciences 103, 3357-
3362. 
 
Song WH, Zhang JY, Guo J, Zhang JH, Ding F, Li LY, Sun ZT. (2010). Role of dissolved 
zinc ion and reactive oxygen species in cytotoxicity of ZnO nanoparticles. Toxicology Letters 
199, 389-397. 
 
Soto K, Garza KM, Murr LE. (2007). Cytotoxic effects of aggregated nanomaterials. Acta 
Biomaterialia 3, 351-358. 
263 
 
Speit G, Schutz P, Hoffmann H. (2004). Sensitivity of FPG protein towards alkylation 
damage in the comet assay. Toxicology Letters 146, 151-158. 
 
Smith PJ, Giroud M, Wiggins HL, Gower F, Thorley JA, Stolpe B, Mazzolini J, Dyson RJ, 
Rappoport JZ. (2012). Cellular entry of nanoparticles via serum sensitive clathrin-mediated 
endocytosis and plasma membrane permeabilization. International Journal of Nanomedicine 
7, 2045-2055. 
 
Stern ST, Adiseshaiah PP, Crist RM. (2012). Autophagy and lysosomal dysfunction as 
emerging mechanisms of nanomaterial toxicity. Particle and Fibre Toxicology DOI: 
10.1186/1743-8977-9-20. 
 
Szalai AJ, Nataf S, Hu XZ, Barnum SR. (2002). Experimental allergic encephalomyelitis is 
inhibited in transgenic mice expressing human C reactive protein. The Journal of 
Immunology 168, 5792-5797. 
 
Takenaka S, Karg E, Moller W, Roth C, Ziesenis A, Heinzmann U, Scharamel P, Heyder J. 
(2001). Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. 
Environmental Health Perspectives 4, 547-551. 
 
Teigs G, Lohse AW. (2009). Immune tolerance: What is unique about the liver. Journal of 
Autoimmunity 34, 1-6. 
 
Teixeira J., Soares P, Benfieto S, Gasper A, Garrido J, Murphy MP, Borges F. (2012). 
Rational discovery and development of mitochondria-targeted antioxidant based on cinnamic 
acid scaffold. Free Radical Research 46, 600-611. 
 
Teow Y, Asharani PV, Hande MP, Valiyaveettil S. (2011). Health impact and safety 
engineered nanomaterials. Chemical Communications 47, 7025-7038. 
 
Tetley TD. (2007). Health effects of nanomaterials. Bionanotechnology 35, 527-531. 
 
Tredicucci A. (2009). Quantum dots: Long life in zero dimensions. Nature Materials 8, 775-
776. 
264 
 
Tsuchiya T, Oguri I, Yamakoshi YN, Miyata N. (1996). Novel harmful effects of 60 fullerene 
on mouse embryos in vitro and in vivo. FEBS letters 393, 139-145. 
 
Tsuji JS, Maynard AD, Howard PC, James JT, Lam CW, Warheit DB, Santamaria AB. 
(2006). Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of 
nanoparticles. Toxicological Sciences 89, 42-50. 
 
Vermeire S, Van Assche G, Rutgeerts P. (2005). The role of C-reactive protein as an 
inflammatory marker in gastrointestinal diseases. Nature Clinical Practice – Gastroenterology 
and Hepatology 2, 580-586. 
 
Villar E, Polkinghorne KR, Chang SH, Chadban SJ, McDonald SP. (2009). Effect of type 2 
diabetes on mortality risk associated with end-stage kidney disease. Diabetologia 52, 2536-
2541. 
 
Villeneuve JP, Pichette V. (2004). Cytochrome P450 and the liver diseases. Current Drug 
Metabolism 5: 273-282. 
 
vom Dahl S, Hallbrucker C, Lang F,  Gerok W, Häussinger D. (1991). Regulation of liver 
cell volume and proteolysis by glucagon and insulin. Biochemical Journal 278, 771–777. 
 
Wagner V, Dullaart A, Bock AK, Zweck A. (2006). The emerging nanomedicine landscape. 
Nature Biotechnology 24, 1211-1217. 
 
Walter PB, Fung EB, Killilea DW, Jiang Q, Hudes M, Madden J, Porter J, Evans P, 
Vichinsky E, Harmatz P. (2006). Oxidative stress and inflammation in iron-overloaded 
patients with beta-thalassaemia or sickle cell disease. British Journal of Haematology 135, 
254–263. 
 
Wang F, Gao F, Lan M, Yuan H, Huang Y, Liu J. (2009). Oxidative stress contributes to 
silica nanoparticle induced cytotoxicity in human embryonic kidney cells. Toxicology in vitro 
23, 808-815. 
265 
 
Wang J, Li N, Zheng L, Wang SS, Wang Y, Zhao XY, Duan YM, Cui YL, Zhou M, Cai JW, 
Gong SJ, Wang H, Hong FS. (2011a). P38-Nrf-2 signalling pathway of oxidative stress in 
mice caused by nanoparticulate TiO2. Biological Trace Element Research 140, 186-197. 
 
Wang J, Zhou G, Chen C, Yu H, Wang T, Ma Y, Jia G, Gao Y, Li B, Sun J, Li Y, Jiao F, 
Zhao Y, Chai Z. (2007a). Acute toxicity and bio-distribution of different sized titanium 
dioxide particles in mice after oral administration. Toxicology Letters 168, 17-185.  
 
Wang JJ, Sanderson BJ, Wang H. (2007b). Cyto- and genotoxicity of ultrafine TiO2 particles 
in cultured human lymphoblastoid cells. Mutation Research 628, 99-106. 
 
Wang YG, Aker WG, Hwang HM, Yedjou CG, Yu HT, Tchounwou PB. (2011b). A study of 
the mechanism of in vitro cytotoxicity of metal oxide nanoparticles using catfish primary 
heaptocytes and human HepG2 cells. Science of the Total Environment 409, 4753-4762. 
 
Wanninger J, Neumeier M, Weigert J, Bauer S, Weiss TS, Schaffler A, Krempl C, Bleyl C, 
Aslanidis C, Scholmerich J, Buechler C. (2009). Adiponectin stimulated CXCL8 release in 
primary human hepatocytes is regulated by ERK1/ERK2, p38 MAPK, NF kappa B and 
STAT 3 signalling pathways. American Journal of Physiology-Gastrointestinal and liver 
Physiology 297, 611-618. 
 
Westerink WMA, Schoonen WGEJ. (2007). Cytochrome P450 enzyme levels in HepG2 cells 
and cryopreserved primary human hepatocytes and their induction in HepG2 cells. 
Toxicology in vitro 21: 1581-1591. 
 
Whelan RS, Kaplinskiy V, Kitsis RN. (2010). Cell death in pathogenesis of heart disease: 
mechanisms and significance. Annual Review of Physiology 72, 19-44. 
 
Whitby KT, Clark WE, Marple VA, Sverdrup GM, Sem GJ, Willeke K, Liu BYH, Pui DYH. 
(1975). Characterisation of California aerosols size distribution of freeway aerosol. 
Atmospheric Environment 9, 463-482. 
 
266 
 
Wick P, Manser P, Limbach LK, Dettlaff-Weglikowska U, Jrumeich F, Roth S, Stark WJ, 
Bruinink A. (2007). The degree and kind of agglomeration affect carbon nanotube 
cytotoxicity. Toxicology Letters 168, 121-131. 
 
Wildgoose GG, Wilkins SJ, Williams GR, France RR, Carnahan DL, Jiang L, Jones TG, 
Compton RG. (2005). Graphite powder and multi-walled carbon nanotubes chemically 
modified with 4-nitrobenzylamine. Chemphyschem 6, 352-362. 
 
Wilklund SJ, Agurelli E. (2003). Aspects of design and statistical analysis in the Comet 
assay. Mutagenesis 18, 167-175. 
 
Wong SWY, Leung PTY, Djurisic  AB, Leung KMY. (2010). Toxicities of nano zinc oxide 
of five marine organisms: influences of aggregate sizes and ion solubility. Analytical and 
Bioanalytical Chemistry 396, 609-618. 
 
Wongkajornslip A, Sa-Ngiamsuntorn K, Hongeng S. (2012). Development of immortalized 
Hepatocyte-like cells from hMSCs. Methods in Molecular Biology 826, 73-87. 
 
Woodrow Wilson website - accessed 23-7-2012.  
(http://www.nanotechproject.org/inventories/consumer/browse/products/)  
 
World Health Organization, 2012. The Global UV project - acessed 6-7-2011. 
(http://www.who.int/uv/publications/en/Intersunguide.pdf) 
 
Wu HX, Liu G, Zhuang YM, Wu DM, Zhang HQ, Yang H, Hu H, Yang SP. (2011). The 
behaviour after intravenous injection in mice of multiwalled carbon nanotube/Fe3O4 hybrid 
MRI contrast agents. Biomaterials 21, 4867-4876. 
 
Xia T, Kovochich M, Brant J, Hotze M, Sempf J, Oberley T, Sioutas C, Yeh JI, Wiesner MR, 
Nel AE. (2006). Comparison of the abilities of ambient and manufactured nanoparticles to 
induce cellular toxicity according to an oxidative stress paradigm. Nano Letters 6, 1794-
1807. 
267 
 
Xia T, Kovochich M, Liong M, Madler M, Gilbert B, Shi H, Yeh JI, Zink JI, Nel AE. (2008). 
Comparison of mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on 
dissolution and oxidative stress properties. American Chemical Society 10, 2121-2134. 
 
Xiong R, Lu W, Yue P, Xu R, Li J, Chen T, Wang P. (2008). Distribution of an intravenous 
injectable nimodipine nano-suspension in mice. The Journal of Pharmacy and Pharmacology 
60, 1155-1159. 
 
Yamanaka YJ, Leong KW. (2008). Enginnering strategies to enhance nanoparticle-mediated 
oral delivery. Journal of Biomaterials Science 19, 1549-1570. 
 
Yang J, Srinivasan A, Sun Y, Mrazek J, Shu Z, Kickhoefer VA, Rome LH. (2012). Vault 
nanoparticles engineered with the protein transduction domain, TAT48, enhancer cellular 
uptake. Integrative Biology: quantitative biosciences from nano to micro – ahead of print. 
 
Yang L, Froio RM, Sciuto TE, Dvorak AM, Alon R, Luscinskas FW. (2005). ICAM-1 
regulates neutrophil adhesion and transcellular migration of TNF-α activated vascular 
endothelium under flow. Blood 15, 584-592. 
 
Yokel RA, MacPhail RC. (2011). Engineered nanomaterials: exposures, hazards and risk 
preventation. Occupational Medicine and Toxicology 6, 7. 
 
Yue ZG, Wei W, Lv PP, Yue H, Wang LY, Su ZG, Ma GH. (2011). Surface charges affects 
cellular uptake trafficking and intracellular of chitosan-based nanoparticles. 
Biomacromolecules 12, 2440-2446. 
 
Zamjahn JB, Quinton LJ, Mack JC, Frevert CW, Nelson S, Bagby GJ. (2011). Differential 
flux of macrophage inflammatory protein-2 and cytokine induced neutrophil chemoattractant 
from the lung after intrapulmonary delivery. American Journal of Physiology – Lung cellular 
and Molecular Physiology 301, 568-574.   
 
Zhang LW, Yu WW, Colvin VL, Monteiro-Riviere NA. (2008). Biological interactions of 
quantum dot nanoparticles in skin and in human epidermal keratinocytes. Toxicology and 
Applied Pharmacology 228, 200-211. 
268 
 
Zhao F, Zhao Y, Liu Y, Chang XL, Chen CY, Zhao YL. (2011). Cellular uptake, intracellular 
trafficking and cytotoxicity of nanomaterials. Small 7, 1322-1337. 
 
Zheng XO, Wu R, Chen YG. (2011). Effects of ZnO nanoparticles on wastewater biological 
nitrogen and phosphorous removal. Environmental Science and Technology 45, 2826-2832. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
269 
 
 
 
 
 
 
 
 
 
 
Appendix 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
270 
 
A1 Surface functionalisation of titanium dioxide 
 
Briefly 300 g of 10 nm-sized rutile TiO2 (NRCWE 001) was suspended in 1.5 l of 20% 
methanol in water. The suspension was stirred and 250 ml of 3-aminopropyltriethoxysilane 
(purity 99%, Sigma-Aldrich, Denmark) was added slowly. The reaction was sonicated with a 
Branson Sonifier S-450D (Branson, USA) mounted with a disruptor horn, on ice at full power 
for 1 hr with 10 s on and 10 s off cycles. The suspension was stirred for 24 hr at room 
temperature. The titanium dioxide product was collected and was washed sequentially with 
100%, 50%, 20%, 10% and 0% methanol in water by centrifugation for 30 mins at 35000 g. 
The material was dried for 2 days at 110°C. The recovery product was 267 g of amino-TiO2. 
 
A total of 136 g of amino-TiO2 (NRCWE 002) was suspended in 200 ml dry of toluene in a 
three-necked round bottom flask. This was followed by the addition of 100 g of succinic 
anhydride (99%) (Sigma-Aldrich, Denmark) in 200 ml of dry tetrahydrofuran was added 
slowly and the reaction was sonicated. The reaction was refluxed for 36 hr and the product 
was collected on a fine porosity glass filter funnel under a slight negative pressure. The 
product was washed by centrifugation (see above) twice in 100% and once in each 50% 
methanol, 0.1 M sodium acetate and twice in water. It was dried at 80°C for 2 days. The 
recovery amount was 90 g.  
 
The zeta potential of the amino-TiO2 was +35 mV and of the carboxy-TiO2 was -29 mV at 
pH 7.4 in water (Malvern Nano ZetaSizer, Malvern Instruments, UK) and it was stable over 
24 hr. 
 
 
 
 
 
 
 
 
 
 
 
271 
 
A2 Nanomaterial characterisation  
 
Briefly, phase compositions and average crystallites sizes were determined from powder X-
ray diffractograms obtained at room temperature (25°C) using a Bruker D8 Advanced 
diffractometer in reflection mode with Bragg-Brentano geometry. A sealed Cu X-ray tube 
was run at 40kV and 40 mA, wavelength Cu Kα1 1.5406 Å from a primary beam Ge 
monochromator, fixed divergence slit 0.2°, step size 0.02, step time 1 s step
-1
, linear PSD 
detector (Lynx-eye) with opening angle 3.3°. The sample holders used for the reflection data 
were either a standard sample holder containing an approximately 2 mm thick sample or a 
single Si sample holder. One NM 300 sample was measured as transmission in a capillary. 
The phases were identified by using the EVA 14.0 software from Bruker AXS (copyright 
1996-2007 Bruker AXS). The ratios and size were calculated using Topas 4.1 from Bruker 
(copyright 1999, 2008 Bruker AXS). 
 
The hydrodynamic size distributions of the NMs dispersed in biological media were 
determined in the 0.128 - 0.256 mg/ml concentration range (lower concentrations were too 
low for DLS measurements) by Dynamic Light Scattering (DLS) using a Nicomp Submicron 
Particle Sizer Autodilute
®
 Model 370 (Santa Barbara, USA). The employed instrument can 
automatically recognize, in the 0.5 - 6000 nm range, up to three size distributions of materials 
concurrently present through a patented software algorithm. No significant size differences 
were found at different concentration levels.  
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A3 HE oxidation 
 
The HK-2 cells were seeded in 12 well plates (10
4
 cells per cm
2
 in 1 ml of complete RPMI) 
and incubated for 48 hr at 37ºC and 5% CO2. Cells were exposed to the materials or controls 
for 4 hr at 37ºC, 5% CO2. The treatment was removed and the cells were washed with 
complete RPMI. Cells were then harvested with 0.05% trypsin/EDTA and centrifuged at 300 
g for 5 min before being re-suspended in complete RPMI without phenol red containing 1 
µM of dihydroethidium (HE) (Sigma, France) for 30 min at 37°C in the dark and analysed by 
CyAn ADP LX DakoCytomation cytometer (Beckman Coulter, France). Excitation and 
emission wavelengths were 488 and 620 nm respectively. Minimum of 10000 cells was 
analyzed after exclusion of cellular debris and NMs from the analysis by gating on the 620 
nm Log versus FS area graph.  
 
Hydroethidium is the chemically reduced form of the commonly used DNA intercalating dye 
ethidium bromide (Kalyanaraman., 2011). This reduced dye is therefore useful for detection 
of oxidative activities in viable intact cells. Only once it is internalized and dehydrogenated 
(oxidized) to ethidium, it can intercalate into DNA. Normally due to their compromised 
membranes, only dead cells are typically labelled by ethidium bromide when it selectively 
binds to DNA. However HE is a neutral probe and is able to penetrate the cell membrane of 
live cells, staining their cytoplasm blue as well as the chromatin/nucleus of living cells red. 
 
Dihydroethidium was used for the flow cytometric measurement of superoxide production. 
Dihydroethidium is rapidly oxidized to ethidium (a red fluorescent compound) by H2O2 (in 
the presence of peroxidase) and superoxide. Ethidium is trapped in the nucleus by 
intercalating into DNA, leading to an increase of ethidium fluorescence.  
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A4 Intratracheal instillation 
 
The mice were anesthetized using 4% isoflurane in an induction chamber. The anaesthesia 
was maintained using 2.5% isoflurane via an intubation aid (UNO BV, The Netherlands) 
during the intratracheal instillation as previously described (Sadauskas, et al., 2009b). A 
diode light was placed against the larynx, the tongue was pressed towards the lower jaw and 
the trachea was intubated using a 22 gauge with a shortened needle. A 50 µl suspension of 
the nanomaterials was instilled followed by 200 µl air. After the procedure the mice were 
transferred back to cages. Inter control mice were anaesthetised, but no instillation procedure 
was performed. Vehicle control mice received the dispersion media without nanomaterials 
(2% serum in MilliQ).  
 
The study set-up included three animals per group and a dose-range of 0, 1, 4, 8, 16, 32, 64 
and 128 µg/mouse of each NM. The animals were dissected 24 hr after instillation. The liver 
was then divided into five pieces.  For the analysis reported here, the middle lobe was frozen 
in liquid nitrogen for GSH depletion measurements (about 0.4 g of tissue).  
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A5 Flow cytometry 
 
Prior to fluorescence-associated cell sorting, the cells were fixed for 10 min in 4% 
paraformaldehyde and then washed in PBS. A CD163 Alexa-647-labelled antibody 
(MCA342A647) (AbD Serotec, UK) was used to detect Kupffer cells and a CD68-PE 
(MCA341PE) (AbD Serotec, UK) to detect non-resident macrophages and utilised as 
recommended by the manufacturer. 
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A6 Immunofluorescence 
 
To detect phagocytic Kupffer cells, 200 nm fluorescent polystyrene beads were added to the 
cell cultures for 2 hr, before being rinsed out. The cells were then fixed with PFA, 
permeabilised, blocked with 10% FCS in PBS and stained with a sheep anti rat albumin 
antibody (1:500) (A110-134A) (Bethyl Laboratories, UK) and an anti-sheep Alexa-568 
secondary antibody (1:1000) (Life Technologies, UK). Hoechst 33342 (Life Technologies, 
UK) was used as a nuclear stain. 
 
